Document
false203--12-31Q32019P.O. Box 4505, 201 Merritt 7Norwalk06851-1056CT00017704500000108772968-30000038500000000020.0060.00P3YP3Y22100000012700000000002300000044000000020P3Y0.500.50 0001770450 2019-01-01 2019-09-30 0001770450 xrx:XeroxCorporationMember 2019-01-01 2019-09-30 0001770450 2019-10-31 0001770450 2018-01-01 2018-09-30 0001770450 2019-07-01 2019-09-30 0001770450 2018-07-01 2018-09-30 0001770450 us-gaap:ServiceMember 2019-01-01 2019-09-30 0001770450 us-gaap:ProductMember 2019-07-01 2019-09-30 0001770450 us-gaap:FinancialServiceMember 2019-01-01 2019-09-30 0001770450 us-gaap:ServiceMember 2018-07-01 2018-09-30 0001770450 us-gaap:FinancialServiceMember 2018-07-01 2018-09-30 0001770450 us-gaap:ProductMember 2019-01-01 2019-09-30 0001770450 us-gaap:ProductMember 2018-01-01 2018-09-30 0001770450 us-gaap:FinancialServiceMember 2019-07-01 2019-09-30 0001770450 us-gaap:ProductMember 2018-07-01 2018-09-30 0001770450 us-gaap:ServiceMember 2018-01-01 2018-09-30 0001770450 us-gaap:ServiceMember 2019-07-01 2019-09-30 0001770450 us-gaap:FinancialServiceMember 2018-01-01 2018-09-30 0001770450 2019-09-30 0001770450 2018-12-31 0001770450 2018-09-30 0001770450 2019-06-30 0001770450 2017-12-31 0001770450 2018-06-30 0001770450 xrx:XeroxCorporationMember 2018-01-01 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:ServiceMember 2018-07-01 2018-09-30 0001770450 xrx:XeroxCorporationMember 2018-07-01 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:ProductMember 2019-07-01 2019-09-30 0001770450 xrx:XeroxCorporationMember 2019-07-01 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:ProductMember 2018-01-01 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:ServiceMember 2019-07-01 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:FinancialServiceMember 2018-01-01 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:ProductMember 2019-01-01 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:FinancialServiceMember 2018-07-01 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:ProductMember 2018-07-01 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:FinancialServiceMember 2019-01-01 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:ServiceMember 2019-01-01 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:ServiceMember 2018-01-01 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:FinancialServiceMember 2019-07-01 2019-09-30 0001770450 xrx:XeroxCorporationMember 2018-12-31 0001770450 xrx:XeroxCorporationMember 2019-09-30 0001770450 xrx:XeroxCorporationMember 2018-09-30 0001770450 xrx:XeroxCorporationMember 2018-06-30 0001770450 xrx:XeroxCorporationMember 2019-06-30 0001770450 xrx:XeroxCorporationMember 2017-12-31 0001770450 us-gaap:ServiceMember srt:RestatementAdjustmentMember 2018-01-01 2018-09-30 0001770450 us-gaap:ProductMember srt:ScenarioPreviouslyReportedMember 2018-01-01 2018-09-30 0001770450 us-gaap:ProductMember srt:RestatementAdjustmentMember 2018-01-01 2018-09-30 0001770450 us-gaap:ServiceMember srt:ScenarioPreviouslyReportedMember 2018-01-01 2018-09-30 0001770450 us-gaap:CommonStockMember 2019-08-01 2019-08-01 0001770450 2019-07-31 2019-07-31 0001770450 2019-08-01 2019-08-01 0001770450 us-gaap:EmployeeRelocationMember xrx:SharedServicesArrangementHCLTechnologiesMember 2019-01-01 2019-09-30 0001770450 2019-03-01 2019-03-31 0001770450 us-gaap:EmployeeRelocationMember xrx:SharedServicesArrangementHCLTechnologiesMember 2019-07-01 2019-09-30 0001770450 2019-08-01 0001770450 us-gaap:ServiceMember srt:RestatementAdjustmentMember 2018-07-01 2018-09-30 0001770450 us-gaap:ProductMember srt:ScenarioPreviouslyReportedMember 2018-07-01 2018-09-30 0001770450 us-gaap:ServiceMember srt:ScenarioPreviouslyReportedMember 2018-07-01 2018-09-30 0001770450 us-gaap:ProductMember srt:RestatementAdjustmentMember 2018-07-01 2018-09-30 0001770450 us-gaap:AdditionalPaidInCapitalMember 2019-08-01 2019-08-01 0001770450 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0001770450 us-gaap:ManufacturedProductOtherMember us-gaap:AccountingStandardsUpdate201602Member 2019-07-01 2019-09-30 0001770450 xrx:ASU201802Member us-gaap:RetainedEarningsMember 2019-01-01 2019-09-30 0001770450 us-gaap:ManufacturedProductOtherMember us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 2019-09-30 0001770450 xrx:ASU201802Member us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0001770450 2018-01-01 2018-12-31 0001770450 2017-01-01 2017-12-31 0001770450 us-gaap:ServiceMember us-gaap:AccountingStandardsUpdate201602Member 2018-01-01 2018-09-30 0001770450 us-gaap:ServiceMember us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 2019-09-30 0001770450 us-gaap:ProductMember us-gaap:SalesChannelThroughIntermediaryMember 2018-01-01 2018-09-30 0001770450 us-gaap:MaintenanceMember 2019-01-01 2019-09-30 0001770450 us-gaap:MaintenanceMember 2018-01-01 2018-09-30 0001770450 us-gaap:MaintenanceMember 2018-07-01 2018-09-30 0001770450 xrx:SuppliesPaperAndOtherSalesMember 2018-01-01 2018-09-30 0001770450 us-gaap:ManufacturedProductOtherMember 2018-07-01 2018-09-30 0001770450 xrx:OtherGeographicalMarketsMember 2018-01-01 2018-09-30 0001770450 us-gaap:ProductMember us-gaap:SalesChannelDirectlyToConsumerMember 2019-07-01 2019-09-30 0001770450 xrx:RentalAndOtherMember 2019-07-01 2019-09-30 0001770450 xrx:RentalAndOtherMember 2019-01-01 2019-09-30 0001770450 country:US 2018-01-01 2018-09-30 0001770450 xrx:OtherGeographicalMarketsMember 2019-01-01 2019-09-30 0001770450 us-gaap:ManufacturedProductOtherMember 2019-07-01 2019-09-30 0001770450 xrx:ServiceArrangementsMember 2018-07-01 2018-09-30 0001770450 us-gaap:ManufacturedProductOtherMember 2019-01-01 2019-09-30 0001770450 country:CA 2019-01-01 2019-09-30 0001770450 xrx:RentalAndOtherMember 2018-01-01 2018-09-30 0001770450 us-gaap:ProductMember xrx:SalesChannelDirectEquipmentLeaseMember 2019-07-01 2019-09-30 0001770450 us-gaap:ProductMember xrx:SalesChannelDirectEquipmentLeaseMember 2018-07-01 2018-09-30 0001770450 xrx:ServiceArrangementsMember 2019-07-01 2019-09-30 0001770450 us-gaap:ProductMember xrx:SalesChannelDirectEquipmentLeaseMember 2018-01-01 2018-09-30 0001770450 xrx:SuppliesPaperAndOtherSalesMember 2019-01-01 2019-09-30 0001770450 srt:EuropeMember 2019-01-01 2019-09-30 0001770450 xrx:SuppliesPaperAndOtherSalesMember 2019-07-01 2019-09-30 0001770450 country:US 2018-07-01 2018-09-30 0001770450 xrx:ServiceArrangementsMember 2018-01-01 2018-09-30 0001770450 us-gaap:MaintenanceMember 2019-07-01 2019-09-30 0001770450 srt:EuropeMember 2018-07-01 2018-09-30 0001770450 us-gaap:ProductMember us-gaap:SalesChannelDirectlyToConsumerMember 2018-01-01 2018-09-30 0001770450 us-gaap:ProductMember us-gaap:SalesChannelDirectlyToConsumerMember 2018-07-01 2018-09-30 0001770450 xrx:OtherGeographicalMarketsMember 2019-07-01 2019-09-30 0001770450 us-gaap:ProductMember us-gaap:SalesChannelThroughIntermediaryMember 2019-01-01 2019-09-30 0001770450 country:CA 2018-01-01 2018-09-30 0001770450 xrx:SuppliesPaperAndOtherSalesMember 2018-07-01 2018-09-30 0001770450 us-gaap:ManufacturedProductOtherMember 2018-01-01 2018-09-30 0001770450 xrx:OtherGeographicalMarketsMember 2018-07-01 2018-09-30 0001770450 srt:EuropeMember 2018-01-01 2018-09-30 0001770450 country:CA 2018-07-01 2018-09-30 0001770450 xrx:ServiceArrangementsMember 2019-01-01 2019-09-30 0001770450 country:CA 2019-07-01 2019-09-30 0001770450 xrx:RentalAndOtherMember 2018-07-01 2018-09-30 0001770450 country:US 2019-07-01 2019-09-30 0001770450 us-gaap:ProductMember us-gaap:SalesChannelThroughIntermediaryMember 2018-07-01 2018-09-30 0001770450 us-gaap:ProductMember us-gaap:SalesChannelThroughIntermediaryMember 2019-07-01 2019-09-30 0001770450 srt:EuropeMember 2019-07-01 2019-09-30 0001770450 us-gaap:ProductMember us-gaap:SalesChannelDirectlyToConsumerMember 2019-01-01 2019-09-30 0001770450 us-gaap:ProductMember xrx:SalesChannelDirectEquipmentLeaseMember 2019-01-01 2019-09-30 0001770450 country:US 2019-01-01 2019-09-30 0001770450 xrx:ContractFulfillmentCostsandInducementsMember 2019-07-01 2019-09-30 0001770450 xrx:ContractFulfillmentCostsandInducementsMember 2019-09-30 0001770450 xrx:ContractFulfillmentCostsandInducementsMember 2018-12-31 0001770450 xrx:ContractFulfillmentCostsandInducementsMember 2019-01-01 2019-09-30 0001770450 xrx:ContractFulfillmentCostsandInducementsMember 2018-07-01 2018-09-30 0001770450 xrx:ContractFulfillmentCostsandInducementsMember 2018-01-01 2018-09-30 0001770450 xrx:RabbitCopiersInc.AndHeritageBusinessSystemsInc.Member 2019-04-01 2019-06-30 0001770450 xrx:RabbitCopiersInc.AndHeritageBusinessSystemsInc.Member 2019-06-30 0001770450 us-gaap:OtherNoncurrentAssetsMember 2018-12-31 0001770450 us-gaap:OtherCurrentAssetsMember 2019-09-30 0001770450 us-gaap:OtherCurrentAssetsMember 2018-12-31 0001770450 us-gaap:OtherNoncurrentAssetsMember 2019-09-30 0001770450 us-gaap:AccountsReceivableMember 2018-12-31 0001770450 us-gaap:AccountsReceivableMember 2019-09-30 0001770450 us-gaap:AccountsReceivableMember 2019-01-01 2019-09-30 0001770450 us-gaap:AccountsReceivableMember 2018-07-01 2018-09-30 0001770450 us-gaap:AccountsReceivableMember 2018-01-01 2018-09-30 0001770450 us-gaap:AccountsReceivableMember 2019-07-01 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:IndustrialMember 2018-12-31 0001770450 country:FR 2019-09-30 0001770450 country:US xrx:GraphicArtsMember 2018-12-31 0001770450 srt:EuropeMember us-gaap:UnbilledRevenuesMember 2018-12-31 0001770450 xrx:EuropeCentralMember 2018-12-31 0001770450 srt:EuropeMember us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:HealthcareIndustryMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2019-09-30 0001770450 xrx:UKIrelandMember us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2019-09-30 0001770450 xrx:UKIrelandMember us-gaap:BilledRevenuesMember 2018-12-31 0001770450 country:US us-gaap:BilledRevenuesMember xrx:FinanceAndOtherServicesMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:FinanceAndOtherServicesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2019-09-30 0001770450 country:US xrx:FinanceAndOtherServicesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2018-12-31 0001770450 country:US us-gaap:BilledRevenuesMember xrx:OtherFinancingReceivableMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2018-12-31 0001770450 xrx:OthercountriesMember 2019-09-30 0001770450 xrx:UKIrelandMember 2018-12-31 0001770450 xrx:EuropeCentralMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2018-12-31 0001770450 country:US xrx:OtherFinancingReceivableMember 2018-12-31 0001770450 country:US xrx:HealthcareIndustryMember 2018-12-31 0001770450 country:US us-gaap:BilledRevenuesMember xrx:FinanceAndOtherServicesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2018-12-31 0001770450 country:US us-gaap:BilledRevenuesMember xrx:FinanceAndOtherServicesMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2018-12-31 0001770450 country:FR xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2019-09-30 0001770450 country:CA us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2018-12-31 0001770450 xrx:EuropeNordicsMember us-gaap:BilledRevenuesMember 2018-12-31 0001770450 xrx:EuropeNordicsMember us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2018-12-31 0001770450 country:US us-gaap:UnbilledRevenuesMember xrx:HealthcareIndustryMember 2018-12-31 0001770450 country:US us-gaap:UnbilledRevenuesMember 2018-12-31 0001770450 country:US us-gaap:UnbilledRevenuesMember xrx:GraphicArtsMember 2019-09-30 0001770450 xrx:OthercountriesMember us-gaap:BilledRevenuesMember 2018-12-31 0001770450 xrx:UKIrelandMember us-gaap:UnbilledRevenuesMember 2019-09-30 0001770450 country:US 2019-09-30 0001770450 xrx:UKIrelandMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:HealthcareIndustryMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:IndustrialMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2019-09-30 0001770450 country:US xrx:HealthcareIndustryMember 2019-09-30 0001770450 country:US xrx:GraphicArtsMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2018-12-31 0001770450 xrx:EuropeCentralMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2019-09-30 0001770450 xrx:UKIrelandMember us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2018-12-31 0001770450 country:US us-gaap:BilledRevenuesMember xrx:IndustrialMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2019-09-30 0001770450 xrx:EuropeNordicsMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2018-12-31 0001770450 country:US us-gaap:BilledRevenuesMember xrx:GraphicArtsMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:GraphicArtsMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2019-09-30 0001770450 country:US xrx:FinanceAndOtherServicesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:GovernmentAndEducationMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2018-12-31 0001770450 country:CA us-gaap:UnbilledRevenuesMember 2018-12-31 0001770450 xrx:EuropeCentralMember us-gaap:UnbilledRevenuesMember 2019-09-30 0001770450 xrx:EuropeCentralMember us-gaap:UnbilledRevenuesMember 2018-12-31 0001770450 country:US xrx:GovernmentAndEducationMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2019-09-30 0001770450 xrx:UKIrelandMember us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2018-12-31 0001770450 country:US xrx:OtherFinancingReceivableMember 2019-09-30 0001770450 country:US xrx:FinanceAndOtherServicesMember 2018-12-31 0001770450 country:US us-gaap:UnbilledRevenuesMember xrx:HealthcareIndustryMember 2019-09-30 0001770450 us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2018-12-31 0001770450 xrx:EuropeNordicsMember us-gaap:BilledRevenuesMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:HealthcareIndustryMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2018-12-31 0001770450 country:US us-gaap:BilledRevenuesMember xrx:HealthcareIndustryMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2018-12-31 0001770450 xrx:EuropeSouthernMember 2018-12-31 0001770450 srt:EuropeMember us-gaap:UnbilledRevenuesMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:IndustrialMember 2019-09-30 0001770450 xrx:OthercountriesMember us-gaap:UnbilledRevenuesMember 2018-12-31 0001770450 xrx:OthercountriesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2019-09-30 0001770450 country:CA us-gaap:BilledRevenuesMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2019-09-30 0001770450 xrx:EuropeSouthernMember us-gaap:BilledRevenuesMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2018-12-31 0001770450 country:US us-gaap:BilledRevenuesMember xrx:GraphicArtsMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2018-12-31 0001770450 country:US xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2019-09-30 0001770450 country:US us-gaap:UnbilledRevenuesMember xrx:FinanceAndOtherServicesMember 2018-12-31 0001770450 country:US xrx:HealthcareIndustryMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2019-09-30 0001770450 country:CA us-gaap:BilledRevenuesMember 2019-09-30 0001770450 country:US us-gaap:UnbilledRevenuesMember xrx:OtherFinancingReceivableMember 2019-09-30 0001770450 country:US us-gaap:UnbilledRevenuesMember xrx:FinanceAndOtherServicesMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:GovernmentAndEducationMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2019-09-30 0001770450 us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2019-09-30 0001770450 xrx:EuropeSouthernMember us-gaap:BilledRevenuesMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:FinanceAndOtherServicesMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:GovernmentAndEducationMember 2018-12-31 0001770450 us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2018-12-31 0001770450 us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2019-09-30 0001770450 xrx:OthercountriesMember us-gaap:BilledRevenuesMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2018-12-31 0001770450 country:US us-gaap:BilledRevenuesMember xrx:OtherFinancingReceivableMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2019-09-30 0001770450 country:FR us-gaap:UnbilledRevenuesMember 2018-12-31 0001770450 xrx:OthercountriesMember us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2019-09-30 0001770450 xrx:EuropeNordicsMember us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:OtherFinancingReceivableMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2018-12-31 0001770450 country:US xrx:IndustrialMember 2018-12-31 0001770450 country:US xrx:FinanceAndOtherServicesMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:GraphicArtsMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2019-09-30 0001770450 xrx:EuropeNordicsMember us-gaap:UnbilledRevenuesMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2018-12-31 0001770450 srt:EuropeMember us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2018-12-31 0001770450 country:US xrx:GraphicArtsMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:OtherFinancingReceivableMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:GraphicArtsMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2018-12-31 0001770450 xrx:OthercountriesMember us-gaap:UnbilledRevenuesMember 2019-09-30 0001770450 country:FR us-gaap:BilledRevenuesMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2018-12-31 0001770450 xrx:EuropeCentralMember us-gaap:BilledRevenuesMember 2019-09-30 0001770450 country:CA us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2019-09-30 0001770450 xrx:EuropeSouthernMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2019-09-30 0001770450 xrx:EuropeCentralMember us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2018-12-31 0001770450 srt:EuropeMember us-gaap:BilledRevenuesMember 2019-09-30 0001770450 xrx:EuropeSouthernMember us-gaap:UnbilledRevenuesMember 2019-09-30 0001770450 country:US us-gaap:UnbilledRevenuesMember xrx:GovernmentAndEducationMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:GraphicArtsMember 2018-12-31 0001770450 country:FR us-gaap:BilledRevenuesMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:OtherFinancingReceivableMember 2018-12-31 0001770450 xrx:EuropeCentralMember us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2018-12-31 0001770450 xrx:OthercountriesMember us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2018-12-31 0001770450 country:US us-gaap:BilledRevenuesMember xrx:OtherFinancingReceivableMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2019-09-30 0001770450 country:US us-gaap:UnbilledRevenuesMember xrx:GraphicArtsMember 2018-12-31 0001770450 country:US us-gaap:UnbilledRevenuesMember xrx:GovernmentAndEducationMember 2018-12-31 0001770450 xrx:EuropeNordicsMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2019-09-30 0001770450 xrx:UKIrelandMember us-gaap:BilledRevenuesMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2018-12-31 0001770450 us-gaap:UnbilledRevenuesMember 2019-09-30 0001770450 xrx:EuropeCentralMember us-gaap:BilledRevenuesMember 2018-12-31 0001770450 xrx:EuropeNordicsMember us-gaap:UnbilledRevenuesMember 2018-12-31 0001770450 country:US us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:HealthcareIndustryMember 2018-12-31 0001770450 country:CA 2019-09-30 0001770450 xrx:EuropeNordicsMember us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2019-09-30 0001770450 country:CA xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2019-09-30 0001770450 country:FR us-gaap:UnbilledRevenuesMember 2019-09-30 0001770450 xrx:OthercountriesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2018-12-31 0001770450 xrx:OthercountriesMember 2018-12-31 0001770450 xrx:UKIrelandMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:GovernmentAndEducationMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2018-12-31 0001770450 country:US us-gaap:BilledRevenuesMember xrx:FinanceAndOtherServicesMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2018-12-31 0001770450 country:CA 2018-12-31 0001770450 xrx:EuropeNordicsMember us-gaap:BilledRevenuesMember 2019-09-30 0001770450 us-gaap:BilledRevenuesMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:IndustrialMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2018-12-31 0001770450 country:CA us-gaap:BilledRevenuesMember 2018-12-31 0001770450 srt:EuropeMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2018-12-31 0001770450 xrx:UKIrelandMember us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2018-12-31 0001770450 country:US us-gaap:BilledRevenuesMember xrx:GovernmentAndEducationMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2018-12-31 0001770450 xrx:EuropeSouthernMember us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2018-12-31 0001770450 xrx:OthercountriesMember us-gaap:BilledRevenuesMember 2019-09-30 0001770450 country:FR us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2019-09-30 0001770450 xrx:EuropeNordicsMember us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2018-12-31 0001770450 xrx:OthercountriesMember us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:OtherFinancingReceivableMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2018-12-31 0001770450 srt:EuropeMember us-gaap:BilledRevenuesMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2019-09-30 0001770450 xrx:EuropeNordicsMember 2018-12-31 0001770450 country:US us-gaap:BilledRevenuesMember xrx:GraphicArtsMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2019-09-30 0001770450 xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2018-12-31 0001770450 country:US xrx:HealthcareIndustryMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2018-12-31 0001770450 country:US xrx:GraphicArtsMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:IndustrialMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2018-12-31 0001770450 srt:EuropeMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2019-09-30 0001770450 xrx:OthercountriesMember us-gaap:BilledRevenuesMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2019-09-30 0001770450 xrx:EuropeSouthernMember us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2019-09-30 0001770450 country:US us-gaap:UnbilledRevenuesMember xrx:IndustrialMember 2018-12-31 0001770450 xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:HealthcareIndustryMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2018-12-31 0001770450 xrx:UKIrelandMember us-gaap:UnbilledRevenuesMember 2018-12-31 0001770450 country:CA us-gaap:BilledRevenuesMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2018-12-31 0001770450 srt:EuropeMember 2018-12-31 0001770450 country:FR us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2018-12-31 0001770450 country:US us-gaap:BilledRevenuesMember xrx:OtherFinancingReceivableMember 2019-09-30 0001770450 country:US xrx:IndustrialMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2019-09-30 0001770450 country:US us-gaap:UnbilledRevenuesMember 2019-09-30 0001770450 us-gaap:BilledRevenuesMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2018-12-31 0001770450 country:CA us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2019-09-30 0001770450 xrx:EuropeSouthernMember us-gaap:BilledRevenuesMember 2018-12-31 0001770450 xrx:UKIrelandMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2018-12-31 0001770450 country:US us-gaap:BilledRevenuesMember 2018-12-31 0001770450 xrx:EuropeSouthernMember us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2018-12-31 0001770450 srt:EuropeMember 2019-09-30 0001770450 country:CA us-gaap:UnbilledRevenuesMember 2019-09-30 0001770450 xrx:EuropeNordicsMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:HealthcareIndustryMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2019-09-30 0001770450 srt:EuropeMember us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2019-09-30 0001770450 country:US 2018-12-31 0001770450 country:US us-gaap:BilledRevenuesMember xrx:IndustrialMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:GraphicArtsMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2018-12-31 0001770450 country:US us-gaap:BilledRevenuesMember 2019-09-30 0001770450 country:US xrx:GovernmentAndEducationMember 2018-12-31 0001770450 srt:EuropeMember us-gaap:BilledRevenuesMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2018-12-31 0001770450 country:US xrx:GovernmentAndEducationMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:FinanceAndOtherServicesMember 2018-12-31 0001770450 country:US us-gaap:BilledRevenuesMember xrx:GovernmentAndEducationMember 2019-09-30 0001770450 xrx:EuropeCentralMember us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2018-12-31 0001770450 country:US xrx:OtherFinancingReceivableMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2018-12-31 0001770450 country:US us-gaap:BilledRevenuesMember xrx:HealthcareIndustryMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2019-09-30 0001770450 xrx:EuropeCentralMember us-gaap:BilledRevenuesMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2019-09-30 0001770450 country:FR us-gaap:BilledRevenuesMember 2018-12-31 0001770450 xrx:EuropeSouthernMember us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2019-09-30 0001770450 xrx:UKIrelandMember us-gaap:BilledRevenuesMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2019-09-30 0001770450 country:US xrx:GovernmentAndEducationMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2018-12-31 0001770450 country:US xrx:OtherFinancingReceivableMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2019-09-30 0001770450 country:US us-gaap:UnbilledRevenuesMember xrx:IndustrialMember 2019-09-30 0001770450 srt:EuropeMember us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2018-12-31 0001770450 country:FR xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2018-12-31 0001770450 country:US xrx:IndustrialMember 2019-09-30 0001770450 us-gaap:UnbilledRevenuesMember 2018-12-31 0001770450 xrx:EuropeSouthernMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2018-12-31 0001770450 us-gaap:BilledRevenuesMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2019-09-30 0001770450 xrx:EuropeSouthernMember 2019-09-30 0001770450 country:CA us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2018-12-31 0001770450 country:FR us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2019-09-30 0001770450 srt:EuropeMember us-gaap:BilledRevenuesMember 2018-12-31 0001770450 country:FR us-gaap:BilledRevenuesMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2019-09-30 0001770450 xrx:EuropeCentralMember us-gaap:BilledRevenuesMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2018-12-31 0001770450 country:US xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2018-12-31 0001770450 country:US us-gaap:BilledRevenuesMember xrx:GovernmentAndEducationMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2019-09-30 0001770450 xrx:EuropeCentralMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:IndustrialMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2018-12-31 0001770450 xrx:OthercountriesMember us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2018-12-31 0001770450 country:US us-gaap:BilledRevenuesMember xrx:GovernmentAndEducationMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2019-09-30 0001770450 xrx:EuropeSouthernMember us-gaap:UnbilledRevenuesMember 2018-12-31 0001770450 xrx:EuropeCentralMember us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestment1to60DaysPastDueMember 2019-09-30 0001770450 xrx:EuropeSouthernMember us-gaap:BilledRevenuesMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2019-09-30 0001770450 country:US us-gaap:BilledRevenuesMember xrx:FinanceAndOtherServicesMember 2019-09-30 0001770450 xrx:EuropeNordicsMember us-gaap:BilledRevenuesMember xrx:FinanceReceivableRecordedInvestmentCurrent1to30DaysPastInvoiceDateMember 2018-12-31 0001770450 country:FR 2018-12-31 0001770450 xrx:UKIrelandMember us-gaap:BilledRevenuesMember 2019-09-30 0001770450 country:CA xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2018-12-31 0001770450 country:US xrx:IndustrialMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueandStillAccruingMember 2018-12-31 0001770450 country:US us-gaap:UnbilledRevenuesMember xrx:OtherFinancingReceivableMember 2018-12-31 0001770450 us-gaap:BilledRevenuesMember 2018-12-31 0001770450 country:FR us-gaap:BilledRevenuesMember xrx:FinanceReceivablesRecordedInvestmentGreaterthan60DaysPastDueMember 2018-12-31 0001770450 xrx:OthercountriesMember 2018-04-01 2018-06-30 0001770450 country:CA 2018-04-01 2018-06-30 0001770450 srt:EuropeMember 2019-04-01 2019-06-30 0001770450 xrx:OthercountriesMember 2018-03-31 0001770450 srt:EuropeMember 2018-01-01 2018-03-31 0001770450 2018-01-01 2018-03-31 0001770450 2019-03-31 0001770450 xrx:OthercountriesMember 2018-09-30 0001770450 country:US 2018-04-01 2018-06-30 0001770450 srt:EuropeMember 2018-04-01 2018-06-30 0001770450 country:US 2019-01-01 2019-03-31 0001770450 country:US 2019-04-01 2019-06-30 0001770450 xrx:OthercountriesMember 2018-01-01 2018-03-31 0001770450 country:CA 2019-06-30 0001770450 country:US 2018-01-01 2018-03-31 0001770450 country:CA 2019-03-31 0001770450 srt:EuropeMember 2019-03-31 0001770450 xrx:OthercountriesMember 2019-04-01 2019-06-30 0001770450 country:CA 2018-01-01 2018-03-31 0001770450 xrx:OthercountriesMember 2017-12-31 0001770450 srt:EuropeMember 2018-03-31 0001770450 country:US 2018-03-31 0001770450 srt:EuropeMember 2018-06-30 0001770450 country:CA 2019-04-01 2019-06-30 0001770450 xrx:OthercountriesMember 2018-07-01 2018-09-30 0001770450 srt:EuropeMember 2018-09-30 0001770450 2019-01-01 2019-03-31 0001770450 2018-04-01 2018-06-30 0001770450 xrx:OthercountriesMember 2019-01-01 2019-03-31 0001770450 2019-04-01 2019-06-30 0001770450 country:US 2018-09-30 0001770450 country:US 2017-12-31 0001770450 srt:EuropeMember 2017-12-31 0001770450 country:CA 2018-03-31 0001770450 xrx:OthercountriesMember 2019-07-01 2019-09-30 0001770450 srt:EuropeMember 2019-06-30 0001770450 xrx:OthercountriesMember 2019-06-30 0001770450 country:CA 2019-01-01 2019-03-31 0001770450 country:CA 2018-06-30 0001770450 srt:EuropeMember 2019-01-01 2019-03-31 0001770450 country:CA 2018-09-30 0001770450 xrx:OthercountriesMember 2018-06-30 0001770450 country:US 2019-03-31 0001770450 country:CA 2017-12-31 0001770450 xrx:OthercountriesMember 2019-03-31 0001770450 country:US 2019-06-30 0001770450 2018-03-31 0001770450 country:US 2018-06-30 0001770450 country:US xrx:HealthcareIndustryMember us-gaap:InternalInvestmentGradeMember 2018-12-31 0001770450 srt:EuropeMember us-gaap:InternalNoninvestmentGradeMember 2018-12-31 0001770450 xrx:OthercountriesMember us-gaap:InternalInvestmentGradeMember 2018-12-31 0001770450 country:CA xrx:GraphicArtsMember 2018-12-31 0001770450 country:CA xrx:GovernmentAndEducationMember us-gaap:SubstandardMember 2018-12-31 0001770450 country:CA xrx:FinanceAndOtherServicesMember us-gaap:InternalInvestmentGradeMember 2019-09-30 0001770450 country:US xrx:OtherFinancingReceivableMember us-gaap:SubstandardMember 2018-12-31 0001770450 xrx:EuropeNordicsMember us-gaap:InternalNoninvestmentGradeMember 2018-12-31 0001770450 country:FR us-gaap:InternalInvestmentGradeMember 2018-12-31 0001770450 srt:EuropeMember us-gaap:SubstandardMember 2018-12-31 0001770450 srt:EuropeMember us-gaap:InternalInvestmentGradeMember 2018-12-31 0001770450 xrx:EuropeCentralMember us-gaap:SubstandardMember 2018-12-31 0001770450 srt:EuropeMember us-gaap:InternalNoninvestmentGradeMember 2019-09-30 0001770450 country:CA xrx:IndustrialMember 2018-12-31 0001770450 country:US xrx:GraphicArtsMember us-gaap:InternalInvestmentGradeMember 2019-09-30 0001770450 xrx:EuropeSouthernMember us-gaap:InternalInvestmentGradeMember 2019-09-30 0001770450 xrx:EuropeSouthernMember us-gaap:InternalNoninvestmentGradeMember 2018-12-31 0001770450 country:US xrx:FinanceAndOtherServicesMember us-gaap:SubstandardMember 2019-09-30 0001770450 country:US xrx:FinanceAndOtherServicesMember us-gaap:InternalInvestmentGradeMember 2018-12-31 0001770450 us-gaap:InternalNoninvestmentGradeMember 2018-12-31 0001770450 country:CA xrx:GovernmentAndEducationMember 2019-09-30 0001770450 country:US xrx:IndustrialMember us-gaap:SubstandardMember 2019-09-30 0001770450 country:FR us-gaap:InternalNoninvestmentGradeMember 2019-09-30 0001770450 country:CA xrx:GovernmentAndEducationMember us-gaap:InternalInvestmentGradeMember 2019-09-30 0001770450 country:CA us-gaap:SubstandardMember 2019-09-30 0001770450 xrx:EuropeSouthernMember us-gaap:SubstandardMember 2018-12-31 0001770450 us-gaap:InternalInvestmentGradeMember 2018-12-31 0001770450 country:CA xrx:IndustrialMember us-gaap:SubstandardMember 2019-09-30 0001770450 xrx:EuropeCentralMember us-gaap:SubstandardMember 2019-09-30 0001770450 country:US xrx:IndustrialMember us-gaap:InternalNoninvestmentGradeMember 2018-12-31 0001770450 country:CA xrx:GraphicArtsMember us-gaap:InternalNoninvestmentGradeMember 2018-12-31 0001770450 xrx:EuropeNordicsMember us-gaap:InternalInvestmentGradeMember 2018-12-31 0001770450 country:CA us-gaap:SubstandardMember 2018-12-31 0001770450 country:CA xrx:OtherFinancingReceivableMember us-gaap:SubstandardMember 2018-12-31 0001770450 xrx:EuropeSouthernMember us-gaap:SubstandardMember 2019-09-30 0001770450 country:US xrx:GraphicArtsMember us-gaap:SubstandardMember 2019-09-30 0001770450 country:FR us-gaap:SubstandardMember 2018-12-31 0001770450 country:CA xrx:OtherFinancingReceivableMember 2019-09-30 0001770450 country:US us-gaap:InternalNoninvestmentGradeMember 2018-12-31 0001770450 xrx:UKIrelandMember us-gaap:SubstandardMember 2018-12-31 0001770450 country:CA xrx:OtherFinancingReceivableMember us-gaap:InternalInvestmentGradeMember 2018-12-31 0001770450 country:CA us-gaap:InternalInvestmentGradeMember 2018-12-31 0001770450 country:US us-gaap:SubstandardMember 2018-12-31 0001770450 country:CA xrx:GovernmentAndEducationMember us-gaap:SubstandardMember 2019-09-30 0001770450 country:US xrx:OtherFinancingReceivableMember us-gaap:InternalInvestmentGradeMember 2018-12-31 0001770450 country:US xrx:GraphicArtsMember us-gaap:SubstandardMember 2018-12-31 0001770450 xrx:EuropeSouthernMember us-gaap:InternalNoninvestmentGradeMember 2019-09-30 0001770450 country:US xrx:GovernmentAndEducationMember us-gaap:InternalInvestmentGradeMember 2018-12-31 0001770450 country:CA xrx:OtherFinancingReceivableMember us-gaap:SubstandardMember 2019-09-30 0001770450 us-gaap:SubstandardMember 2019-09-30 0001770450 country:CA xrx:GraphicArtsMember us-gaap:InternalInvestmentGradeMember 2018-12-31 0001770450 xrx:OthercountriesMember us-gaap:InternalNoninvestmentGradeMember 2019-09-30 0001770450 country:CA xrx:FinanceAndOtherServicesMember 2018-12-31 0001770450 country:CA xrx:FinanceAndOtherServicesMember us-gaap:InternalNoninvestmentGradeMember 2018-12-31 0001770450 us-gaap:InternalNoninvestmentGradeMember 2019-09-30 0001770450 country:US xrx:HealthcareIndustryMember us-gaap:SubstandardMember 2018-12-31 0001770450 country:US us-gaap:InternalInvestmentGradeMember 2018-12-31 0001770450 country:CA xrx:OtherFinancingReceivableMember us-gaap:InternalNoninvestmentGradeMember 2019-09-30 0001770450 country:US xrx:FinanceAndOtherServicesMember us-gaap:InternalNoninvestmentGradeMember 2018-12-31 0001770450 country:CA xrx:GovernmentAndEducationMember us-gaap:InternalNoninvestmentGradeMember 2019-09-30 0001770450 country:US us-gaap:SubstandardMember 2019-09-30 0001770450 xrx:EuropeCentralMember us-gaap:InternalNoninvestmentGradeMember 2019-09-30 0001770450 xrx:OthercountriesMember us-gaap:SubstandardMember 2018-12-31 0001770450 xrx:OthercountriesMember us-gaap:InternalInvestmentGradeMember 2019-09-30 0001770450 country:FR us-gaap:InternalInvestmentGradeMember 2019-09-30 0001770450 country:US xrx:GovernmentAndEducationMember us-gaap:SubstandardMember 2019-09-30 0001770450 country:US xrx:IndustrialMember us-gaap:InternalNoninvestmentGradeMember 2019-09-30 0001770450 country:CA xrx:OtherFinancingReceivableMember us-gaap:InternalNoninvestmentGradeMember 2018-12-31 0001770450 country:US xrx:GraphicArtsMember us-gaap:InternalInvestmentGradeMember 2018-12-31 0001770450 country:CA xrx:FinanceAndOtherServicesMember us-gaap:SubstandardMember 2018-12-31 0001770450 country:CA xrx:GraphicArtsMember us-gaap:InternalInvestmentGradeMember 2019-09-30 0001770450 country:US xrx:GovernmentAndEducationMember us-gaap:SubstandardMember 2018-12-31 0001770450 country:US xrx:GraphicArtsMember us-gaap:InternalNoninvestmentGradeMember 2018-12-31 0001770450 country:US xrx:GovernmentAndEducationMember us-gaap:InternalNoninvestmentGradeMember 2019-09-30 0001770450 xrx:EuropeNordicsMember us-gaap:InternalNoninvestmentGradeMember 2019-09-30 0001770450 country:US xrx:OtherFinancingReceivableMember us-gaap:SubstandardMember 2019-09-30 0001770450 country:CA xrx:GraphicArtsMember us-gaap:SubstandardMember 2019-09-30 0001770450 country:CA xrx:IndustrialMember 2019-09-30 0001770450 srt:EuropeMember us-gaap:SubstandardMember 2019-09-30 0001770450 country:US xrx:GovernmentAndEducationMember us-gaap:InternalNoninvestmentGradeMember 2018-12-31 0001770450 country:CA xrx:GovernmentAndEducationMember 2018-12-31 0001770450 country:CA xrx:FinanceAndOtherServicesMember us-gaap:InternalNoninvestmentGradeMember 2019-09-30 0001770450 country:US xrx:IndustrialMember us-gaap:SubstandardMember 2018-12-31 0001770450 country:US us-gaap:InternalInvestmentGradeMember 2019-09-30 0001770450 country:CA xrx:GraphicArtsMember us-gaap:InternalNoninvestmentGradeMember 2019-09-30 0001770450 xrx:EuropeSouthernMember us-gaap:InternalInvestmentGradeMember 2018-12-31 0001770450 country:US xrx:OtherFinancingReceivableMember us-gaap:InternalNoninvestmentGradeMember 2019-09-30 0001770450 country:US xrx:HealthcareIndustryMember us-gaap:InternalInvestmentGradeMember 2019-09-30 0001770450 country:US xrx:GovernmentAndEducationMember us-gaap:InternalInvestmentGradeMember 2019-09-30 0001770450 xrx:OthercountriesMember us-gaap:SubstandardMember 2019-09-30 0001770450 country:US xrx:HealthcareIndustryMember us-gaap:InternalNoninvestmentGradeMember 2018-12-31 0001770450 country:US xrx:FinanceAndOtherServicesMember us-gaap:SubstandardMember 2018-12-31 0001770450 country:CA us-gaap:InternalNoninvestmentGradeMember 2018-12-31 0001770450 xrx:UKIrelandMember us-gaap:InternalNoninvestmentGradeMember 2019-09-30 0001770450 country:CA xrx:IndustrialMember us-gaap:InternalInvestmentGradeMember 2018-12-31 0001770450 country:US xrx:IndustrialMember us-gaap:InternalInvestmentGradeMember 2019-09-30 0001770450 country:CA xrx:IndustrialMember us-gaap:SubstandardMember 2018-12-31 0001770450 country:US us-gaap:InternalNoninvestmentGradeMember 2019-09-30 0001770450 country:US xrx:HealthcareIndustryMember us-gaap:SubstandardMember 2019-09-30 0001770450 xrx:UKIrelandMember us-gaap:SubstandardMember 2019-09-30 0001770450 country:CA xrx:IndustrialMember us-gaap:InternalNoninvestmentGradeMember 2019-09-30 0001770450 country:US xrx:OtherFinancingReceivableMember us-gaap:InternalNoninvestmentGradeMember 2018-12-31 0001770450 country:CA xrx:IndustrialMember us-gaap:InternalInvestmentGradeMember 2019-09-30 0001770450 xrx:EuropeNordicsMember us-gaap:InternalInvestmentGradeMember 2019-09-30 0001770450 country:US xrx:IndustrialMember us-gaap:InternalInvestmentGradeMember 2018-12-31 0001770450 country:US xrx:FinanceAndOtherServicesMember us-gaap:InternalInvestmentGradeMember 2019-09-30 0001770450 country:US xrx:OtherFinancingReceivableMember us-gaap:InternalInvestmentGradeMember 2019-09-30 0001770450 country:CA xrx:OtherFinancingReceivableMember 2018-12-31 0001770450 country:US xrx:HealthcareIndustryMember us-gaap:InternalNoninvestmentGradeMember 2019-09-30 0001770450 country:CA xrx:FinanceAndOtherServicesMember 2019-09-30 0001770450 country:CA xrx:GraphicArtsMember us-gaap:SubstandardMember 2018-12-31 0001770450 xrx:EuropeCentralMember us-gaap:InternalNoninvestmentGradeMember 2018-12-31 0001770450 country:CA xrx:IndustrialMember us-gaap:InternalNoninvestmentGradeMember 2018-12-31 0001770450 country:CA xrx:OtherFinancingReceivableMember us-gaap:InternalInvestmentGradeMember 2019-09-30 0001770450 country:CA us-gaap:InternalNoninvestmentGradeMember 2019-09-30 0001770450 country:CA us-gaap:InternalInvestmentGradeMember 2019-09-30 0001770450 country:CA xrx:GraphicArtsMember 2019-09-30 0001770450 us-gaap:SubstandardMember 2018-12-31 0001770450 xrx:UKIrelandMember us-gaap:InternalNoninvestmentGradeMember 2018-12-31 0001770450 us-gaap:InternalInvestmentGradeMember 2019-09-30 0001770450 country:US xrx:GraphicArtsMember us-gaap:InternalNoninvestmentGradeMember 2019-09-30 0001770450 country:CA xrx:FinanceAndOtherServicesMember us-gaap:SubstandardMember 2019-09-30 0001770450 country:US xrx:FinanceAndOtherServicesMember us-gaap:InternalNoninvestmentGradeMember 2019-09-30 0001770450 xrx:EuropeNordicsMember us-gaap:SubstandardMember 2018-12-31 0001770450 xrx:EuropeNordicsMember us-gaap:SubstandardMember 2019-09-30 0001770450 country:FR us-gaap:InternalNoninvestmentGradeMember 2018-12-31 0001770450 xrx:UKIrelandMember us-gaap:InternalInvestmentGradeMember 2019-09-30 0001770450 xrx:OthercountriesMember us-gaap:InternalNoninvestmentGradeMember 2018-12-31 0001770450 xrx:EuropeCentralMember us-gaap:InternalInvestmentGradeMember 2019-09-30 0001770450 country:CA xrx:GovernmentAndEducationMember us-gaap:InternalNoninvestmentGradeMember 2018-12-31 0001770450 srt:EuropeMember us-gaap:InternalInvestmentGradeMember 2019-09-30 0001770450 country:FR us-gaap:SubstandardMember 2019-09-30 0001770450 country:CA xrx:GovernmentAndEducationMember us-gaap:InternalInvestmentGradeMember 2018-12-31 0001770450 xrx:UKIrelandMember us-gaap:InternalInvestmentGradeMember 2018-12-31 0001770450 country:CA xrx:FinanceAndOtherServicesMember us-gaap:InternalInvestmentGradeMember 2018-12-31 0001770450 xrx:EuropeCentralMember us-gaap:InternalInvestmentGradeMember 2018-12-31 0001770450 us-gaap:AssetsLeasedToOthersMember 2019-09-30 0001770450 xrx:FujiXeroxCo.Ltd.Member 2019-01-01 2019-09-30 0001770450 xrx:OtherEquityInvestmentsMember 2019-01-01 2019-09-30 0001770450 xrx:FujiXeroxCo.Ltd.Member 2018-07-01 2018-09-30 0001770450 xrx:OtherEquityInvestmentsMember 2019-07-01 2019-09-30 0001770450 xrx:FujiXeroxCo.Ltd.Member 2019-07-01 2019-09-30 0001770450 xrx:OtherEquityInvestmentsMember 2018-07-01 2018-09-30 0001770450 xrx:OtherEquityInvestmentsMember 2018-01-01 2018-09-30 0001770450 xrx:FujiXeroxCo.Ltd.Member 2018-01-01 2018-09-30 0001770450 xrx:FujifilmHoldingsCorporationMember srt:RestatementAdjustmentMember xrx:FujiXeroxCo.Ltd.Member 2018-01-01 2018-03-31 0001770450 xrx:FujiXeroxCo.Ltd.Member 2018-03-31 0001770450 xrx:FujiXeroxCo.Ltd.Member 2019-09-30 0001770450 xrx:FujiXeroxCo.Ltd.Member 2018-01-01 2018-03-31 0001770450 xrx:NonParentEquityInvestmentOwnerMember srt:RestatementAdjustmentMember xrx:FujiXeroxCo.Ltd.Member 2018-01-01 2018-03-31 0001770450 xrx:RestructuringAssetImpairmentsMember 2019-07-01 2019-09-30 0001770450 us-gaap:EmployeeSeveranceMember 2019-07-01 2019-09-30 0001770450 xrx:RestructuringAssetImpairmentsMember 2019-01-01 2019-03-31 0001770450 us-gaap:EmployeeSeveranceMember 2019-04-01 2019-06-30 0001770450 us-gaap:ContractTerminationMember 2019-07-01 2019-09-30 0001770450 us-gaap:ContractTerminationMember 2019-04-01 2019-06-30 0001770450 us-gaap:ContractTerminationMember 2019-01-01 2019-03-31 0001770450 xrx:RestructuringAssetImpairmentsMember 2019-06-30 0001770450 xrx:RestructuringAssetImpairmentsMember 2019-04-01 2019-06-30 0001770450 us-gaap:EmployeeSeveranceMember 2019-01-01 2019-03-31 0001770450 xrx:RestructuringAssetImpairmentsMember 2018-12-31 0001770450 us-gaap:EmployeeSeveranceMember 2019-03-31 0001770450 us-gaap:EmployeeSeveranceMember 2018-12-31 0001770450 us-gaap:ContractTerminationMember 2018-12-31 0001770450 us-gaap:EmployeeSeveranceMember 2019-06-30 0001770450 xrx:RestructuringAssetImpairmentsMember 2019-03-31 0001770450 us-gaap:ContractTerminationMember 2019-06-30 0001770450 us-gaap:ContractTerminationMember 2019-09-30 0001770450 us-gaap:ContractTerminationMember 2019-03-31 0001770450 xrx:RestructuringAssetImpairmentsMember 2019-09-30 0001770450 us-gaap:EmployeeSeveranceMember 2019-09-30 0001770450 xrx:ContractualSeveranceCostsMember 2019-01-01 2019-09-30 0001770450 xrx:ConsultingAndOtherCostsMember 2019-07-01 2019-09-30 0001770450 xrx:ContractualSeveranceCostsMember 2019-07-01 2019-09-30 0001770450 xrx:RetentionRelatedSeveranceBonusesMember 2019-07-01 2019-09-30 0001770450 xrx:RetentionRelatedSeveranceBonusesMember 2019-01-01 2019-09-30 0001770450 xrx:ConsultingAndOtherCostsMember 2019-01-01 2019-09-30 0001770450 xrx:RestructuringAssetImpairmentsMember 2019-01-01 2019-09-30 0001770450 us-gaap:ContractTerminationMember 2019-01-01 2019-09-30 0001770450 us-gaap:EmployeeSeveranceMember 2019-01-01 2019-09-30 0001770450 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2018-12-31 0001770450 us-gaap:OtherCurrentAssetsMember us-gaap:OptionMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-30 0001770450 us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-30 0001770450 us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001770450 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001770450 us-gaap:OtherLiabilitiesMember 2018-12-31 0001770450 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-30 0001770450 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001770450 us-gaap:OtherAssetsMember 2019-09-30 0001770450 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001770450 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2018-12-31 0001770450 us-gaap:OtherAssetsMember 2018-12-31 0001770450 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-30 0001770450 us-gaap:OtherLiabilitiesMember 2019-09-30 0001770450 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001770450 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-30 0001770450 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-30 0001770450 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2019-09-30 0001770450 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2018-12-31 0001770450 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2019-09-30 0001770450 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2019-09-30 0001770450 us-gaap:OtherCurrentAssetsMember us-gaap:OptionMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001770450 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:ForeignCurrencyGainLossMember 2018-07-01 2018-09-30 0001770450 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:ForeignCurrencyGainLossMember 2019-01-01 2019-09-30 0001770450 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:ForeignCurrencyGainLossMember 2018-01-01 2018-09-30 0001770450 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:ForeignCurrencyGainLossMember 2019-07-01 2019-09-30 0001770450 xrx:SeniorNotesDue2021Member 2019-09-30 0001770450 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-30 0001770450 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001770450 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2019-01-01 2019-09-30 0001770450 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2018-01-01 2018-09-30 0001770450 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2018-07-01 2018-09-30 0001770450 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2018-07-01 2018-09-30 0001770450 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2019-01-01 2019-09-30 0001770450 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2019-07-01 2019-09-30 0001770450 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2019-07-01 2019-09-30 0001770450 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2018-01-01 2018-09-30 0001770450 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2019-01-01 2019-09-30 0001770450 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2018-01-01 2018-09-30 0001770450 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2019-07-01 2019-09-30 0001770450 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2018-07-01 2018-09-30 0001770450 xrx:SeniorNotesDue2021Member us-gaap:FairValueHedgingMember 2019-01-01 2019-09-30 0001770450 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001770450 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeForwardMember 2018-12-31 0001770450 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeForwardMember 2019-09-30 0001770450 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateSwapMember 2018-12-31 0001770450 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0001770450 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateSwapMember 2019-09-30 0001770450 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:OptionMember 2019-09-30 0001770450 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:OptionMember 2018-12-31 0001770450 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsNonrecurringMember 2019-09-30 0001770450 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsNonrecurringMember 2018-12-31 0001770450 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsNonrecurringMember 2018-12-31 0001770450 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsNonrecurringMember 2019-09-30 0001770450 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-09-30 0001770450 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-01-01 2018-12-31 0001770450 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-09-30 0001770450 srt:ScenarioForecastMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001770450 country:US us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-09-30 0001770450 us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-09-30 0001770450 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-12-31 0001770450 srt:ScenarioForecastMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001770450 srt:ScenarioForecastMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001770450 country:US us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-09-30 0001770450 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-09-30 0001770450 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-01-01 2018-09-30 0001770450 srt:ScenarioForecastMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-12-31 0001770450 country:US us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-12-31 0001770450 us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-12-31 0001770450 us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-09-30 0001770450 country:US us-gaap:QualifiedPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-09-30 0001770450 country:US us-gaap:PensionPlansDefinedBenefitMember 2019-07-01 2019-09-30 0001770450 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-07-01 2018-09-30 0001770450 country:US us-gaap:PensionPlansDefinedBenefitMember 2018-07-01 2018-09-30 0001770450 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-07-01 2019-09-30 0001770450 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-07-01 2018-09-30 0001770450 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-07-01 2019-09-30 0001770450 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-07-01 2018-09-30 0001770450 us-gaap:ParentMember 2018-07-01 2018-09-30 0001770450 us-gaap:NoncontrollingInterestMember 2018-07-01 2018-09-30 0001770450 us-gaap:NoncontrollingInterestMember 2018-09-30 0001770450 us-gaap:RetainedEarningsMember 2018-07-01 2018-09-30 0001770450 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001770450 us-gaap:NoncontrollingInterestMember 2018-06-30 0001770450 us-gaap:TreasuryStockMember 2018-07-01 2018-09-30 0001770450 us-gaap:RetainedEarningsMember 2018-06-30 0001770450 us-gaap:RetainedEarningsMember 2018-09-30 0001770450 us-gaap:ParentMember 2018-09-30 0001770450 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2018-09-30 0001770450 us-gaap:SeriesBPreferredStockMember us-gaap:ParentMember 2018-07-01 2018-09-30 0001770450 us-gaap:CommonStockMember 2018-09-30 0001770450 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0001770450 us-gaap:CommonStockMember 2018-06-30 0001770450 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0001770450 us-gaap:SeriesBPreferredStockMember us-gaap:RetainedEarningsMember 2018-07-01 2018-09-30 0001770450 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-30 0001770450 us-gaap:SeriesBPreferredStockMember 2018-07-01 2018-09-30 0001770450 us-gaap:ParentMember 2018-06-30 0001770450 us-gaap:CommonStockMember 2018-07-01 2018-09-30 0001770450 us-gaap:TreasuryStockMember 2018-06-30 0001770450 us-gaap:TreasuryStockMember 2018-09-30 0001770450 us-gaap:TreasuryStockMember 2019-07-01 2019-09-30 0001770450 us-gaap:ParentMember 2019-07-01 2019-09-30 0001770450 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001770450 us-gaap:ParentMember 2019-06-30 0001770450 us-gaap:CommonStockMember 2019-09-30 0001770450 us-gaap:SeriesBPreferredStockMember us-gaap:ParentMember 2019-07-01 2019-09-30 0001770450 us-gaap:NoncontrollingInterestMember 2019-09-30 0001770450 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001770450 us-gaap:TreasuryStockMember 2019-09-30 0001770450 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0001770450 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001770450 us-gaap:CommonStockMember 2019-07-01 2019-09-30 0001770450 us-gaap:NoncontrollingInterestMember 2019-06-30 0001770450 us-gaap:ParentMember 2019-09-30 0001770450 us-gaap:TreasuryStockMember 2019-06-30 0001770450 us-gaap:RetainedEarningsMember 2019-06-30 0001770450 us-gaap:RetainedEarningsMember 2019-09-30 0001770450 us-gaap:CommonStockMember 2019-06-30 0001770450 us-gaap:NoncontrollingInterestMember 2019-07-01 2019-09-30 0001770450 us-gaap:SeriesBPreferredStockMember 2019-07-01 2019-09-30 0001770450 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0001770450 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0001770450 us-gaap:SeriesBPreferredStockMember us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0001770450 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001770450 us-gaap:RetainedEarningsMember 2019-01-01 2019-09-30 0001770450 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-09-30 0001770450 us-gaap:SeriesBPreferredStockMember us-gaap:RetainedEarningsMember 2019-01-01 2019-09-30 0001770450 us-gaap:TreasuryStockMember 2019-01-01 2019-09-30 0001770450 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-09-30 0001770450 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0001770450 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001770450 us-gaap:NoncontrollingInterestMember 2018-12-31 0001770450 us-gaap:ParentMember 2019-01-01 2019-09-30 0001770450 us-gaap:SeriesBPreferredStockMember us-gaap:ParentMember 2019-01-01 2019-09-30 0001770450 us-gaap:SeriesBPreferredStockMember 2019-01-01 2019-09-30 0001770450 us-gaap:RetainedEarningsMember 2018-12-31 0001770450 us-gaap:ParentMember 2018-12-31 0001770450 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001770450 us-gaap:CommonStockMember 2019-01-01 2019-09-30 0001770450 us-gaap:CommonStockMember 2018-12-31 0001770450 us-gaap:TreasuryStockMember 2018-12-31 0001770450 us-gaap:SeriesBPreferredStockMember us-gaap:RetainedEarningsMember 2018-01-01 2018-09-30 0001770450 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001770450 us-gaap:ParentMember 2017-12-31 0001770450 us-gaap:TreasuryStockMember 2017-12-31 0001770450 us-gaap:SeriesBPreferredStockMember 2018-01-01 2018-09-30 0001770450 us-gaap:ParentMember 2018-01-01 2018-09-30 0001770450 us-gaap:RetainedEarningsMember 2018-01-01 2018-09-30 0001770450 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001770450 us-gaap:CommonStockMember 2017-12-31 0001770450 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-09-30 0001770450 us-gaap:SeriesBPreferredStockMember us-gaap:ParentMember 2018-01-01 2018-09-30 0001770450 us-gaap:TreasuryStockMember 2018-01-01 2018-09-30 0001770450 us-gaap:RetainedEarningsMember 2017-12-31 0001770450 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-09-30 0001770450 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-09-30 0001770450 us-gaap:NoncontrollingInterestMember 2017-12-31 0001770450 us-gaap:CommonStockMember 2018-01-01 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:RetainedEarningsMember 2018-12-31 0001770450 xrx:XeroxCorporationMember us-gaap:ParentMember 2019-01-01 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001770450 xrx:XeroxCorporationMember us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:CommonStockMember 2018-12-31 0001770450 xrx:XeroxCorporationMember us-gaap:CommonStockMember 2019-01-01 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:RetainedEarningsMember 2019-01-01 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:RetainedEarningsMember 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001770450 xrx:XeroxCorporationMember us-gaap:NoncontrollingInterestMember 2018-12-31 0001770450 xrx:XeroxCorporationMember us-gaap:NoncontrollingInterestMember 2019-01-01 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:NoncontrollingInterestMember 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:TreasuryStockMember 2019-01-01 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:TreasuryStockMember 2018-12-31 0001770450 xrx:XeroxCorporationMember us-gaap:ParentMember 2018-12-31 0001770450 xrx:XeroxCorporationMember us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:TreasuryStockMember 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:ParentMember 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:CommonStockMember 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:ParentMember 2018-06-30 0001770450 xrx:XeroxCorporationMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0001770450 xrx:XeroxCorporationMember us-gaap:ParentMember 2018-07-01 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:TreasuryStockMember 2018-07-01 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:CommonStockMember 2018-07-01 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:RetainedEarningsMember 2018-06-30 0001770450 xrx:XeroxCorporationMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-07-01 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:CommonStockMember 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:NoncontrollingInterestMember 2018-06-30 0001770450 xrx:XeroxCorporationMember us-gaap:RetainedEarningsMember 2018-07-01 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:NoncontrollingInterestMember 2018-07-01 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:RetainedEarningsMember 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:TreasuryStockMember 2018-06-30 0001770450 xrx:XeroxCorporationMember us-gaap:CommonStockMember 2018-06-30 0001770450 xrx:XeroxCorporationMember us-gaap:TreasuryStockMember 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:ParentMember 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001770450 xrx:XeroxCorporationMember us-gaap:NoncontrollingInterestMember 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:ParentMember 2019-07-01 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:TreasuryStockMember 2019-06-30 0001770450 xrx:XeroxCorporationMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001770450 xrx:XeroxCorporationMember us-gaap:TreasuryStockMember 2019-07-01 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:NoncontrollingInterestMember 2019-07-01 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:NoncontrollingInterestMember 2019-06-30 0001770450 xrx:XeroxCorporationMember us-gaap:CommonStockMember 2019-07-01 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001770450 xrx:XeroxCorporationMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:CommonStockMember 2019-06-30 0001770450 xrx:XeroxCorporationMember us-gaap:RetainedEarningsMember 2019-06-30 0001770450 xrx:XeroxCorporationMember us-gaap:ParentMember 2019-06-30 0001770450 xrx:XeroxCorporationMember us-gaap:NoncontrollingInterestMember 2017-12-31 0001770450 xrx:XeroxCorporationMember us-gaap:TreasuryStockMember 2018-01-01 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:RetainedEarningsMember 2018-01-01 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:TreasuryStockMember 2017-12-31 0001770450 xrx:XeroxCorporationMember us-gaap:ParentMember 2018-01-01 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:CommonStockMember 2017-12-31 0001770450 xrx:XeroxCorporationMember us-gaap:ParentMember 2017-12-31 0001770450 xrx:XeroxCorporationMember us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:RetainedEarningsMember 2017-12-31 0001770450 xrx:XeroxCorporationMember us-gaap:CommonStockMember 2018-01-01 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:NoncontrollingInterestMember 2018-01-01 2018-09-30 0001770450 xrx:XeroxCorporationMember us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001770450 xrx:XeroxCorporationMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001770450 us-gaap:PerformanceSharesMember xrx:Below30DollarsMember xrx:TSRMember 2019-01-01 2019-09-30 0001770450 us-gaap:PerformanceSharesMember xrx:A40DollarsandAboveMember xrx:TSRMember 2019-01-01 2019-09-30 0001770450 us-gaap:PerformanceSharesMember xrx:A35DollarsMember xrx:TSRMember 2019-01-01 2019-09-30 0001770450 us-gaap:PerformanceSharesMember xrx:A30DollarsMember xrx:TSRMember 2019-01-01 2019-09-30 0001770450 us-gaap:PerformanceSharesMember xrx:TSRMember 2019-01-01 2019-09-30 0001770450 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-09-30 0001770450 us-gaap:PerformanceSharesMember xrx:PerformanceBasedMember 2019-01-01 2019-09-30 0001770450 us-gaap:PerformanceSharesMember xrx:TSRMember xrx:ImpliedVolatilityMember 2019-01-01 2019-09-30 0001770450 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2019-01-01 2019-09-30 0001770450 us-gaap:PerformanceSharesMember xrx:TSRMember xrx:DailyStockReturnsMember 2019-01-01 2019-09-30 0001770450 us-gaap:PerformanceSharesMember xrx:TotalRevenueMember 2019-01-01 2019-09-30 0001770450 us-gaap:PerformanceSharesMember xrx:FreeCashFlowMember 2019-01-01 2019-09-30 0001770450 us-gaap:PerformanceSharesMember us-gaap:MeasurementInputSharePriceMember 2019-01-01 2019-09-30 0001770450 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2019-01-01 2019-09-30 0001770450 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2019-01-01 2019-09-30 0001770450 srt:MaximumMember 2019-01-01 2019-09-30 0001770450 srt:MinimumMember 2019-01-01 2019-09-30 0001770450 us-gaap:PerformanceSharesMember 2019-01-01 2019-09-30 0001770450 us-gaap:EmployeeStockOptionMember 2019-07-01 2019-09-30 0001770450 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-09-30 0001770450 us-gaap:ConvertiblePreferredStockMember 2019-01-01 2019-09-30 0001770450 xrx:RestrictedStockAndPerformanceSharesMember 2018-07-01 2018-09-30 0001770450 us-gaap:ConvertiblePreferredStockMember 2018-07-01 2018-09-30 0001770450 xrx:RestrictedStockAndPerformanceSharesMember 2019-07-01 2019-09-30 0001770450 xrx:RestrictedStockAndPerformanceSharesMember 2018-01-01 2018-09-30 0001770450 us-gaap:ConvertiblePreferredStockMember 2018-01-01 2018-09-30 0001770450 us-gaap:EmployeeStockOptionMember 2018-07-01 2018-09-30 0001770450 xrx:RestrictedStockAndPerformanceSharesMember 2019-01-01 2019-09-30 0001770450 xrx:RestrictedStockAndPerformanceSharesMember 2018-01-01 2018-09-30 0001770450 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-09-30 0001770450 us-gaap:ConvertiblePreferredStockMember 2019-01-01 2019-09-30 0001770450 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-09-30 0001770450 us-gaap:ConvertiblePreferredStockMember 2018-01-01 2018-09-30 0001770450 us-gaap:EmployeeStockOptionMember 2018-07-01 2018-09-30 0001770450 xrx:RestrictedStockAndPerformanceSharesMember 2019-01-01 2019-09-30 0001770450 us-gaap:ConvertiblePreferredStockMember 2019-07-01 2019-09-30 0001770450 us-gaap:EmployeeStockOptionMember 2019-07-01 2019-09-30 0001770450 us-gaap:ConvertiblePreferredStockMember 2018-07-01 2018-09-30 0001770450 xrx:RestrictedStockAndPerformanceSharesMember 2019-07-01 2019-09-30 0001770450 us-gaap:ConvertiblePreferredStockMember 2019-07-01 2019-09-30 0001770450 xrx:RestrictedStockAndPerformanceSharesMember 2018-07-01 2018-09-30 0001770450 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-09-30 0001770450 xrx:BrazilContingenciesMember 2018-12-31 0001770450 xrx:BrazilContingenciesMember 2019-09-30 0001770450 us-gaap:PerformanceGuaranteeMember 2019-09-30 0001770450 xrx:TransactionsToCombineXeroxAndFujiXeroxMember us-gaap:PendingLitigationMember 2018-06-18 0001770450 xrx:TransactionsToCombineXeroxAndFujiXeroxMember us-gaap:PendingLitigationMember 2018-02-01 2018-02-28 0001770450 2014-05-09 2014-05-09 0001770450 xrx:TransactionsToCombineXeroxAndFujiXeroxMember us-gaap:PendingLitigationMember 2018-06-18 2018-06-18 0001770450 xrx:ConduentEntitiesMember 2019-02-15 2019-02-15 0001770450 xrx:FUJIFILMAsiaPacificPte.Ltd.Member xrx:FujiXeroxCo.Ltd.Member us-gaap:SubsequentEventMember 2019-11-08 2019-11-08 0001770450 us-gaap:SubsequentEventMember 2019-11-08 2019-11-08 0001770450 xrx:FujiXeroxCo.Ltd.Member us-gaap:SubsequentEventMember 2019-11-05 2019-11-05 0001770450 xrx:XeroxHoldingsCorporationMember xrx:FujiXeroxCo.Ltd.Member us-gaap:SubsequentEventMember 2019-11-04 0001770450 us-gaap:SeniorNotesMember xrx:SeniorNotesDue2019Member us-gaap:SubsequentEventMember 2019-11-08 2019-11-08 0001770450 xrx:XeroxHoldingsCorporationMember xrx:FujiXeroxCo.Ltd.Member us-gaap:SubsequentEventMember 2019-11-05 2019-11-05 0001770450 xrx:FUJIFILMAsiaPacificPte.Ltd.Member us-gaap:SubsequentEventMember 2019-11-05 2019-11-05 0001770450 xrx:XeroxCorporationMember xrx:FujiXeroxCo.Ltd.Member us-gaap:SubsequentEventMember 2019-11-05 2019-11-05 0001770450 srt:SubsidiariesMember xrx:XeroxHoldingsCorporationMember us-gaap:SubsequentEventMember 2019-11-05 2019-11-05 0001770450 xrx:FujiXeroxCo.Ltd.Member us-gaap:SubsequentEventMember 2019-11-08 2019-11-08 0001770450 xrx:XeroxCorporationMember xrx:FujiXeroxCo.Ltd.Member us-gaap:SubsequentEventMember 2019-11-05 xbrli:pure iso4217:USD xbrli:shares iso4217:USD xbrli:shares xrx:employee xrx:Employees iso4217:JPY xrx:complaint xrx:trading_day xrx:class_action

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended: September 30, 2019
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                        to
https://cdn.kscope.io/4367b8c46193a5347e24add5672640dd-xeroxlogoredrgbtma07.jpg
XEROX HOLDINGS CORPORATION
XEROX CORPORATION
 (Exact Name of Registrant as specified in its charter)
New York
001-39013
83-3933743
New York
001-04471
16-0468020
(State or other jurisdiction of incorporation or organization)
(Commission File Number)
(IRS Employer
Identification No.)
 
 
 
 
P.O. Box 4505, 201 Merritt 7
Norwalk, Connecticut 06851-1056
 
 
(Address of principal executive offices)
 
 
 
 
(203) 968-3000
(Registrant's telephone number, including area code)
 
Securities registered pursuant to Section 12(b) of the Act:
Common Stock, $1 par value
XRX
New York Stock Exchange
Title of each class
Trading Symbol
Name of each exchange on which registered
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. 
Xerox Holdings Corporation Yes  No               Xerox Corporation Yes  No 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). 
Xerox Holdings Corporation Yes  No               Xerox Corporation Yes  No 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.            
Xerox Holdings Corporation
 
 
Xerox Corporation
 
Large accelerated filer
 
Large accelerated filer
Accelerated filer
 
Accelerated filer
Non-accelerated filer
 
Non-accelerated filer
Smaller reporting company
 
Smaller reporting company
Emerging growth company
 
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Xerox Holdings Corporation o     Xerox Corporation o
Indicate by a check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Xerox Holdings Corporation Yes  No               Xerox Corporation Yes  No 
Class
 
Outstanding at October 31, 2019
Xerox Holdings Corporation Common Stock, $1 par value
 
216,188,261 shares



Table of Contents                                  
 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q and any exhibits to this Report contain “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. The words “anticipate”, “believe”, “estimate”, “expect”, “intend”, “will”, “should”, "targeting", "projecting", "driving" and similar expressions, as they relate to us, our performance and/or our technology, are intended to identify forward-looking statements. These statements reflect management’s current beliefs, assumptions and expectations and are subject to a number of factors that may cause actual results to differ materially. Such factors include but are not limited to: our ability to address our business challenges in order to reverse revenue declines, reduce costs and increase productivity so that we can invest in and grow our business; our ability to attract and retain key personnel; changes in economic and political conditions, trade protection measures, licensing requirements and tax laws in the United States and in the foreign countries in which we do business; the imposition of new or incremental trade protection measures such as tariffs and import or export restrictions; changes in foreign currency exchange rates; our ability to successfully develop new products, technologies and service offerings and to protect our intellectual property rights; the risk that multi-year contracts with governmental entities could be terminated prior to the end of the contract term and that civil or criminal penalties and administrative sanctions could be imposed on us if we fail to comply with the terms of such contracts and applicable law; the risk that partners, subcontractors and software vendors will not perform in a timely, quality manner; actions of competitors and our ability to promptly and effectively react to changing technologies and customer expectations; our ability to obtain adequate pricing for our products and services and to maintain and improve cost efficiency of operations, including savings from restructuring actions; the risk that confidential and/or individually identifiable information of ours, our customers, clients and employees could be inadvertently disclosed or disclosed as a result of a breach of our security systems due to cyber attacks or other intentional acts; reliance on third parties, including subcontractors, for manufacturing of products and provision of services; the exit of the United Kingdom from the European Union; our ability to manage changes in the printing environment and expand equipment placements; interest rates, cost of borrowing and access to credit markets; funding requirements associated with our employee pension and retiree health benefit plans; the risk that our operations and products may not comply with applicable worldwide regulatory requirements, particularly environmental regulations and directives and anti-corruption laws; the outcome of litigation and regulatory proceedings to which we may be a party; any potential termination or restructuring of our relationship with Fujifilm Holdings Corporation; the shared services arrangements entered into by us as part of Project Own It; and other factors that are set forth in the “Risk Factors” section, the “Legal Proceedings” section, the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section and other sections of this Quarterly Report on Form 10-Q, and Xerox Corporation's 2018 Annual Report on Form 10-K, as well as in Xerox Corporation's and Xerox Holdings Corporation's Quarterly Reports on Form 10-Q and Current Reports on Form 8-K filed with the Securities and Exchange Commission (SEC). These forward-looking statements speak only as of the date of this report or as of the date to which they refer, and Xerox assumes no obligation to update any forward looking statements as a result of new information or future events or developments, except as required by law.


Xerox 2019 Form 10-Q
1


Table of Contents                                  
 

XEROX HOLDINGS CORPORATION
XEROX CORPORATION
FORM 10-Q
September 30, 2019
TABLE OF CONTENTS
 
 
Page
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For additional information about Xerox Holdings Corporation and Xerox Corporation and access to our Annual Reports to Shareholders and SEC filings, free of charge, please visit our website at www.xerox.com/investor. Any information on or linked from the website is not incorporated by reference into this Form 10-Q.
 

Xerox 2019 Form 10-Q
2


Table of Contents                                  
 

PART I — FINANCIAL INFORMATION
ITEM 1 — FINANCIAL STATEMENTS

XEROX HOLDINGS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
(in millions, except per-share data)
 
2019
 
2018
 
2019
 
2018
Revenues
 
 
 
 
 
 
 
 
Sales(1)
 
$
804

 
$
856

 
$
2,379

 
$
2,628

Services, maintenance and rentals(1)
 
1,336

 
1,431

 
4,132

 
4,465

Financing
 
60

 
65

 
184

 
204

Total Revenues
 
2,200

 
2,352

 
6,695

 
7,297

Costs and Expenses
 
 
 
 
 
 
 
 
Cost of sales(1)
 
515

 
539

 
1,531

 
1,664

Cost of services, maintenance and rentals(1)
 
772

 
838

 
2,400

 
2,620

Cost of financing
 
33

 
33

 
98

 
100

Research, development and engineering expenses
 
100

 
102

 
280

 
303

Selling, administrative and general expenses
 
513

 
583

 
1,580

 
1,835

Restructuring and related costs
 
27

 
29

 
176

 
91

Amortization of intangible assets
 
9

 
12

 
35

 
36

Transaction and related costs, net
 
4

 
(33
)
 
8

 
63

Other expenses, net
 
(3
)
 
57

 
74

 
126

Total Costs and Expenses
 
1,970

 
2,160

 
6,182

 
6,838

Income before Income Taxes and Equity Income
 
230

 
192

 
513

 
459

Income tax expense
 
66

 
142

 
108

 
220

Equity in net income (loss) of unconsolidated affiliates
 
58

 
43

 
137

 
(6
)
Net Income
 
222

 
93

 
542

 
233

Less: Net income attributable to noncontrolling interests
 
1

 
4

 
7

 
9

Net Income Attributable to Xerox Holdings
 
$
221

 
$
89

 
$
535

 
$
224

 
 
 
 
 
 
 
 
 
Basic Earnings per Share
 
$
0.99

 
$
0.34

 
$
2.34

 
$
0.84

Diluted Earnings per Share
 
$
0.96

 
$
0.34

 
$
2.27

 
$
0.83

_____________
(1)
Certain prior year amounts have been conformed to the current year presentation. Refer to Note 1 - Basis of Presentation for additional information.



The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

Xerox 2019 Form 10-Q
3


Table of Contents                                  
 

XEROX HOLDINGS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
(in millions)
 
2019
 
2018
 
2019
 
2018
Net Income
 
$
222

 
$
93

 
$
542

 
$
233

Less: Net income attributable to noncontrolling interests
 
1

 
4

 
7

 
9

Net Income Attributable to Xerox Holdings
 
221

 
89

 
535

 
224

 
 
 
 
 
 
 
 
 
Other Comprehensive (Loss) Income, Net(1)
 
 
 
 
 
 
 
 
Translation adjustments, net
 
(155
)
 
(13
)
 
(122
)
 
(159
)
Unrealized gains (losses), net
 
1

 
(9
)
 
3

 
5

Changes in defined benefit plans, net
 
(48
)
 
83

 
(38
)
 
191

Other Comprehensive (Loss) Income, Net
 
(202
)
 
61

 
(157
)
 
37

Less: Other comprehensive income, net attributable to noncontrolling interests
 
1

 

 
1

 

Other Comprehensive (Loss) Income, Net Attributable to Xerox Holdings
 
(203
)
 
61

 
(158
)
 
37

 
 
 
 
 
 
 
 
 
Comprehensive Income, Net
 
20

 
154

 
385

 
270

Less: Comprehensive income, net attributable to noncontrolling interests
 
2

 
4

 
8

 
9

Comprehensive Income, Net Attributable to Xerox Holdings
 
$
18

 
$
150

 
$
377

 
$
261

__________________________

(1) Refer to Note 20 - Other Comprehensive (Loss) Income for gross components of Other comprehensive (loss) income, net, reclassification adjustments out of Accumulated other comprehensive loss and related tax effects.


The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.


Xerox 2019 Form 10-Q
4


Table of Contents                                  
 

XEROX HOLDINGS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(in millions, except share data in thousands)
 
September 30,
2019
 
December 31,
2018
Assets
 
 
 
 
Cash and cash equivalents
 
$
922

 
$
1,084

Accounts receivable, net
 
1,188

 
1,276

Billed portion of finance receivables, net
 
106

 
105

Finance receivables, net
 
1,145

 
1,218

Inventories
 
758

 
818

Other current assets
 
221

 
194

Total current assets
 
4,340

 
4,695

Finance receivables due after one year, net
 
2,037

 
2,149

Equipment on operating leases, net
 
374

 
442

Land, buildings and equipment, net
 
442

 
499

Investments in affiliates, at equity
 
1,517

 
1,403

Intangible assets, net
 
203

 
220

Goodwill
 
3,853

 
3,867

Deferred tax assets
 
688

 
740

Other long-term assets
 
1,206

 
859

Total Assets
 
$
14,660

 
$
14,874

Liabilities and Equity
 
 
 
 
Short-term debt and current portion of long-term debt
 
$
1,602

 
$
961

Accounts payable
 
1,070

 
1,091

Accrued compensation and benefits costs
 
321

 
349

Accrued expenses and other current liabilities
 
930

 
850

Total current liabilities
 
3,923

 
3,251

Long-term debt
 
3,230

 
4,269

Pension and other benefit liabilities
 
1,599

 
1,482

Post-retirement medical benefits
 
335

 
350

Other long-term liabilities
 
473

 
269

Total Liabilities
 
9,560

 
9,621

 
 
 
 
 
Commitments and Contingencies (See Note 22)
 


 


Convertible Preferred Stock
 
214

 
214

 
 
 
 
 
Common stock
 
221

 
232

Additional paid-in capital
 
3,000

 
3,321

Treasury stock, at cost
 
(68
)
 
(55
)
Retained earnings
 
5,552

 
5,072

Accumulated other comprehensive loss
 
(3,850
)
 
(3,565
)
Xerox Holdings shareholders’ equity
 
4,855

 
5,005

Noncontrolling interests
 
31

 
34

Total Equity
 
4,886

 
5,039

Total Liabilities and Equity
 
$
14,660

 
$
14,874

 
 
 
 
 
Shares of common stock issued
 
221,292

 
231,690

Treasury stock
 
(2,329
)
 
(2,067
)
Shares of Common Stock Outstanding
 
218,963

 
229,623




The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

Xerox 2019 Form 10-Q
5


Table of Contents                                  
 

XEROX HOLDINGS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
(in millions)
 
2019
 
2018
 
2019
 
2018
Cash Flows from Operating Activities
 
 
 
 
 
 
 
 
Net income
 
$
222

 
$
93

 
$
542

 
$
233

Adjustments required to reconcile Net income to Cash flows from operating activities
 
 
 
 
 
 
 
 
Depreciation and amortization
 
104

 
122

 
332

 
398

Provisions
 
16

 
16

 
58

 
56

Net gain on sales of businesses and assets
 
(19
)
 
(3
)
 
(20
)
 
(35
)
Undistributed equity in net income of unconsolidated affiliates
 
(59
)
 
(43
)
 
(102
)
 
9

Stock-based compensation
 
11

 
15

 
41

 
44

Restructuring and asset impairment charges
 
8

 
29

 
80

 
91

Payments for restructurings
 
(17
)
 
(39
)
 
(71
)
 
(130
)
Defined benefit pension cost
 
21

 
36

 
89

 
89

Contributions to defined benefit pension plans
 
(37
)
 
(36
)
 
(107
)
 
(111
)
Decrease in accounts receivable and billed portion of finance receivables
 
51

 
1

 
62

 
37

Decrease (increase) in inventories
 
16

 
(20
)
 
33

 
(91
)
Increase in equipment on operating leases
 
(41
)
 
(63
)
 
(113
)
 
(182
)
Decrease in finance receivables
 
5

 
39

 
124

 
181

(Increase) decrease in other current and long-term assets
 
(14
)
 
(4
)
 
1

 
17

Increase (decrease) in accounts payable
 
21

 
(31
)
 
(34
)
 
12

(Decrease) increase in accrued compensation
 
(15
)
 
4

 
(99
)
 
(97
)
Increase in other current and long-term liabilities
 
27

 
15

 
19

 
11

Net change in income tax assets and liabilities
 
40

 
124

 
27

 
165

Net change in derivative assets and liabilities
 
5

 
21

 
15

 
(2
)
Other operating, net
 
11

 
(2
)
 
18

 
30

Net cash provided by operating activities
 
356

 
274

 
895

 
725

Cash Flows from Investing Activities
 
 
 
 
 
 
 
 
Cost of additions to land, buildings, equipment and software
 
(17
)
 
(23
)
 
(48
)
 
(73
)
Proceeds from sales of businesses and assets
 
20

 

 
21

 
32

Acquisitions, net of cash acquired
 

 

 
(42
)
 

Other investing, net
 
1

 

 
1

 
1

Net cash provided by (used in) investing activities
 
4

 
(23
)
 
(68
)
 
(40
)
Cash Flows from Financing Activities
 
 
 
 
 
 
 
 
Net payments on short-term debt
 

 
(1
)
 

 
(2
)
Proceeds from issuance of long-term debt
 
2

 
2

 
7

 
7

Payments on long-term debt
 

 
(1
)
 
(406
)
 
(311
)
Dividends
 
(61
)
 
(69
)
 
(183
)
 
(204
)
Payments to acquire treasury stock, including fees
 
(68
)
 
(284
)
 
(368
)
 
(284
)
Other financing, net
 
(10
)
 
(6
)
 
(33
)
 
(21
)
Net cash used in financing activities
 
(137
)
 
(359
)
 
(983
)
 
(815
)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
 
(20
)
 
(1
)
 
(13
)
 
(20
)
Increase (decrease) in cash, cash equivalents and restricted cash
 
203

 
(109
)
 
(169
)
 
(150
)
Cash, cash equivalents and restricted cash at beginning of period
 
776

 
1,327

 
1,148

 
1,368

Cash, Cash Equivalents and Restricted Cash at End of Period
 
$
979

 
$
1,218

 
$
979

 
$
1,218



The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.


Xerox 2019 Form 10-Q
6


Table of Contents                                  
 

XEROX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
(in millions, except per-share data)
 
2019
 
2018
 
2019
 
2018
Revenues
 
 
 
 
 
 
 
 
Sales(1)
 
$
804

 
$
856

 
$
2,379

 
$
2,628

Services, maintenance and rentals(1)
 
1,336

 
1,431

 
4,132

 
4,465

Financing
 
60

 
65

 
184

 
204

Total Revenues
 
2,200

 
2,352

 
6,695

 
7,297

Costs and Expenses
 
 
 
 
 
 
 
 
Cost of sales(1)
 
515

 
539

 
1,531

 
1,664

Cost of services, maintenance and rentals(1)
 
772

 
838

 
2,400

 
2,620

Cost of financing
 
33

 
33

 
98

 
100

Research, development and engineering expenses
 
100

 
102

 
280

 
303

Selling, administrative and general expenses
 
513

 
583

 
1,580

 
1,835

Restructuring and related costs
 
27

 
29

 
176

 
91

Amortization of intangible assets
 
9

 
12

 
35

 
36

Transaction and related costs, net
 
4

 
(33
)
 
8

 
63

Other expenses, net
 
(3
)
 
57

 
74

 
126

Total Costs and Expenses
 
1,970

 
2,160

 
6,182

 
6,838

Income before Income Taxes and Equity Income
 
230

 
192

 
513

 
459

Income tax expense
 
66

 
142

 
108

 
220

Equity in net income (loss) of unconsolidated affiliates
 
58

 
43

 
137

 
(6
)
Net Income
 
222

 
93

 
542

 
233

Less: Net income attributable to noncontrolling interests
 
1

 
4

 
7

 
9

Net Income Attributable to Xerox
 
$
221

 
$
89

 
$
535

 
$
224

_____________
(1)
Certain prior year amounts have been conformed to the current year presentation. Refer to Note 1 - Basis of Presentation for additional information.



The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.


Xerox 2019 Form 10-Q
7


Table of Contents                                  
 

XEROX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
(in millions)
 
2019
 
2018
 
2019
 
2018
Net Income
 
$
222

 
$
93

 
$
542

 
$
233

Less: Net income attributable to noncontrolling interests
 
1

 
4

 
7

 
9

Net Income Attributable to Xerox
 
221

 
89

 
535

 
224

 
 
 
 
 
 
 
 
 
Other Comprehensive (Loss) Income, Net(1)
 

 

 

 

Translation adjustments, net
 
(155
)
 
(13
)
 
(122
)
 
(159
)
Unrealized gains (losses), net
 
1

 
(9
)
 
3

 
5

Changes in defined benefit plans, net
 
(48
)
 
83

 
(38
)
 
191

Other Comprehensive (Loss) Income, Net
 
(202
)
 
61

 
(157
)
 
37

Less: Other comprehensive income, net attributable to noncontrolling interests
 
1

 

 
1

 

Other Comprehensive (Loss) Income, Net Attributable to Xerox
 
(203
)
 
61

 
(158
)
 
37

 
 
 
 
 
 
 
 
 
Comprehensive Income, Net
 
20

 
154

 
385

 
270

Less: Comprehensive income, net attributable to noncontrolling interests
 
2

 
4

 
8

 
9

Comprehensive Income, Net Attributable to Xerox
 
$
18

 
$
150

 
$
377

 
$
261

__________________________

(1) Refer to Note 20 - Other Comprehensive (Loss) Income for gross components of Other comprehensive (loss) income, net, reclassification adjustments out of Accumulated other comprehensive loss and related tax effects.



The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.


Xerox 2019 Form 10-Q
8


Table of Contents                                  
 

XEROX CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(in millions, except share data in thousands)
 
September 30,
2019
 
December 31,
2018
Assets
 
 
 
 
Cash and cash equivalents
 
$
922

 
$
1,084

Accounts receivable, net
 
1,188

 
1,276

Billed portion of finance receivables, net
 
106

 
105

Finance receivables, net
 
1,145

 
1,218

Inventories
 
758

 
818

Other current assets
 
229

 
194

Total current assets
 
4,348

 
4,695

Finance receivables due after one year, net
 
2,037

 
2,149

Equipment on operating leases, net
 
374

 
442

Land, buildings and equipment, net
 
442

 
499

Investments in affiliates, at equity
 
1,517

 
1,403

Intangible assets, net
 
203

 
220

Goodwill
 
3,853

 
3,867

Deferred tax assets
 
688

 
740

Other long-term assets
 
1,206

 
859

Total Assets
 
$
14,668

 
$
14,874

Liabilities and Equity
 
 
 
 
Short-term debt and current portion of long-term debt
 
$
1,602

 
$
961

Accounts payable
 
1,070

 
1,091

Accrued compensation and benefits costs
 
321

 
349

Accrued expenses and other current liabilities
 
862

 
850

Total current liabilities
 
3,855

 
3,251

Long-term debt
 
3,230

 
4,269

Pension and other benefit liabilities
 
1,599

 
1,482

Post-retirement medical benefits
 
335

 
350

Other long-term liabilities
 
473

 
269

Total Liabilities
 
9,492

 
9,621

 
 
 
 
 
Commitments and Contingencies (See Note 22)
 


 


Convertible Preferred Stock
 

 
214

 
 
 
 
 
Common stock
 

 
232

Additional paid-in capital
 
3,441

 
3,321

Treasury stock, at cost
 

 
(55
)
Retained earnings
 
5,554

 
5,072

Accumulated other comprehensive loss
 
(3,850
)
 
(3,565
)
Xerox shareholders’ equity
 
5,145

 
5,005

Noncontrolling interests
 
31

 
34

Total Equity
 
5,176

 
5,039

Total Liabilities and Equity
 
$
14,668

 
$
14,874

 
 
 
 
 
Shares of common stock issued
 

 
231,690

Treasury stock
 

 
(2,067
)
Shares of Common Stock Outstanding
 

 
229,623





The accompanying notes are an integral part of these Condensed Consolidated Financial Statements. 

Xerox 2019 Form 10-Q
9


Table of Contents                                  
 

XEROX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
(in millions)
 
2019
 
2018
 
2019
 
2018
Cash Flows from Operating Activities
 
 
 
 
 
 
 
 
Net income
 
$
222

 
$
93

 
$
542

 
$
233

Adjustments required to reconcile Net income to Cash flows from operating activities
 
 
 
 
 
 
 
 
Depreciation and amortization
 
104

 
122

 
332

 
398

Provisions
 
16

 
16

 
58

 
56

Net gain on sales of businesses and assets
 
(19
)
 
(3
)
 
(20
)
 
(35
)
Undistributed equity in net income of unconsolidated affiliates
 
(59
)
 
(43
)
 
(102
)
 
9

Stock-based compensation
 
11

 
15

 
41

 
44

Restructuring and asset impairment charges
 
8

 
29

 
80

 
91

Payments for restructurings
 
(17
)
 
(39
)
 
(71
)
 
(130
)
Defined benefit pension cost
 
21

 
36

 
89

 
89

Contributions to defined benefit pension plans
 
(37
)
 
(36
)
 
(107
)
 
(111
)
Decrease in accounts receivable and billed portion of finance receivables
 
51

 
1

 
62

 
37

Decrease (increase) in inventories
 
16

 
(20
)
 
33

 
(91
)
Increase in equipment on operating leases
 
(41
)
 
(63
)
 
(113
)
 
(182
)
Decrease in finance receivables
 
5

 
39

 
124

 
181

(Increase) decrease in other current and long-term assets
 
(14
)
 
(4
)
 
1

 
17

Increase (decrease) in accounts payable
 
21

 
(31
)
 
(34
)
 
12

(Decrease) increase in accrued compensation
 
(15
)
 
4

 
(99
)
 
(97
)
Increase in other current and long-term liabilities
 
27

 
15

 
19

 
11

Net change in income tax assets and liabilities
 
40

 
124

 
27

 
165

Net change in derivative assets and liabilities
 
5

 
21

 
15

 
(2
)
Other operating, net
 
11

 
(2
)
 
18

 
30

Net cash provided by operating activities
 
356

 
274

 
895

 
725

Cash Flows from Investing Activities
 
 
 
 
 
 
 
 
Cost of additions to land, buildings, equipment and software
 
(17
)
 
(23
)
 
(48
)
 
(73
)
Proceeds from sales of businesses and assets
 
20

 

 
21

 
32

Acquisitions, net of cash acquired
 

 

 
(42
)
 

Other investing, net
 
1

 

 
1

 
1

Net cash provided by (used in) investing activities
 
4

 
(23
)
 
(68
)
 
(40
)
Cash Flows from Financing Activities
 
 
 
 
 
 
 
 
Net payments on short-term debt
 

 
(1
)
 

 
(2
)
Proceeds from issuance of long-term debt
 
2

 
2

 
7

 
7

Payments on long-term debt
 

 
(1
)
 
(406
)
 
(311
)
Dividends
 
(59
)
 
(69
)
 
(181
)
 
(204
)
Payments to acquire treasury stock, including fees
 

 
(284
)
 
(300
)
 
(284
)
Distributions to parent
 
(73
)
 

 
(73
)
 

Other financing, net
 
(7
)
 
(6
)
 
(30
)
 
(21
)
Net cash used in financing activities
 
(137
)
 
(359
)
 
(983
)
 
(815
)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
 
(20
)
 
(1
)
 
(13
)
 
(20
)
Increase (decrease) in cash, cash equivalents and restricted cash
 
203

 
(109
)
 
(169
)
 
(150
)
Cash, cash equivalents and restricted cash at beginning of period
 
776

 
1,327

 
1,148

 
1,368

Cash, Cash Equivalents and Restricted Cash at End of Period
 
$
979

 
$
1,218

 
$
979

 
$
1,218



The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

Xerox 2019 Form 10-Q
10


Table of Contents                                  
 

XEROX HOLDINGS CORPORATION
XEROX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(in millions, except per-share data and where otherwise noted)

Note 1 – Basis of Presentation
References to “Xerox Holdings” refer to Xerox Holdings Corporation and its consolidated subsidiaries while references to “Xerox” refer to Xerox Corporation and its consolidated subsidiaries. References herein to “we,” “us,” “our,” the “Company” refer collectively to both Xerox Holdings and Xerox unless the context suggests otherwise.

The accompanying unaudited Condensed Consolidated Financial Statements represent the respective, consolidated results and financial results of Xerox Holdings and Xerox and all respective companies that each registrant directly or indirectly controls, either through majority ownership or otherwise. This is a combined report of Xerox Holdings and Xerox, which includes separate unaudited Condensed Consolidated Financial Statements for each registrant.
The accompanying unaudited Condensed Consolidated Financial Statements have been prepared for both registrants in accordance with the accounting policies described in Xerox's 2018 Annual Report on Form 10-K ("2018 Annual Report") except as noted herein, and the interim reporting requirements of Form 10-Q. Accordingly, certain information and note disclosures normally included in our annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. You should read these Condensed Consolidated Financial Statements in conjunction with the Consolidated Financial Statements included in Xerox's 2018 Annual Report.
In our opinion, all adjustments, which are necessary for a fair statement of financial position, operating results and cash flows for the interim periods presented, have been made. These adjustments consist of normal recurring items. Interim results of operations are not necessarily indicative of the results of the full year.
For convenience and ease of reference, we refer to the financial statement caption “Income before Income Taxes and Equity Income” as “pre-tax income.”
Notes to the Condensed Consolidated Financial Statements reflect the activity for both Xerox Holdings and Xerox for all periods presented, unless otherwise noted.
Corporate Reorganization
On March 6, 2019, the Xerox Board of Directors approved a reorganization (the “Reorganization”) of the Company's corporate structure into a holding company structure. The Reorganization was subject to the approval of shareholders, which was obtained at the annual shareholders meeting held May 21, 2019.
On July 31, 2019, Xerox completed the Reorganization, pursuant to which Xerox became a direct, wholly-owned subsidiary of Xerox Holdings. The business operations, directors and executive officers of the Company did not change as a result of the Reorganization.
In this Reorganization, shareholders of Xerox (the predecessor publicly held parent company) became shareholders of Xerox Holdings on a one-for-one basis; maintaining the same number of shares and ownership percentage as held in Xerox immediately prior to the Reorganization. In addition, the individual holder of the shares of Xerox’s Series B Preferred Stock exchanged those shares for the same number of shares of Xerox Holdings Series A Preferred Stock. Each share of Xerox Holdings Series A Preferred Stock has the same designations, rights, powers and preferences, and the same qualifications, limitations and restrictions as the shares of Xerox Series B Preferred Stock, with the addition of certain voting rights. In connection with the Reorganization, Xerox Holdings assumed each of the Xerox stock plans, all unexercised and unexpired options to purchase Xerox common stock and each right to acquire or vest in a share of Xerox common stock, including restricted stock unit awards, performance share awards and deferred stock units that are outstanding under the Xerox stock plans. In addition, Xerox Holdings became a guarantor of Xerox’s existing Credit Facility.
The Reorganization was accounted for as a transaction among entities under common control and is expected to be a tax-free transaction for U.S. federal income tax purposes. Shares of Xerox Holdings common stock trade on the New York Stock Exchange under the ticker symbol “XRX”, formerly used by Xerox.
Subsequent to the Reorganization, Xerox Holdings contributed the Xerox Series B Preferred Stock it held to Xerox in exchange for additional capital and Xerox subsequently extinguished the Series B Preferred Stock. The contribution and extinguishment were recorded at carrying value. In addition, the capital structure of Xerox was modified such that

Xerox 2019 Form 10-Q
11


Table of Contents                                  
 

its issued and outstanding common shares now held by Xerox Holdings were exchanged for 100 shares of Xerox $1 par value common stock. Accordingly, we reclassified approximately $221 from Xerox’s Common stock to Additional paid-in capital.
Shared Services Arrangement with HCL Technologies
In March 2019, as part of Project Own It, we entered into a shared services arrangement with HCL Technologies (HCL) pursuant to which we are outsourcing certain global administrative and support functions, including, among others, selected information technology and finance functions (excluding accounting). The transition of these functions to HCL is expected to take up to 18 months. HCL is expected to make certain up-front and ongoing investments in software, tools and other technology to consolidate, optimize and automate the transferred functions with the goal of providing improved service levels and significant cost savings. The shared services arrangement with HCL includes a total aggregate spending commitment by us of approximately $1.3 billion over the next 7 years. However, we can terminate the arrangement at any time at our discretion, subject to payment of termination fees that decline over the term or for cause. The spending commitment excludes restructuring and related costs we are expected to incur in connection with the transition of the contemplated functions - refer to Note 12 - Restructuring Programs for additional information. The transfer of employees associated with the HCL arrangement in certain countries is subject to compliance with works council and other employment regulatory requirements in those countries, which may delay the transfer as well as the expected savings from the arrangement.
We incurred net charges of approximately $38 and $68 for three and nine months ended September 30, 2019, respectively, associated with this arrangement. The cost has been allocated to the various functional expense lines in the Condensed Consolidated Income Statements based on an assessment of the nature and amount of the costs incurred for the various transferred functions prior to their transfer to HCL.
Change in Presentation
During first quarter 2019, we realigned portions of our business to support our new revenue strategy. This realignment included the combination and consolidation of certain sales units to better service customers consistently across the company. In connection with that realignment, we changed the classification of revenues and related costs from certain service arrangements to consistently conform the presentation of those amounts among our various business units. Prior year amounts were also revised as follows to conform to the 2019 presentation.
 
 
Three Months Ended September 30, 2018
 
 
As Reported
 
Change
 
As Revised
Sales
 
$
943

 
$
(87
)
 
$
856

Services, maintenance and rentals
 
1,344

 
87

 
1,431

 
 
 
 
 
 
 
Cost of sales
 
$
570

 
$
(31
)
 
$
539

Cost of services, maintenance and rentals
 
807

 
31

 
838

 
 
Nine Months Ended September 30, 2018
 
 
As Reported
 
Change
 
As Revised
Sales
 
$
2,893

 
$
(265
)
 
$
2,628

Services, maintenance and rentals
 
4,200

 
265

 
4,465

 
 
 
 
 
 
 
Cost of sales
 
$
1,755

 
$
(91
)
 
$
1,664

Cost of services, maintenance and rentals
 
2,529

 
91

 
2,620


The revised presentation does not impact Total Revenues, Total Costs and Expenses or Net Income.

Xerox 2019 Form 10-Q
12


Table of Contents                                  
 

Note 2 – Recent Accounting Pronouncements
Xerox Holdings and Xerox consider the applicability and impact of all Accounting Standards Updates (ASUs) issued by the Financial Accounting Standards Board (FASB). The ASUs listed below apply to both registrants. ASUs not listed below were assessed and determined to be not applicable to the Consolidated Financial Statements of either registrant.
Accounting Standard Updates to be Adopted:
Financial Instruments - Credit Losses
In June 2016, the FASB issued ASU 2016-13, Financial Instruments Credit Losses - Measurement of Credit Losses on Financial Instruments, with additional updates and amendments being issued in 2018 and 2019. This update requires measurement and recognition of expected credit losses for financial assets on an expected loss model rather than an incurred loss model. The update impacts financial assets including net investment in leases that are not accounted for at fair value through Net Income. This update is effective for our fiscal year beginning January 1, 2020. We continue to evaluate the impact of the adoption of ASU 2016-13, which is expected to primarily impact the estimation of our Allowance for doubtful accounts for Accounts Receivables and Finance Receivables. We currently do not expect the new guidance to have a material impact on our financial condition, results of operations or cash flows however, the impact will be dependent on future economic conditions.
Intangibles - Internal-Use Software
In August 2018, the FASB issued ASU 2018-15, Intangibles - Goodwill and Other - Internal Use Software (Subtopic 350-40), Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract. This update aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The update provides criteria for determining which implementation costs to capitalize as an asset related to the service contract and which costs to expense. The capitalized implementation costs are required to be expensed over the term of the hosting arrangement. The update also clarifies the presentation requirements for reporting such costs in the entity’s financial statements. This update is effective for our fiscal year beginning January 1, 2020. We continue to evaluate the impact of the adoption of ASU 2018-15 on our Consolidated Financial Statements. Since we currently capitalize these implementation costs, we do not currently expect the new guidance to have a material impact on our financial condition, results of operations or cash flows.
Accounting Standard Updates Adopted in 2019:
Leases
On January 1, 2019, we adopted ASU 2016-02, Leases (ASC Topic 842). This update, as well as additional amendments and targeted improvements issued in 2018 and early 2019, supersedes existing lease accounting guidance found under ASC 840, Leases (“ASC 840”) and requires the recognition of right-to-use assets and lease obligations by lessees for those leases originally classified as operating leases under prior lease guidance. Effective with the adoption, leases are classified as either finance or operating, with classification affecting the pattern of expense recognition. Short-term leases with a term of 12 months or less are not required to be recognized. The update also requires qualitative and quantitative disclosure of key information regarding the amount, timing and uncertainty of cash flows arising from leasing arrangements to increase transparency and comparability among companies. The accounting for lessors does not fundamentally change with this update except for changes to conform and align guidance to the lessee guidance, as well as to the revenue recognition guidance in ASU 2014-09. Some of these conforming changes, such as those related to the definition of lease term and minimum lease payments, resulted in certain lease arrangements, that would have been previously accounted for as operating leases, to be classified and accounted for as sales-type leases with a corresponding up-front recognition of equipment sales revenue.
Upon adoption, we applied the transition option, whereby prior comparative periods are not retrospectively presented in the Condensed Consolidated Financial Statements. We also elected the package of practical expedients not to reassess prior conclusions related to contracts containing leases, lease classification and initial direct costs and the lessee practical expedient to combine lease and non-lease components for certain asset classes (real estate lease arrangements for offices and warehouses). Additionally, we made a policy election to not recognize right-of-use assets and lease liabilities for short-term leases for all asset classes. We elected the package of practical expedients from both the Lessee and Lessor prospective, to the extent applicable.
Lessee accounting - the adoption of this update resulted in an increase to assets and related liabilities of approximately $385 (approximately $440 undiscounted) primarily related to leases of facilities. Lessor accounting - the adoption of

Xerox 2019 Form 10-Q
13


Table of Contents                                  
 

this update resulted in an increase to equipment sales for the three and nine months ended September 30, 2019 of approximately $9 and $20, respectively, in 2019 as compared to the prior year periods.
Refer to Note 3 - Adoption of New Leasing Standard - Lessee and Note 4 - Adoption of New Leasing Standard - Lessor for additional transitional disclosures related to the adoption of this standard.
Financial Instruments - Derivatives
In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities, with additional updates and amendments being issued in 2018 and 2019. The amendments in this update expand and refine hedge accounting for both financial and non-financial risk components, align the recognition and presentation of the effects of hedging instruments with the same income statement line item that the hedged item is reported and include certain targeted improvements to ease the application of current guidance related to the assessment of hedge effectiveness. We adopted ASU 2017-12 effective for our fiscal year beginning January 1, 2019, and it did not have a material impact on our financial condition, results of operations or cash flows.
Income Taxes
In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. We adopted ASU 2018-02 effective for our fiscal year beginning January 1, 2019 and upon adoption reclassified $127 from Accumulated other comprehensive loss (AOCL) to Retained earnings related to the stranded tax effects resulting from the Tax Cuts and Jobs Act ("Tax Act") enacted in December 2017. The reclassification was primarily related to the stranded tax effects associated with amounts in AOCL from our retirement-related benefit plans. Accordingly, the adoption of this update eliminated the stranded tax effects resulting from the Tax Act. However, because the update only relates to the reclassification of the income tax effects of the Tax Act, the underlying guidance that requires that the effect of a change in tax laws or rates be included in Income from continuing operations is not affected.
Other Updates
In 2018, the FASB also issued the following ASUs, which impact the Company but did not have or are not expected to have a material impact on our financial condition, results of operations or cash flows upon adoption. Those updates are as follows:
Collaborative Arrangements: ASU 2018-18, (Topic 808) Clarifying the Interaction between Topic 808 and Topic 606. This update is effective for our fiscal year beginning January 1, 2020.
Compensation - Retirement Benefits - Defined Benefit Plans - General: ASU 2018-14, (Topic 715-20) Changes to the Disclosure Requirements for Defined Benefit Plans. This update is effective for our fiscal year beginning January 1, 2020.
Fair Value Measurement: ASU 2018-13, (Topic 820) Disclosure Framework. This update is effective for our fiscal year beginning January 1, 2020.

Note 3 – Adoption of New Leasing Standard - Lessee
Refer to Note 2 - Recent Accounting Pronouncements - Leases, for additional information related to the adoption of ASU 2016-02, Leases (ASC Topic 842).
Lessee Summary:
We determine at inception whether an arrangement is a lease. Our leases do not include assets of a specialized nature, or the transfer of ownership at the end of the lease, and the exercise of end-of-lease purchase options, which are primarily in our equipment leases, is not reasonably assured at lease inception. Accordingly, the two primary criteria we use to classify transactions as operating or finance leases are: (i) a review of the lease term to determine if it is equal to or greater than 75% of the economic life of the asset, and (ii) a review of the present value of the minimum lease payments to determine if they are equal to or greater than 90% of the fair market value of the asset at the inception of the lease. Right-of-use ("ROU") assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. We also assess arrangements for goods or services to determine if the arrangement contains a lease at its inception. This assessment first considers whether there is an implicitly or explicitly identified asset in the arrangement and then whether there is a right to control the use of the asset. If there is an embedded lease within a contract, the Company determines the classification of the lease at the lease inception date consistent with standalone leases of assets.
Operating leases are included in Other long-term assets, Accrued expenses and other current liabilities, and Other long-term liabilities in our Condensed Consolidated Balance Sheets. Finance leases are included in Land, buildings

Xerox 2019 Form 10-Q
14


Table of Contents                                  
 

and equipment, net, Accrued expenses and other current liabilities, and Other long-term liabilities in our Condensed Consolidated Balance Sheets.
Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. Since the implicit rate for most of our leases is not readily determinable, we use our incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate of interest that we would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments, in a similar economic environment and over a similar term. The rate is dependent on several factors, including the lease term and currency of the lease payments.
Lease terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate the lease, as we do not have reasonable certainty at lease inception that these options will be exercised. We generally consider the economic life of our operating lease ROU assets to be comparable to the useful life of similar owned assets. We have elected the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases with a lease term of twelve months or less. Our leases generally do not provide a residual guarantee. The operating lease ROU asset also excludes lease incentives.
Lease expense is recognized on a straight-line basis over the lease term. We have lease agreements with lease and non-lease components. These components are accounted for separately for vehicle and equipment leases. We account for the lease and non-lease components as a single lease component for real estate leases of offices and warehouses.
We review the impairment of our ROU assets consistent with the approach applied for our other long-lived assets. We review the recoverability of our long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on our ability to recover the carrying value of the asset from the expected undiscounted future pre-tax cash flows of the related operations. We have elected to include the carrying amount of operating lease liabilities in any tested asset group and include the associated operating lease payments in the undiscounted future pre-tax cash flows.
Operating Leases
We have operating leases for real estate and vehicles in our domestic and international operations and for certain equipment in our domestic operations. Additionally, we have identified embedded operating leases within certain supply chain contracts for warehouses, primarily within our domestic operations. Our leases have remaining terms of up to ten years and a variety of renewal and/or termination options.
The components of lease expense are as follows:
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 30, 2019
Operating lease expense
 
$
31

 
$
97

Short-term lease expense
 
6

 
16

Variable lease expense(1)
 
12

 
37

Sublease income
 

 
(1
)
Total Lease expense
 
$
49

 
$
149

_____________
(1)
Variable lease expense is related to our leased real estate for offices and warehouses and primarily includes labor and operational costs as well as taxes and insurance.
As of September 30, 2019, we have an additional real estate operating lease that has not yet commenced. This operating lease has an obligation and corresponding ROU asset of $23 and will commence in December 2019 with a lease term of approximately 10 years.
Operating leases ROU assets, net and operating lease liabilities were reported in the Condensed Consolidated Balance Sheets as follows:
 
 
September 30,
2019
Other long-term assets
 
$
297

 
 
 
Accrued expenses and other current liabilities
 
$
88

Other long-term liabilities
 
235

Total Operating lease liabilities
 
$
323



Xerox 2019 Form 10-Q
15


Table of Contents                                  
 

Supplemental information related to operating leases is as follows:
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 30, 2019
Cash paid for amounts included in the measurement of lease liabilities - Operating cash flows
 
$
31

 
$
95

Right-of-use assets obtained in exchange for new lease liabilities (1)
 
5

 
28

Weighted-average remaining lease term
 
 
 
4 years

Weighted-average discount rate
 
 
 
5.63
%
_____________
(1)
Includes the impact of new leases as well as remeasurements and modifications to existing leases.
Maturities and additional information related to operating lease liabilities are as follows:
 
 
September 30,
2019
2019(1)
 
$
30

2020
 
105

2021
 
80

2022
 
66

2023
 
49

Thereafter
 
35

Total Lease payments
 
365

Less: Imputed interest
 
42

Total Operating lease liabilities
 
$
323

_____________
(1)
Represents the future minimum operating lease payments expected to be made over the remaining balance of the year.
Finance Leases
Xerox has one finance lease for equipment and related infrastructure within an outsourced warehouse supply arrangement in the U.S. The lease expires in December 2023 and has a remaining lease obligation of $7 as of September 30, 2019 based on a discount rate of 4.07%. The Right-of-use asset balance associated with this finance lease of $7 is included in Land, buildings and equipment, net in the Condensed Consolidated Balance Sheet.
Prior Period Disclosures under ASC 840
For the years ended December 31, 2018 and 2017, operating lease expense, net of sublease income, were $147 and $161, respectively.
Future minimum operating lease commitments that have initial or remaining non-cancelable lease terms in excess of one year at December 31, 2018 were as follows:
 
 
December 31,
2018
2019
 
$
114

2020
 
88

2021
 
64

2022
 
50

2023
 
36

Thereafter
 
27

Total Operating lease commitments
 
$
379



Xerox 2019 Form 10-Q
16


Table of Contents                                  
 

Note 4 – Adoption of New Leasing Standard - Lessor
Refer to Note 2 - Recent Accounting Pronouncements - Leases, for additional information related to the adoption of ASU 2016-02, Leases (ASC Topic 842).
Lessor Summary: The following represent updated disclosures to our Revenue Recognition policies as a result of the adoption of ASC Topic 842.
Bundled Lease Arrangements: A portion of our direct sales of equipment to end customers are made through bundled lease arrangements which typically include equipment, services (maintenance and managed services) and financing components where the customer pays a single negotiated fixed minimum monthly payment for all elements over the contractual lease term. These arrangements also typically include an incremental, variable component for page volumes in excess of the contractual page volume minimums, which are often expressed in terms of price-per-image or page. Revenues under these bundled lease arrangements are allocated considering the relative standalone selling prices of the lease and non-lease deliverables included in the bundled arrangement. Lease deliverables include the equipment and financing, while the non-lease deliverables generally consist of the services, which include supplies. Consistent with the guidance in ASC 842 and ASC 606, regarding the allocation of fixed and variable consideration, we only consider the fixed payments for purposes of allocation to the lease elements of the contract. The fixed minimum monthly payments are multiplied by the number of months in the contract term to arrive at the total fixed lease payments that the customer is obligated to make over the lease term. Amounts allocated to the equipment and financing elements are then subjected to the accounting estimates noted below under Leases to ensure the values reflect standalone selling prices.
The remainder of any fixed payments, as well as the variable payments, are allocated to non-lease elements because the variable consideration for incremental page volume or usage is considered attributable to the delivery of those elements. The consideration for the non-lease elements is not dependent on the consideration for equipment and vice versa and the consideration for the equipment and services is priced at the appropriate standalone values; therefore, the relative standalone selling price allocation method is not necessary. The revenue associated with the non-lease elements are normally accounted for as a single performance obligation being delivered in a series with delivery being measured as the usage billed to the customer. Accordingly, revenue from these agreements is recognized in a manner consistent with the guidance for Maintenance and Services agreements.
Leases: The two primary accounting provisions we use to classify transactions as sales-type or operating leases are: (i) a review of the lease term to determine if it is for the major part of the economic life of the underlying equipment (defined as greater than 75%); and (ii) a review of the present value of the lease payments to determine if they are equal to or greater than substantially all of the fair market value of the equipment at the inception of the lease (defined as greater than 90%). Equipment placements included in arrangements meeting these conditions are accounted for as sales-type leases and revenue is recognized in a manner consistent with Equipment. Equipment placements included in arrangements that do not meet these conditions are accounted for as operating leases and revenue is recognized over the term of the lease.
We consider the economic life of most of our products to be five years, since this represents the most frequent contractual lease term for our principal products and only a small percentage of our leases are for original terms longer than five years. There is no significant after-market for our used equipment. We believe five years is representative of the period during which the equipment is expected to be economically usable, with normal service, for the purpose for which it is intended.
We perform an analysis of the stand-alone selling price of equipment based on cash selling prices during the applicable period. The cash selling prices are compared to the range of values determined for our leases. The range of cash selling prices must be reasonably consistent with the lease selling prices in order for us to determine that such lease prices reflects stand-alone value.
Our lease pricing interest rates, which are used in determining customer payments in a bundled lease arrangement, are developed based upon a variety of factors including local prevailing rates in the marketplace and the customer’s credit history, industry and credit class. We reassess our pricing interest rates quarterly based on changes in the local prevailing rates in the marketplace. The pricing interest rates generally equal the implicit rates within the leases, as corroborated by our comparisons of cash to lease selling prices noted above.
Additional Lease Payments: Certain leases may require the customer to pay property taxes and insurance on the equipment. In these instances, the amounts for property taxes and insurance that we invoice to customers and pay to third parties are considered variable payments and are recorded as other revenues and other cost of revenues, respectively. Amounts related to property taxes and insurance are not material. We exclude from variable payments all lessor costs that are explicitly required to be paid directly by a lessee on behalf of the lessor to a third party.

Xerox 2019 Form 10-Q
17


Table of Contents                                  
 

Presentation: Revenue from sales-type leases is presented on a gross basis when the company enters into a lease to realize value from a product that it would otherwise sell in its ordinary course of business, whereas in transactions where the company enters into a lease for the purpose of generating revenue by providing financing, the profit or loss, if any, is presented on a net basis. In addition, we have elected to account for sales tax and other similar taxes collected from a lessee as lessee costs and therefore we exclude these costs from contract consideration and variable consideration and present revenue net of these costs.
The components of lease income are as follows:
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2019
 
2018
 
2019
 
2018
Lease income - sales type
 
$
200

 
$
175

 
$
484

 
$
507

Interest income on lease receivables
 
60

 
65

 
184

 
204

Lease income - operating leases(1)
 
99

 
109

 
303

 
331

Variable lease income
 
25

 
28

 
80

 
89

Total Lease income
 
$
384

 
$
377

 
$
1,051

 
$
1,131


_____________
(1)
Operating lease income for the nine months ended September 30, 2019 and 2018 exclude service revenues of $30 and $28, respectively, which were reported in operating lease income for the three months ended March 31, 2019 and 2018.
Profit at lease commencement on sales type leases was estimated to be approximately $86 and $76 for the three months ended September 30, 2019 and 2018, respectively, and approximately $206 and $221 for the nine months ended September 30, 2019 and 2018, respectively.
Note 5 – Revenue
Revenues disaggregated by primary geographic markets, major product lines, and sales channels are as follows:
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
 
2019
 
2018
 
2019
 
2018
Primary geographical markets(1):
 
 
 
 
 
 
 
 
United States
 
$
1,364

 
$
1,414

 
$
4,028

 
$
4,307

Europe
 
521

 
587

 
1,705

 
1,923

Canada
 
123

 
133

 
377

 
424

Other
 
192

 
218

 
585

 
643

Total Revenues
 
$
2,200

 
$
2,352

 
$
6,695

 
$
7,297

 
 
 
 
 
 
 
 
 
Major product and services lines:
 
 
 
 
 
 
 
 
Equipment
 
$
494

 
$
511

 
$
1,446

 
$
1,571

Supplies, paper and other sales
 
310

 
345

 
933

 
1,057

Maintenance agreements(2)
 
568

 
618

 
1,775

 
1,958

Service arrangements(3)
 
611

 
649

 
1,883

 
2,007

Rental and other
 
157

 
164

 
474

 
500

Financing
 
60

 
65

 
184

 
204

Total Revenues(4)
 
$
2,200

 
$
2,352

 
$
6,695

 
$
7,297

 
 
 
 
 
 
 
 
 
Sales channels:
 
 
 
 
 
 
 
 
Direct equipment lease(5)
 
$
200

 
$
175

 
$
484

 
$
507

Distributors & resellers(6)
 
301

 
324

 
949

 
1,043

Customer direct
 
303

 
357

 
946

 
1,078

Total Sales(4)
 
$
804

 
$
856

 
$
2,379

 
$
2,628

_____________
(1)
Geographic area data is based upon the location of the subsidiary reporting the revenue.
(2)
Includes revenues from maintenance agreements on sold equipment as well as revenues associated with service agreements sold through our channel partners as Xerox Partner Print Services (XPPS).
(3)
Primarily includes revenues from our Managed Services offerings (formerly our Managed Document Services arrangements). Also includes revenues from embedded operating leases, which were not significant.
(4)
Certain prior year amounts have been revised to conform to the current year presentation. Refer to Note 1 - Basis of Presentation - Change in Presentation, for additional information.
(5)
Primarily reflects direct sales through bundled lease arrangements.
(6)
Primarily reflects sales through our two-tier distribution channels.

Xerox 2019 Form 10-Q
18


Table of Contents                                  
 

Contract Assets and Liabilities: We normally do not have contract assets, which are primarily unbilled accounts receivable that are conditional on something other than the passage of time. Our contract liabilities, which represent billings in excess of revenue recognized, are primarily related to advanced billings for maintenance and other services to be performed and were approximately $138 and $116 at September 30, 2019 and December 31, 2018, respectively. The majority of the balance at September 30, 2019 will be amortized to revenue over approximately the next 30 months.
Contract Costs: Incremental direct costs of obtaining a contract primarily include sales commissions paid to sales people and agents in connection with the placement of equipment with associated post sale services arrangements. These costs are deferred and amortized on the straight-line basis over the estimated contract term, which is currently estimated to be approximately four years. We pay commensurate sales commissions upon customer renewals, therefore our amortization period is aligned to our initial contract term. Incremental direct costs are as follows:
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
 
2019
 
2018
 
2019
 
2018
Incremental direct costs of obtaining a contract
 
$
20

 
$
22

 
$
56

 
$
62

Amortization of incremental direct costs
 
23

 
25

 
66

 
72


The balance of deferred incremental direct costs net of accumulated amortization at September 30, 2019 and December 31, 2018 was $162 and $172, respectively. This amount is expected to be amortized over its estimated period of benefit, which we currently estimate to be approximately four years.
We may also incur costs associated with our services arrangements to generate or enhance resources and assets that will be used to satisfy our future performance obligations included in these arrangements. These costs are considered contract fulfillment costs and are amortized over the contractual service period of the arrangement to cost of services. In addition, we also provide inducements to certain customers in various forms, including contractual credits, which are capitalized and amortized as a reduction of revenue over the term of the contract. As of September 30, 2019 and December 31, 2018 amounts deferred associated with contract fulfillment costs and inducements were $13 and $12, respectively. The related amortization for the three months ended September 30, 2019 and 2018 was $1 and $0, respectively and $4 and $3 for the nine months ended September 30, 2019 and 2018, respectively.
Note 6 – Acquisitions
Xerox is focused on increasing its Small and Mid-sized (SMB) coverage through resellers and partners (including multi-brand dealers) and continued distribution acquisitions. During the second quarter of 2019, acquisitions totaled $38 and included Rabbit Copiers, Inc. (Rabbit Office Automation (ROA)), a San Francisco Bay area dealer, and Heritage Business Systems, Inc. (HBS), a Delaware Valley dealer. Both dealers expand our distribution and increase the number of resources in these geographies and provide office technology sales, services and supplies in those markets.
The operating results of these acquisitions are not material to our financial statements and are included within our results from the acquisition date. The purchase prices were all cash for 100% ownership of the acquired companies and were primarily allocated to Intangible assets, net and Goodwill. The allocations are based on preliminary management estimates, which continue to be reviewed, and are expected to be finalized in the fourth quarter 2019 and may include input and support from third-party valuations. Any adjustments to the allocations are not expected to be material.

Xerox 2019 Form 10-Q
19


Table of Contents                                  
 

Note 7 – Supplementary Financial Information
Cash, Cash Equivalents and Restricted Cash
Cash, cash equivalents and restricted cash amounts were as follows:
 
 
September 30,
2019
 
December 31,
2018
Cash and cash equivalents
 
$
922

 
$
1,084

Restricted cash
 
 
 
 
    Litigation deposits in Brazil
 
57

 
61

    Other restricted cash
 

 
3

    Total Restricted cash
 
57

 
64

Cash, cash equivalents and restricted cash
 
$
979

 
$
1,148


Restricted cash primarily relates to escrow cash deposits made in Brazil associated with ongoing litigation. As more fully discussed in Note 22 - Contingencies and Litigation, various litigation matters in Brazil require us to make cash deposits to escrow as a condition of continuing the litigation. Restricted cash amounts are classified in our Condensed Consolidated Balance Sheets based on when the cash is expected to be contractually or judicially released.
Restricted cash was reported in the Condensed Consolidated Balance Sheets as follows:
 
 
September 30,
2019
 
December 31,
2018
Other current assets
 
$

 
$
1

Other long-term assets
 
57

 
63

Total Restricted cash
 
$
57

 
$
64


Supplemental Cash Flow Information
Summarized cash flow information is as follows:
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
 
2019
 
2018
 
2019
 
2018
Provision for receivables
 
$
13

 
$
11

 
$
40

 
$
37

Provision for inventory
 
3

 
5

 
18

 
19

Provision for product warranty
 
3

 
3

 
10

 
10

Depreciation of buildings and equipment
 
24

 
30

 
77

 
118

Depreciation and obsolescence of equipment on operating leases
 
56

 
62

 
172

 
189

Amortization of internal use software
 
15

 
18

 
48

 
55

Amortization of acquired intangible assets
 
9

 
12

 
35

 
36

Amortization of customer contract costs(1)
 
24

 
25

 
70

 
75

Cost of additions to land, buildings and equipment
 
11

 
15

 
30

 
41

Cost of additions to internal use software
 
6

 
8

 
18

 
32

Common stock dividends - Xerox Holdings
 
57

 
65

 
172

 
193

Preferred stock dividends - Xerox Holdings
 
4

 
4

 
11

 
11

Payments to noncontrolling interests
 
1

 
1

 
14

 
14

Repurchases related to stock-based compensation - Xerox Holdings
 
10

 
5

 
20

 
7

_____________
(1)
Amortization of customer contract costs are reported in (Increase) decrease in other current and long-term assets in the Condensed Consolidated Statements of Cash Flows. Refer to Note 5 - Revenue for additional information on contract costs.

Xerox 2019 Form 10-Q
20


Table of Contents                                  
 

Note 8 – Accounts Receivable, Net
Accounts receivable, net were as follows:
 
 
September 30,
2019
 
December 31,
2018
Invoiced
 
$
939

 
$
999

Accrued
 
305

 
333

Allowance for doubtful accounts
 
(56
)
 
(56
)
Accounts receivable, net
 
$
1,188

 
$
1,276


Amounts to be invoiced in the subsequent quarter for current services provided are included in amounts accrued.
We perform ongoing credit evaluations of our customers and adjust credit limits based upon customer payment history and current creditworthiness. The allowance for uncollectible accounts receivable is determined principally on the basis of past collection experience as well as consideration of current economic conditions and changes in our customer collection trends.
Accounts Receivable Sales Arrangements
Accounts receivable sales arrangements are utilized in the normal course of business as part of our cash and liquidity management. The accounts receivable sold are generally short-term trade receivables with payment due dates of less than 60 days. We have one facility in Europe that enables us to sell accounts receivable associated with our distributor network on an ongoing basis, without recourse. Under this arrangement, we sell our entire interest in the related accounts receivable for cash and no portion of the payment is held back or deferred by the purchaser.
Of the accounts receivable sold and derecognized from our balance sheet, $94 and $131 remained uncollected as of September 30, 2019 and December 31, 2018, respectively.
Accounts receivable sales were as follows:
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
 
2019
 
2018
 
2019
 
2018
Accounts receivable sales(1)
 
$
67

 
$
66

 
$
265

 
$
297

Loss on sales of accounts receivable
 
1

 
1

 
2

 
2

__________________________
(1)
Customers may also enter into structured-payable arrangements that require us to sell our receivables from that customer to a third-party financial institution, which then makes payments to us to settle the customer's receivable. In these instances, we ensure the sale of the receivables are bankruptcy-remote and the payment made to us is without recourse. The activity associated with these arrangements is not reflected in this disclosure, as payments under these arrangements have not been material and these are customer directed arrangements.

Xerox 2019 Form 10-Q
21


Table of Contents                                  
 

Note 9 - Finance Receivables, Net
Finance receivables include sales-type leases and installment loans arising from the marketing of our equipment. These receivables are typically collateralized by a security interest in the underlying assets. Amounts disclosed below at December 31, 2018 were accounted for under ASC 840, Leases, which was superseded by ASC 842, Leases, adopted on January 1, 2019. Differences upon adoption were not material. Refer to Note 2 - Recent Accounting Pronouncements for additional information.
Finance receivables, net were as follows:
 
 
September 30,
2019
 
December 31,
2018
Gross receivables
 
$
3,795

 
$
4,003

Unearned income
 
(414
)
 
(439
)
Subtotal
 
3,381

 
3,564

Residual values
 

 

Allowance for doubtful accounts
 
(93
)
 
(92
)
Finance receivables, net
 
3,288

 
3,472

Less: Billed portion of finance receivables, net
 
106

 
105

Less: Current portion of finance receivables not billed, net
 
1,145

 
1,218

Finance receivables due after one year, net
 
$
2,037

 
$
2,149


A summary of future contractual maturities of our gross finance receivables, including those previously billed is as follows:
 
 
September 30,
2019
 
December 31,
2018
12 Months(1)
 
$
1,471

 
$
1,543

24 Months
 
1,044

 
1,108

36 Months
 
705

 
755

48 Months
 
406

 
425

60 Months
 
152

 
158

Thereafter
 
17

 
14

Total
 
$
3,795

 
$
4,003

__________________
(1)
Includes amounts previously billed of $108 and $107 as of September 30, 2019 and December 31, 2018, respectively.

Xerox 2019 Form 10-Q
22


Table of Contents                                  
 

Finance Receivables – Allowance for Credit Losses and Credit Quality
Finance receivables include sales-type leases, direct financing leases and installment loans arising from the marketing of our equipment. Our finance receivable portfolios are primarily in the U.S., Canada and Europe. We generally establish customer credit limits and estimate the allowance for credit losses on a country or geographic basis. The allowance for Credit Losses is determined principally on the basis of origination year and past collection experience as well as consideration of current economic conditions and changes in our customer collection trends. Our policy and methodology used to establish our allowance for doubtful accounts has been consistently applied over all periods presented.
The allowance for doubtful finance receivables as well as the related investment in finance receivables were as follows:
Allowance for Credit Losses:
 
United States
 
Canada
 
Europe
 
Other(1)
 
Total
Balance at December 31, 2018
 
$
53

 
$
12

 
$
25

 
$
2

 
$
92

Provision
 
4

 
1

 
4

 

 
9

Charge-offs
 
(4
)
 
(1
)
 
(3
)
 

 
(8
)
Recoveries and other(2)
 

 

 

 

 

Balance at March 31, 2019
 
$
53

 
$
12

 
$
26

 
$
2

 
$
93

Provision
 
4

 
1

 
3

 

 
8

Charge-offs
 
(5
)
 
(3
)
 
(3
)
 

 
(11
)
Recoveries and other(2)
 
1

 
2

 

 

 
3

Balance at June 30, 2019
 
$
53

 
$
12

 
$
26

 
$
2

 
$
93

Provision
 
6

 

 
2

 

 
8

Charge-offs
 
(5
)
 
(1
)
 
(3
)
 

 
(9
)
Recoveries and other(2)
 
1

 

 

 

 
1

Balance at September 30, 2019
 
$
55

 
$
11

 
$
25

 
$
2

 
$
93

Finance receivables as of September 30, 2019 collectively evaluated for impairment (3)
 
$
1,900

 
$
318

 
$
1,120

 
$
43

 
$
3,381

 
 
 
 
 
 
 
 
 
 
 
Balance at December 31, 2017
 
$
56

 
$
15

 
$
35

 
$
2

 
$
108

Provision
 
5

 

 
4

 

 
9

Charge-offs
 
(5
)
 
(1
)
 
(4
)
 

 
(10
)
Recoveries and other(2)
 

 

 
1

 

 
1

Balance at March 31, 2018
 
$
56

 
$
14

 
$
36

 
$
2

 
$
108

Provision
 
4

 
1

 
4

 

 
9

Charge-offs
 
(4
)
 
(1
)
 
(3
)
 

 
(8
)
Recoveries and other(2)
 

 

 
(2
)
 

 
(2
)
Balance at June 30, 2018
 
$
56

 
$
14

 
$
35

 
$
2

 
$
107

Provision
 
2

 

 
4

 

 
6

Charge-offs
 
(2
)
 
(2
)
 
(4
)
 

 
(8
)
Recoveries and other(2)
 
1

 
1

 

 

 
2

Balance at September 30, 2018
 
$
57

 
$
13

 
$
35

 
$
2

 
$
107

Finance receivables as of September 30, 2018 collectively evaluated for impairment(3)(4)
 
$
1,960

 
$
352

 
$
1,242

 
$
47

 
$
3,601

__________________
(1)
Includes developing market countries and smaller units.
(2)
Includes the impacts of foreign currency translation and adjustments to reserves necessary to reflect events of non-payment such as customer accommodations and contract terminations.
(3)
Total Finance receivables exclude the allowance for credit losses of $93 and $107 at September 30, 2019 and 2018, respectively.
(4)
As a result of an internal reorganization, XBS amounts, previously classified as Other, were reclassified to the U.S. in first quarter 2019. Prior year amounts have also been reclassified to conform to the current year presentation.

Xerox 2019 Form 10-Q
23


Table of Contents                                  
 

We evaluate our customers based on the following credit quality indicators:
Investment grade: This rating includes accounts with excellent to good business credit, asset quality and capacity to meet financial obligations. These customers are less susceptible to adverse effects due to shifts in economic conditions or changes in circumstance. The rating generally equates to a Standard & Poor's (S&P) rating of BBB- or better. Loss rates in this category are normally less than 1%.
Non-investment grade: This rating includes accounts with average credit risk that are more susceptible to loss in the event of adverse business or economic conditions. This rating generally equates to a BB S&P rating. Although we experience higher loss rates associated with this customer class, we believe the risk is somewhat mitigated by the fact that our leases are fairly well dispersed across a large and diverse customer base. In addition, the higher loss rates are largely offset by the higher rates of return we obtain with such leases. Loss rates in this category are generally in the range of 2% to 5%.
Substandard: This rating includes accounts that have marginal credit risk such that the customer’s ability to make repayment is impaired or may likely become impaired. We use numerous strategies to mitigate risk including higher rates of interest, prepayments, personal guarantees, etc. Accounts in this category include customers who were downgraded during the term of the lease from investment and non-investment grade evaluation when the lease was originated. Accordingly, there is a distinct possibility for a loss of principal and interest or customer default. The loss rates in this category are generally in the range of 7% to 10%.
Credit quality indicators are updated at least annually and the credit quality of any given customer can change during the life of the portfolio. Details about our finance receivables portfolio based on industry and credit quality indicators are as follows:
 
 
September 30, 2019
 
December 31, 2018
 
 
Investment
Grade
 
Non-investment
Grade
 
Substandard
 
Total
Finance
Receivables
 
Investment
Grade
 
Non-investment
Grade
 
Substandard
 
Total
Finance
Receivables
Finance and other services
 
$
166

 
$
332

 
$
87

 
$
585

 
$
177

 
$
334

 
$
88

 
$
599

Government and education
 
440

 
54

 
16

 
510

 
453

 
63

 
9

 
525

Graphic arts
 
70

 
140

 
81

 
291

 
82

 
131

 
87

 
300

Industrial
 
79

 
85

 
16

 
180

 
86

 
82

 
16

 
184

Healthcare
 
61

 
63

 
12

 
136

 
86

 
48

 
9

 
143

Other
 
62

 
107

 
29

 
198

 
63

 
90

 
42

 
195

Total United States(1)
 
878

 
781

 
241

 
1,900

 
947

 
748

 
251

 
1,946

Finance and other services
 
59

 
30

 
17

 
106

 
52

 
33

 
20

 
105

Government and education
 
35

 
4

 
3

 
42

 
38

 
3

 
4

 
45

Graphic arts
 
19

 
26

 
27

 
72

 
22

 
30

 
26

 
78

Industrial
 
18

 
11

 
11

 
40

 
16

 
12

 
9

 
37

Other
 
29

 
18

 
11

 
58

 
34

 
21

 
15

 
70

Total Canada
 
160

 
89

 
69

 
318

 
162

 
99

 
74

 
335

France
 
199

 
141

 
20

 
360

 
232

 
157

 
29

 
418

U.K./Ireland
 
142

 
78

 
6

 
226

 
150

 
87

 
7

 
244

Central(2)
 
169

 
117

 
8

 
294

 
196

 
123

 
8

 
327

Southern(3)
 
57

 
129

 
10

 
196

 
52

 
136

 
17

 
205

Nordics(4)
 
25

 
18

 
1

 
44

 
28

 
15

 
2

 
45

Total Europe(5)
 
592

 
483

 
45

 
1,120

 
658

 
518

 
63

 
1,239

Other(1)
 
28

 
13

 
2

 
43

 
31

 
13

 

 
44

Total
 
$
1,658

 
$
1,366

 
$
357

 
$
3,381

 
$
1,798

 
$
1,378

 
$
388

 
$
3,564

_____________________________
(1)
As a result of an internal reorganization, XBS amounts, previously classified as Other, were reclassified to the U.S. in first quarter 2019. Prior year amounts have also been reclassified to conform to the current year presentation.
(2)
Switzerland, Germany, Austria, Belgium and Holland.
(3)
Italy, Greece, Spain and Portugal.
(4)
Sweden, Norway, Denmark and Finland.
(5)
Prior year amounts have been recasted to conform to the current year presentation.

Xerox 2019 Form 10-Q
24


Table of Contents                                  
 

The aging of our billed finance receivables is based upon the number of days an invoice is past due and is as follows:
 
 
September 30, 2019
 
 
Current
 
31-90
Days
Past Due
 
>90 Days
Past Due
 
Total Billed
 
Unbilled
 
Total
Finance
Receivables
 
>90 Days
and
Accruing
Finance and other services
 
$
15

 
$
4

 
$
3

 
$
22

 
$
563

 
$
585

 
$
15

Government and education
 
17

 
3

 
3

 
23

 
487

 
510

 
19

Graphic arts
 
13

 
1

 
1

 
15

 
276

 
291

 
6

Industrial
 
6

 
2

 
1

 
9

 
171

 
180

 
9

Healthcare
 
4

 
2

 
1

 
7

 
129

 
136

 
6

Other
 
6

 
1

 
1

 
8

 
190

 
198

 
4

Total United States
 
61

 
13

 
10

 
84

 
1,816

 
1,900

 
59

Canada
 
6

 
2

 
2

 
10

 
308

 
318

 
19

France
 
4

 

 

 
4

 
356

 
360

 
25

U.K./Ireland
 
1

 

 

 
1

 
225

 
226

 

Central(2)
 
1

 

 
1

 
2

 
292

 
294

 
8

Southern(3)
 
2

 
1

 
1

 
4

 
192

 
196

 
3

Nordics(4)
 

 

 

 

 
44

 
44

 

Total Europe
 
8

 
1

 
2

 
11

 
1,109

 
1,120

 
36

Other
 
3

 

 

 
3

 
40

 
43

 

Total
 
$
78

 
$
16

 
$
14

 
$
108

 
$
3,273

 
$
3,381

 
$
114

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2018
 
 
Current
 
31-90
Days
Past Due
 
>90 Days
Past Due
 
Total Billed
 
Unbilled
 
Total
Finance
Receivables
 
>90 Days
and
Accruing
Finance and other services
 
$
15

 
$
4

 
$
2

 
$
21

 
$
578

 
$
599

 
$
11

Government and education
 
17

 
4

 
3

 
24

 
501

 
525

 
24

Graphic arts
 
10

 
1

 
1

 
12

 
288

 
300

 
5

Industrial
 
5

 
2

 
1

 
8

 
176

 
184

 
5

Healthcare
 
4

 
2

 
1

 
7

 
136

 
143

 
5

Other
 
5

 
2

 
1

 
8

 
187

 
195

 
4

Total United States(1)
 
56

 
15

 
9

 
80

 
1,866

 
1,946

 
54

Canada
 
7

 
2

 
1

 
10

 
325

 
335

 
22

France
 
5

 

 

 
5

 
413

 
418

 
14

U.K./Ireland
 
2

 

 

 
2

 
242

 
244

 

Central(2)
 
1

 
1

 
1

 
3

 
324

 
327

 
6

Southern(3)
 
3

 
1

 
1

 
5

 
200

 
205

 
6

Nordics(4)
 

 

 

 

 
45

 
45

 

Total Europe
 
11

 
2

 
2

 
15

 
1,224

 
1,239

 
26

Other(1)
 
2

 

 

 
2

 
42

 
44

 

Total
 
$
76

 
$
19

 
$
12

 
$
107

 
$
3,457

 
$
3,564

 
$
102

 _____________________________
(1)
As a result of an internal reorganization, XBS amounts, previously classified as Other, were reclassified to the U.S. in first quarter 2019. Prior year amounts have also been reclassified to conform to the current year presentation.
(2)
Switzerland, Germany, Austria, Belgium and Holland.
(3)Italy, Greece, Spain and Portugal.
(4)Sweden, Norway, Denmark and Finland.


Xerox 2019 Form 10-Q
25


Table of Contents                                  
 

Note 10 – Inventories and Equipment on Operating Leases, Net
The following is a summary of Inventories by major category:
 
 
September 30,
2019
 
December 31,
2018
Finished goods
 
$
623

 
$
699

Work-in-process
 
61

 
49

Raw materials
 
74

 
70

Total Inventories
 
$
758

 
$
818


The transfer of equipment from our inventories to equipment subject to an operating lease is presented in our Condensed Consolidated Statements of Cash Flows in the operating activities section. Equipment on operating leases and similar arrangements consists of our equipment rented to customers and depreciated to estimated salvage value at the end of the lease term. Amounts disclosed below at December 31, 2018 were accounted for under ASC 840, Leases, which was superseded by ASC 842, Leases, adopted on January 1, 2019. Differences upon adoption were not material. Refer to Note 2 - Recent Accounting Pronouncements for additional information.
Equipment on operating leases and the related accumulated depreciation were as follows:
 
 
September 30,
2019
 
December 31,
2018
Equipment on operating leases
 
$
1,457

 
$
1,519

Accumulated depreciation
 
(1,083
)
 
(1,077
)
Equipment on operating leases, net
 
$
374

 
$
442


Estimated minimum future revenues associated with Equipment on operating leases are as follows:
 
 
September 30,
2019
 
December 31,
2018
2019(1)
 
$
63

 
$
260

2020
 
222

 
178

2021
 
140

 
111

2022
 
79

 
61

2023
 
36

 
21

Thereafter
 
9

 
2

Total
 
$
549

 
$
633

_____________
(1)
2019 amount represents the future minimum revenues expected to be earned over the remaining balance of the year.
Total contingent rentals on operating leases, consisting principally of usage charges in excess of minimum contracted amounts, were $25 and $28 for the three months ended September 30, 2019 and 2018, respectively, and $80 and $89 for the nine months ended September 30, 2019 and 2018, respectively.

Xerox 2019 Form 10-Q
26


Table of Contents                                  
 

Note 11 – Investment in Affiliates, at Equity
Our Equity in net income (loss) of unconsolidated affiliates was as follows:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
Fuji Xerox
$
57

 
$
41

 
$
132

 
$
(12
)
Other
1

 
2

 
5

 
6

Total Equity in net income (loss) of unconsolidated affiliates
$
58

 
$
43

 
$
137

 
$
(6
)

Fuji Xerox
Equity in net income (loss) of Fuji Xerox is affected by certain adjustments required to reflect the deferral of profit associated with intercompany sales. These adjustments may result in recorded equity income (loss) that is different from that implied by our 25% ownership interest. In addition, the Equity in net income (loss) of Fuji Xerox for the three months ended September 30, 2019 included no after-tax restructuring and other charges, while after-tax restructuring and other charges for the three months ended September 30, 2018 was $7. After-tax restructuring and other charges for the nine months ended September 30, 2019 and 2018 were $19 and $90, respectively.
Fuji Xerox recorded a cumulative charge of JPY 12 billion (approximately $110 based on the Yen/U.S. Dollar average exchange rate for the quarter ended March 31, 2018 of 108.07) in their net loss for the quarter ended March 31, 2018 (our first quarter 2018) related to the correction of certain out-of-period adjustments and misstatements. Our recognition of 25% of Fuji Xerox’s net loss for Xerox’s first quarter 2018 included an approximately $28 charge related to these adjustments and misstatements.
Summarized financial information for Fuji Xerox was as follows:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
Summary of Operations
 
 
 
 
 
 
 
Revenues
$
2,395

 
$
2,326

 
$
7,001

 
$
7,017

Costs and expenses
2,077

 
2,077

 
6,229

 
6,946

Income before Income Taxes
318

 
249

 
772

 
71

Income tax expense
83

 
84

 
233

 
95

Net Income (Loss)
235

 
165

 
539

 
(24
)
Less: Net income attributable to noncontrolling interests
1

 
1

 
2

 
2

Net Income (Loss) – Fuji Xerox
$
234

 
$
164

 
$
537

 
$
(26
)
Weighted Average Exchange Rate(1)
107.26

 
111.43

 
109.12

 
109.50

_____________________________
(1)
Represents Yen/U.S. dollar exchange rate used to translate.

Xerox 2019 Form 10-Q
27


Table of Contents                                  
 

Note 12 – Restructuring Programs
We engage in restructuring actions, including Project Own It, as well as other transformation efforts in order to reduce our cost structure and realign it to the changing nature of our business and to achieve operating efficiencies through a number of opportunities including reduction of our real estate footprint.
During the nine months ended September 30, 2019, we recorded net restructuring and asset impairment charges of $80, which included $37 of severance costs related to headcount reductions of approximately 450 employees worldwide, $18 of other contractual termination costs and $48 of asset impairment charges. These costs were partially offset by $23 of net reversals, primarily resulting from changes in estimated reserves from prior period initiatives as well as $6 in favorable adjustments from the early termination of prior period impaired leases.
Information related to restructuring program activity is outlined below:
 
 
Severance and
Related Costs
 
Other Contractual Termination Costs(2)
 
Asset Impairments(3)
 
Total
Balance at December 31, 2018
 
$
94

 
$
1

 
$

 
$
95

Provision
 
12

 
14

 
36

 
62

Reversals
 
(8
)
 

 

 
(8
)
Net current period charges(1)
 
4

 
14

 
36

 
54

Charges against reserve and currency
 
(32
)
 
(1
)
 
(36
)
 
(69
)
Balance at March 31, 2019
 
$
66

 
$
14

 
$

 
$
80

Provision
 
13

 
3

 
10

 
26

Reversals
 
(6
)
 

 
(2
)
 
(8
)
Net current period charges(1)
 
7

 
3

 
8

 
18

Charges against reserve and currency
 
(17
)
 
(4
)
 
(8
)
 
(29
)
Balance at June 30, 2019
 
$
56

 
$
13

 
$

 
$
69

Provision
 
12

 
1

 
2

 
15

Reversals
 
(3
)
 
(3
)
 
(1
)
 
(7
)
Net current period charges(1)
 
9

 
(2
)
 
1

 
8

Charges against reserve and currency
 
(16
)
 
(3
)
 
(1
)
 
(20
)
Balance at September 30, 2019
 
$
49

 
$
8

 
$

 
$
57

____________________________
(1)
Represents net amount recognized within the Condensed Consolidated Statements of Income for the period shown for restructuring and asset impairment charges.
(2)
Primarily includes additional costs incurred upon the exit from our facilities including decommissioning costs and associated contractual termination costs.
(3)
Primarily related to the exit and abandonment of leased and owned facilities. The charge includes the accelerated write-off of $36 for leased right-of-use asset balances and $12 for owned asset balances upon exit from the facility net of any potential sublease income or other recovery amounts.
The following table summarizes the reconciliation to the Condensed Consolidated Statements of Cash Flows:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
Charges against reserve and currency
$
(20
)
 
$
(38
)
 
$
(118
)
 
$
(130
)
Effects of foreign currency and other non-cash items
3

 
(1
)
 
47

 

Restructuring cash payments
$
(17
)
 
$
(39
)
 
$
(71
)
 
$
(130
)
In connection with our restructuring programs, we also incurred certain related costs as follows:
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2019
 
2019
Retention related severance/bonuses(1)
 
$
11

 
$
31

Contractual severance costs(2)
 
3

 
41

Consulting and other costs(3)
 
5

 
24

Total
 
$
19

 
$
96

____________________________
(1)
Includes retention related severance and bonuses for employees expected to continue working beyond their minimum notification period before termination.
(2)
Reflects estimated severance and other related costs we are contractually required to pay on employees transferred (approximately 2,200) as part of the shared service arrangement entered into with HCL Technologies.
(3)
Represents professional support services associated with our business transformation initiatives.

Xerox 2019 Form 10-Q
28


Table of Contents                                  
 

Note 13 – Debt
Interest Expense and Income
Interest expense and income were as follows:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
Interest expense(1)
$
60

 
$
61

 
$
178

 
$
184

Interest income(2)
62

 
70

 
193

 
216

____________
(1)
Includes Cost of financing as well as non-financing interest expense that is included in Other expenses, net in the Condensed Consolidated Statements of Income.
(2)
Includes Financing revenue as well as other interest income that is included in Other expenses, net in the Condensed Consolidated Statements of Income.
Note 14 – Financial Instruments
Interest Rate Risk Management
We use interest rate swap agreements to manage our interest rate exposure and to achieve a desired proportion of variable and fixed rate debt. These derivatives may be designated as fair value hedges or cash flow hedges depending on the nature of the risk being hedged.
Fair Value Hedges
As of September 30, 2019, pay variable/receive fixed interest rate swaps with notional amounts of $200 and net asset fair value of $2 were designated and accounted for as fair value hedges. The swaps were structured to hedge the fair value of related debt by converting them from fixed rate instruments to variable rate instruments. No ineffective portion was recorded to earnings for the nine months ended September 30, 2019.
The following is a summary of our fair value hedges at September 30, 2019:
Debt Instrument
 
Year First Designated
 
Notional Amount
 
Net Fair Value
 
Weighted Average Interest Rate Paid
 
Interest Rate Received
 
Basis
 
Maturity
Senior Note 2021
 
2014
 
$
200

 
$
2

 
3.32
%
 
4.5
%
 
Libor
 
2021

Foreign Exchange Risk Management
We are a global company that is exposed to foreign currency exchange rate fluctuations in the normal course of our business. As a part of our foreign exchange risk management strategy, we use derivative instruments, primarily forward contracts and purchased option contracts, to hedge the following foreign currency exposures, thereby reducing volatility of earnings or protecting fair values of assets and liabilities:
Foreign currency-denominated assets and liabilities
Forecasted purchases and sales in foreign currency
At September 30, 2019 and December 31, 2018, we had outstanding forward exchange and purchased option contracts with gross notional values of $982 and $1,103 respectively, with terms of less than 12 months. Approximately 80% of the contracts at September 30, 2019 mature within three months, 10% mature in three to six months and 10% in six to twelve months. The associated currency exposures being hedged at September 30, 2019 were materially consistent with our year-end currency exposures. There has not been any material change in our hedging strategy.
Foreign Currency Cash Flow Hedges
We designate a portion of our foreign currency derivative contracts as cash flow hedges of our foreign currency-denominated inventory purchases, sales and expenses. The net asset fair value of these contracts were $4 and $8 as of September 30, 2019 and December 31, 2018, respectively.

Xerox 2019 Form 10-Q
29


Table of Contents                                  
 

Summary of Derivative Instruments Fair Value
The following table provides a summary of the fair value amounts of our derivative instruments:
Designation of Derivatives
 
Balance Sheet Location
 
September 30,
2019
 
December 31,
2018
Derivatives Designated as Hedging Instruments
 
 
 
 
Foreign exchange contracts - forwards
 
Other current assets
 
$
6

 
$
7

 
 
Accrued expenses and other current liabilities
 
(2
)
 

Foreign currency options
 
Other current assets
 

 
1

Interest rate swaps
 
Other long-term assets
 
2

 

 
 
Other long-term liabilities
 

 
(3
)
 
 
Net designated derivative asset
 
$
6

 
$
5

 
 
 
 
 
 
 
Derivatives NOT Designated as Hedging Instruments
 
 
 
 
Foreign exchange contracts – forwards
 
Other current assets
 
$
1

 
$
7

 
 
Accrued expenses and other current liabilities
 
(4
)
 
(1
)
 
 
Net undesignated derivative asset
 
$
(3
)
 
$
6

 
 
 
 
 
 
 
Summary of Derivatives
 
Total Derivative assets
 
$
9

 
$
15

 
 
Total Derivative liabilities
 
(6
)
 
(4
)
 
 
Net Derivative asset
 
$
3

 
$
11


Summary of Derivative Instruments Gains (Losses)
Derivative gains and (losses) affect the income statement based on whether such derivatives are designated as hedges of underlying exposures. The following is a summary of derivative gains (losses).
Designated Derivative Instruments Gains (Losses)
The following table provides a summary of gains (losses) on derivative instruments:
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
Gain (Loss) on Derivative Instruments
 
2019
 
2018
 
2019
 
2018
Fair Value Hedges - Interest Rate Contracts
 
 
 
 
 
 
 
 
Derivative gain (loss) recognized in interest expense
 
$

 
$
(1
)
 
$
5

 
$
(7
)
Hedged item (loss) gain recognized in interest expense
 

 
1

 
(5
)
 
7

 
 
 
 
 
 
 
 
 
Cash Flow Hedges - Foreign Exchange Forward Contracts and Options
 
 
 
 
 
 
Derivative gain (loss) recognized in OCI (effective portion)
 
$
4

 
$
(13
)
 
$
10

 
$
(3
)
Derivative gain (loss) reclassified from AOCL to income - Cost of sales (effective portion)
 
3

 
(1
)
 
6

 
(13
)

During the three and nine months ended September 30, 2019 and 2018, no amount of ineffectiveness was recorded in the Condensed Consolidated Statements of Income for these designated cash flow hedges and all components of each derivative’s gain or (loss) were included in the assessment of hedge effectiveness. In addition, no amount was recorded for an underlying exposure that did not occur or was not expected to occur.
As of September 30, 2019, a net after-tax gain of $7 was recorded in Accumulated other comprehensive loss associated with our cash flow hedging activity. The entire balance is expected to be reclassified into Net income within the next 12 months, providing an offsetting economic impact against the underlying anticipated transactions.
Non-Designated Derivative Instruments Gains (Losses)
Non-designated derivative instruments are primarily instruments used to hedge foreign currency-denominated assets and liabilities. They are not designated as hedges since there is a natural offset for the remeasurement of the underlying foreign currency-denominated asset or liability.

Xerox 2019 Form 10-Q
30


Table of Contents                                  
 

The following table provides a summary of gains (losses) on non-designated derivative instruments:
Derivatives NOT Designated as Hedging Instruments
 
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
Location of Derivative Gain (Loss)
 
2019
 
2018
 
2019
 
2018
Foreign exchange contracts – forwards
 
Other expense – Currency gain (loss), net
 
$
2

 
$
(7
)
 
$
3

 
$
11

For the three and nine months ended September 30, 2019 currency losses, net were $4 and $6, respectively, and for the three and nine months ended September 30, 2018 were $3 and $2, respectively. Net currency gains and losses include the mark-to-market adjustments of the derivatives not designated as hedging instruments and the related cost of those derivatives as well as the remeasurement of foreign currency-denominated assets and liabilities and are included in Other expenses, net.
Note 15 – Fair Value of Financial Assets and Liabilities
The following table represents assets and liabilities measured at fair value on a recurring basis. The basis for the measurement at fair value in all cases is Level 2 – Significant Other Observable Inputs. 
 
 
September 30,
2019
 
December 31,
2018
Assets
 
 
 
 
Foreign exchange contracts - forwards
 
$
7

 
$
14

Foreign currency options
 

 
1

Interest rate swaps
 
2

 

Deferred compensation investments in mutual funds
 
18

 
16

Total
 
$
27

 
$
31

Liabilities
 
 
 
 
Foreign exchange contracts - forwards
 
$
6

 
$
1

Interest rate swaps
 

 
3

Deferred compensation plan liabilities
 
17

 
16

Total
 
$
23

 
$
20


We utilize the income approach to measure the fair value for our derivative assets and liabilities. The income approach uses pricing models that rely on market observable inputs such as yield curves, currency exchange rates and forward prices, and therefore are classified as Level 2.
Fair value for our deferred compensation plan investments in mutual funds is based on quoted market prices for those funds. Fair value for deferred compensation plan liabilities is based on the fair value of investments corresponding to employees’ investment selections.
Summary of Other Financial Assets and Liabilities
The estimated fair values of our other financial assets and liabilities were as follows:
 
 
September 30, 2019
 
December 31, 2018
 
 
Carrying
Amount
 
Fair
Value
 
Carrying
Amount
 
Fair
Value
Cash and cash equivalents
 
$
922

 
$
922

 
$
1,084

 
$
1,084

Accounts receivable, net
 
1,188

 
1,188

 
1,276

 
1,276

Short-term debt and current portion of long-term debt
 
1,602

 
1,608

 
961

 
966

Long-term debt
 
3,230

 
3,280

 
4,269

 
3,922


The fair value amounts for Cash and cash equivalents and Accounts receivable, net, approximate carrying amounts due to the short maturities of these instruments. The fair value of Short-term debt, including the current portion of long-term debt, and Long-term debt was estimated based on the current rates offered to us for debt of similar maturities (Level 2). The difference between the fair value and the carrying value represents the theoretical net premium or discount we would pay or receive to retire all debt at such date.

Xerox 2019 Form 10-Q
31


Table of Contents                                  
 

Note 16 – Employee Benefit Plans
The components of Net periodic benefit cost and other changes in plan assets and benefit obligations were as follows:
 
 
Three Months Ended September 30,
 
 
 
 
Pension Benefits
 
 
 
 
 
 
U.S. Plans
 
Non-U.S. Plans
 
Retiree Health
Components of Net Periodic Benefit Costs:
 
2019
 
2018
 
2019
 
2018
 
2019
 
2018
Service cost
 
$
1

 
$
1

 
$
5

 
$
6

 
$

 
$
2

Interest cost
 
25

 
35

 
37

 
37

 
3

 
5

Expected return on plan assets
 
(26
)
 
(35
)
 
(56
)
 
(60
)
 

 

Recognized net actuarial loss (gain)
 
7

 
5

 
10

 
14

 
(1
)
 

Amortization of prior service credit
 

 

 

 
(1
)
 
(19
)
 
(1
)
Recognized settlement loss
 
18

 
34

 

 

 

 

Defined benefit plans
 
25

 
40

 
(4
)
 
(4
)
 
(17
)
 
6

Defined contribution plans(1)
 
6

 
9

 
5

 
8

 
n/a

 
n/a

Net Periodic Benefit Cost (Credit)
 
31

 
49

 
1

 
4

 
(17
)
 
6

 
 
 
 
 
 
 
 
 
 
 
 
 
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Loss) Income:
 
 
 
 
 
 
 
 
 
 
 
 
Net actuarial loss (gain)(2)
 
135

 

 

 
(53
)
 
(9
)
 

Amortization of net actuarial (loss) benefit
 
(25
)
 
(39
)
 
(10
)
 
(14
)
 
1

 

Amortization of prior service credit
 

 

 

 
1

 
19

 
1

Total Recognized in Other Comprehensive (Loss) Income(3)
 
110

 
(39
)
 
(10
)
 
(66
)
 
11

 
1

Total Recognized in Net Periodic Benefit Cost and Other Comprehensive (Loss) Income
 
$
141

 
$
10

 
$
(9
)
 
$
(62
)
 
$
(6
)
 
$
7

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nine Months Ended September 30,
 
 
Pension Benefits
 
 
 
 
 
 
U.S. Plans
 
Non-U.S. Plans
 
Retiree Health
Components of Net Periodic Benefit Costs:
 
2019
 
2018
 
2019
 
2018
 
2019
 
2018
Service cost
 
$
2

 
$
2

 
$
17

 
$
19

 
$
1

 
$
4

Interest cost
 
83

 
102

 
114

 
114

 
11

 
18

Expected return on plan assets
 
(77
)
 
(105
)
 
(174
)
 
(185
)
 

 

Recognized net actuarial loss (gain)
 
18

 
17

 
32

 
44

 
(3
)
 

Amortization of prior service credit
 
(1
)
 
(1
)
 
(1
)
 
(3
)
 
(57
)
 
(3
)
Recognized settlement loss
 
76

 
85

 

 

 

 

Defined benefit plans
 
101

 
100

 
(12
)
 
(11
)
 
(48
)
 
19

Defined contribution plans(1)
 
19

 
28

 
17

 
22

 
n/a
 
n/a
Net Periodic Benefit Cost (Credit)
 
120

 
128

 
5

 
11

 
(48
)
 
19

 
 
 
 
 
 
 
 
 
 
 
 
 
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Loss) Income:
 
 
 
 
 
 
 
 
 
 
 
 
Net actuarial loss (gain)(2)
 
171

 
(46
)
 

 
(53
)
 
(9
)
 
10

Amortization of net actuarial (loss) benefit
 
(94
)
 
(102
)
 
(32
)
 
(44
)
 
3

 

Amortization of prior service credit
 
1

 
1

 
1

 
3

 
57

 
3

Total Recognized in Other Comprehensive (Loss) Income(3)
 
78

 
(147
)
 
(31
)
 
(94
)
 
51

 
13

Total Recognized in Net Periodic Benefit Cost (Credit) and Other Comprehensive (Loss) Income
 
$
198

 
$
(19
)
 
$
(26
)
 
$
(83
)
 
$
3

 
$
32

__________________________
(1)
Prior year amounts have been revised to reflect additional cost for previously excluded plans.
(2)
The net actuarial loss (gain) for U.S. Plans primarily reflects (i) the remeasurement of our primary U.S. pension plans as a result of the payment of periodic settlements and (ii) adjustments for the actuarial valuation results based on January 1st plan census data. The non-U.S. plans net actuarial gain for 2018 reflects and out-of-period adjustment of $53 to correct an overstated benefit obligation for our U.K. Funded Pension Plan at December 31, 2017.
(3)
Amounts represent the pre-tax effect included within Other Comprehensive (Loss) Income. Refer to Note 20 - Other Comprehensive (Loss) Income for related tax effects and the after-tax amounts.

Xerox 2019 Form 10-Q
32


Table of Contents                                  
 

Contributions
The following table summarizes cash contributions to our defined benefit pension plans and retiree health benefit plans.
 
 
Nine Months Ended September 30,
 
Year Ended December 31,
 
 
2019
 
2018
 
Estimated 2019
 
2018
U.S. plans
 
$
19

 
$
20

 
$
25

 
$
27

Non-U.S. plans
 
88

 
91

 
115

 
117

Total Pension
 
$
107

 
$
111

 
$
140

 
$
144

 
 
 
 
 
 
 
 
 
Retiree Health
 
$
22

 
$
42

 
$
35

 
$
57


There are no mandatory contributions required in 2019 for our U.S. tax-qualified defined benefit plans to meet the minimum funding requirements.
Note 17 – Shareholders’ Equity of Xerox Holdings
(shares in thousands)
For information related to the Reorganization of Xerox and Xerox Holdings, refer to Note 1 - Basis of Presentation - Corporate Reorganization. The shareholders' equity information presented below reflects the consolidated activity of Xerox Holdings.
 
Common
Stock
 
Additional
Paid-in
Capital
 
Treasury Stock
 
Retained
Earnings
 
AOCL(1)
 
Xerox Holdings
Shareholders’
Equity
 
Non-controlling
Interests
 
Total
Equity
Balance at June 30, 2019
$
225

 
$
3,124

 
$
(131
)
 
$
5,391

 
$
(3,647
)
 
$
4,962

 
$
30

 
$
4,992

Comprehensive income (loss), net

 

 

 
221

 
(203
)
 
18

 
2

 
20

Cash dividends declared - common(3)

 

 

 
(56
)
 

 
(56
)
 

 
(56
)
Cash dividends declared - preferred(4)

 

 

 
(4
)
 

 
(4
)
 

 
(4
)
Stock option and incentive plans, net

 
3

 

 

 

 
3

 

 
3

Payments to acquire treasury stock, including fees

 

 
(68
)
 

 

 
(68
)
 

 
(68
)
Cancellation of treasury stock
(4
)
 
(127
)
 
131

 

 

 

 

 

Distributions to noncontrolling interests

 

 

 

 

 

 
(1
)
 
(1
)
Balance at September 30, 2019
$
221

 
$
3,000

 
$
(68
)
 
$
5,552

 
$
(3,850
)
 
$
4,855

 
$
31

 
$
4,886


 
Common
Stock
 
Additional
Paid-in
Capital
 
Treasury Stock
 
Retained
Earnings
 
AOCL(1)
 
Xerox Holdings
Shareholders’
Equity
 
Non-
controlling
Interests
 
Total
Equity
Balance at June 30, 2018
$
255

 
$
3,920

 
$

 
$
4,974

 
$
(3,772
)
 
$
5,377

 
$
31

 
$
5,408

Comprehensive income, net

 

 

 
89

 
61

 
150

 
4

 
154

Cash dividends declared - common(3)

 

 

 
(62
)
 

 
(62
)
 

 
(62
)
Cash dividends declared - preferred(4)

 

 

 
(4
)
 

 
(4
)
 

 
(4
)
Stock option and incentive plans, net
1

 
10

 

 

 

 
11

 

 
11

Payments to acquire treasury stock, including fees

 

 
(284
)
 

 

 
(284
)
 

 
(284
)
Distributions to noncontrolling interests

 

 

 

 

 

 
(1
)
 
(1
)
Balance at September 30, 2018
$
256

 
$
3,930

 
$
(284
)
 
$
4,997

 
$
(3,711
)
 
$
5,188

 
$
34

 
$
5,222


Xerox 2019 Form 10-Q
33


Table of Contents                                  
 

 
Common
Stock
 
Additional
Paid-in
Capital
 
Treasury Stock
 
Retained
Earnings
 
AOCL(1)
 
Xerox Holdings
Shareholders’
Equity
 
Non-controlling
Interests
 
Total
Equity
Balance at December 31, 2018
$
232

 
$
3,321

 
$
(55
)
 
$
5,072

 
$
(3,565
)
 
$
5,005

 
$
34

 
$
5,039

Cumulative effect of change in accounting principle(2)

 

 

 
127

 
(127
)
 

 

 

Comprehensive income (loss), net

 

 

 
535

 
(158
)
 
377

 
8

 
385

Cash dividends declared - common(3)

 

 

 
(171
)
 

 
(171
)
 

 
(171
)
Cash dividends declared - preferred(4)

 

 

 
(11
)
 

 
(11
)
 

 
(11
)
Stock option and incentive plans, net

 
23

 

 

 

 
23

 

 
23

Payments to acquire treasury stock, including fees

 

 
(368
)
 

 

 
(368
)
 

 
(368
)
Cancellation of treasury stock
(11
)
 
(344
)
 
355

 

 

 

 

 

Distributions to noncontrolling interests

 

 

 

 

 

 
(11
)
 
(11
)
Balance at September 30, 2019
$
221

 
$
3,000

 
$
(68
)
 
$
5,552

 
$
(3,850
)
 
$
4,855

 
$
31

 
$
4,886


 
Common
Stock
 
Additional
Paid-in
Capital
 
Treasury Stock
 
Retained
Earnings
 
AOCL(1)
 
Xerox Holdings
Shareholders’
Equity
 
Non-
controlling
Interests
 
Total
Equity
Balance at December 31, 2017
$
255

 
$
3,893

 
$

 
$
4,856

 
$
(3,748
)
 
$
5,256

 
$
37

 
$
5,293

Cumulative effect of change in accounting principles

 

 

 
120

 

 
120

 

 
120

Comprehensive income, net

 

 

 
224

 
37

 
261

 
9

 
270

Cash dividends declared - common(3)

 

 

 
(192
)
 

 
(192
)
 

 
(192
)
Cash dividends declared - preferred(4)

 

 

 
(11
)
 

 
(11
)
 

 
(11
)
Stock option and incentive plans, net
1

 
37

 

 

 

 
38

 

 
38

Payments to acquire treasury stock, including fees

 

 
(284
)
 

 

 
(284
)
 

 
(284
)
Distributions to noncontrolling interests

 

 

 

 

 

 
(12
)
 
(12
)
Balance at September 30, 2018
$
256

 
$
3,930

 
$
(284
)
 
$
4,997

 
$
(3,711
)
 
$
5,188

 
$
34

 
$
5,222

_____________________________
(1)
Refer to Note 20 - Other Comprehensive (Loss) Income for the components of AOCL.
(2)
Refer to Note 2 - Recent Accounting Pronouncements - Income Taxes, for additional information related to the adoption of ASU 2018-02.
(3)
Cash dividends declared on common stock for the three and nine months ended September 30, 2019 and 2018 were $0.25 per share and $0.75 per share, respectively.
(4)
Cash dividends declared on preferred stock for the three and nine months ended September 30, 2019 and 2018 were $20.00 per share and $60.00 per share, respectively.
Treasury Stock
The following is a summary of the purchases of common stock during 2019:
 
 
Shares
 
Amount
Balance at December 31, 2018
 
2,067

 
$
55

Purchases(1)
 
11,575

 
368

Cancellations
 
(11,313
)
 
(355
)
Balance at September 30, 2019
 
2,329

 
$
68

_____________________________
(1)
Includes associated fees.

Xerox 2019 Form 10-Q
34


Table of Contents                                  
 

Note 18 – Shareholders’ Equity of Xerox
(shares in thousands)
For information related to the Reorganization of Xerox and Xerox Holdings, refer to Note 1 - Basis of Presentation - Corporate Reorganization. The shareholders' equity information presented below reflects the consolidated activity of Xerox.
 
Common
Stock
 
Additional
Paid-in
Capital
 
Treasury Stock
 
Retained
Earnings
 
AOCL(1)
 
Xerox
Shareholders’
Equity
 
Non-controlling
Interests
 
Total
Equity
Balance at June 30, 2019
$
225

 
$
3,124

 
$
(131
)
 
$
5,391

 
$
(3,647
)
 
$
4,962

 
$
30

 
$
4,992

Comprehensive income (loss), net

 

 

 
221

 
(203
)
 
18

 
2

 
20

Dividends declared to parent

 

 

 
(58
)
 

 
(58
)
 

 
(58
)
Stock option and incentive plans, net

 
(2
)
 

 

 

 
(2
)
 

 
(2
)
Cancellation of treasury stock
(4
)
 
(127
)
 
131

 

 

 

 

 

Distributions to noncontrolling interests

 

 

 

 

 

 
(1
)
 
(1
)
Reorganization (3)
(221
)
 
446

 

 

 

 
225

 

 
225

Balance at September 30, 2019
$

 
$
3,441

 
$

 
$
5,554

 
$
(3,850
)
 
$
5,145

 
$
31

 
$
5,176



 
Common
Stock
 
Additional
Paid-in
Capital
 
Treasury Stock
 
Retained
Earnings
 
AOCL(1)
 
Xerox
Shareholders’
Equity
 
Non-
controlling
Interests
 
Total
Equity
Balance at June 30, 2018
$
255

 
$
3,920

 
$

 
$
4,974

 
$
(3,772
)
 
$
5,377

 
$
31

 
$
5,408

Comprehensive income, net

 

 

 
89

 
61

 
150

 
4

 
154

Cash dividends declared - common

 

 

 
(62
)
 

 
(62
)
 

 
(62
)
Cash dividends declared - preferred

 

 

 
(4
)
 

 
(4
)
 

 
(4
)
Stock option and incentive plans, net
1

 
10

 

 

 

 
11

 

 
11

Payments to acquire treasury stock, including fees

 

 
(284
)
 

 

 
(284
)
 

 
(284
)
Distributions to noncontrolling interests

 

 

 

 

 

 
(1
)
 
(1
)
Balance at September 30, 2018
$
256

 
$
3,930

 
$
(284
)
 
$
4,997

 
$
(3,711
)
 
$
5,188

 
$
34

 
$
5,222




Xerox 2019 Form 10-Q
35


Table of Contents                                  
 

 
Common
Stock
 
Additional
Paid-in
Capital
 
Treasury Stock
 
Retained
Earnings
 
AOCL(1)
 
Xerox
Shareholders’
Equity
 
Non-controlling
Interests
 
Total
Equity
Balance at December 31, 2018
$
232

 
$
3,321

 
$
(55
)
 
$
5,072

 
$
(3,565
)
 
$
5,005

 
$
34

 
$
5,039

Cumulative effect of change in accounting principle(2)

 

 

 
127

 
(127
)
 

 

 

Comprehensive income (loss), net

 

 

 
535

 
(158
)
 
377

 
8

 
385

Cash dividends declared - common

 

 

 
(115
)
 

 
(115
)
 

 
(115
)
Cash dividends declared - preferred

 

 

 
(7
)
 

 
(7
)
 

 
(7
)
Dividends declared to parent

 

 

 
(58
)
 

 
(58
)
 

 
(58
)
Stock option and incentive plans, net

 
18

 

 

 

 
18

 

 
18

Payments to acquire treasury stock, including fees

 

 
(300
)
 

 

 
(300
)
 

 
(300
)
Cancellation of treasury stock
(11
)
 
(344
)
 
355

 

 

 

 

 

Distributions to noncontrolling interests

 

 

 

 

 

 
(11
)
 
(11
)
Reorganization(3)
(221
)
 
446

 

 

 

 
225

 

 
225

Balance at September 30, 2019
$

 
$
3,441

 
$

 
$
5,554

 
$
(3,850
)
 
$
5,145

 
$
31

 
$
5,176

 
Common
Stock
 
Additional
Paid-in
Capital
 
Treasury Stock
 
Retained
Earnings
 
AOCL(1)
 
Xerox
Shareholders’
Equity
 
Non-
controlling
Interests
 
Total
Equity
Balance at December 31, 2017
$
255

 
$
3,893

 
$

 
$
4,856

 
$
(3,748
)
 
$
5,256

 
$
37

 
$
5,293

Cumulative effect of change in accounting principles

 

 

 
120

 

 
120

 

 
120

Comprehensive income, net

 

 

 
224

 
37

 
261

 
9

 
270

Cash dividends declared - common

 

 

 
(192
)
 

 
(192
)
 

 
(192
)
Cash dividends declared - preferred

 

 

 
(11
)
 

 
(11
)
 

 
(11
)
Stock option and incentive plans, net
1

 
37

 

 

 

 
38

 

 
38

Payments to acquire treasury stock, including fees

 

 
(284
)
 

 

 
(284
)
 

 
(284
)
Distributions to noncontrolling interests

 

 

 

 

 

 
(12
)
 
(12
)
Balance at September 30, 2018
$
256

 
$
3,930

 
$
(284
)
 
$
4,997

 
$
(3,711
)
 
$
5,188

 
$
34

 
$
5,222

_____________________________
(1)
Refer to Note 20 - Other Comprehensive (Loss) Income for the components of AOCL.
(2)
Refer to Note 2 - Recent Accounting Pronouncements - Income Taxes, for additional information related to the adoption of ASU 2018-02.
(3)
Refer to Note 1 - Basis of Presentation for additional information on the Reorganization of Xerox.
Treasury Stock
The following is a summary of the purchases of common stock during 2019:
 
 
Shares
 
Amount
Balance at December 31, 2018
 
2,067

 
$
55

Purchases(1)
 
9,246

 
300

Cancellations
 
(11,313
)
 
(355
)
Balance at September 30, 2019
 

 
$

_____________________________
(1)
Includes associated fees.

Xerox 2019 Form 10-Q
36


Table of Contents                                  
 

Note 19 – Stock-Based Compensation
(shares in thousands)
We have a long-term incentive plan whereby eligible employees may be granted restricted stock units (RSUs), performance shares (PSs) and stock options (SOs). We grant stock-based compensation awards in order to continue to attract and retain qualified employees and to better align employees' interests with those of our shareholders. Each of these awards is subject to settlement with newly issued shares of our common stock.
Stock-based compensation expense was as follows:
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2019
 
2018
 
2019
 
2018
Stock-based compensation expense, pre-tax
 
$
11

 
$
15

 
$
41

 
$
44

Income tax benefit recognized in earnings
 
3

 
4

 
10

 
11


The board of directors (the "Board") recently approved a change in the timing of our annual grant of awards from April to January to more closely align the grant date with the underlying performance period related to PSs. The following is a summary of the program design and performance metrics effective for our January 2019 grant and grants thereafter, as approved by the Board. Stock options were not awarded under the 2019 grant.
Restricted Stock Units
Compensation expense for RSUs is based upon the grant-date market price and is recognized on a straight-line basis over the vesting period, based on management's estimate of the number of shares expected to vest. RSUs vest on a graded schedule as follows: 25% after one year of service, 25% after two years of service, and 50% after three years of service from the date of grant. Shares awarded to employees who are retirement-eligible at the date of grant, become retirement-eligible during the vesting period, or are terminated not-for-cause (e.g. as part of a restructuring initiative), vest based on service provided from the date of grant to the date of separation. Shares granted through September 30, 2019 under this program were 1,288, with a corresponding weighted-average grant-date fair value of $22.73 per share.
Performance Shares
In connection with the January 2019 grant, the Board approved a change to the PSs performance goals replacing the Total Shareholder Return (TSR) metric with an Absolute Share Price metric focusing on stock price appreciation. The Board retained the Revenue and Free Cash Flow metrics as performance goals as well as the three-year performance period for all measures. The performance metrics are weighted as follows: 25% Revenue, 25% Free Cash Flow and 50% Absolute Share Price. Each PS grant is one-half performance based (Revenue and Free Cash Flow) and one-half market-based (Absolute Share Price). The performance goals are independent of each other and depending on the achievement of these metrics, a recipient of a PS award is entitled to receive a number of shares equal to a percentage, ranging from 0% to 200% of the PS award granted. PSs retain the three-year cliff vesting from the date of grant.
Performance-Based Component
PSs vest contingent upon meeting pre-determined cumulative performance metrics. The fair value of our PSs is based upon the grant-date market price. Compensation expense is recognized on a straight-line basis over the vesting period, based on management's estimate of the number of shares expected to vest. If the cumulative three-year actual results exceed the stated targets, all plan participants have the potential to earn additional shares of common stock up to a maximum overachievement of 100% of the original grant. If the stated targets are not met, any recognized compensation cost would be reversed. Shares granted through September 30, 2019 under this program were 714, with a corresponding weighted-average grant-date fair value of $22.62 per share.
Market-Based Component
The Absolute Share Price metric is based on Xerox's average closing price for the last 20 trading days of the performance period, inclusive of dividends during the three-year performance period. Payout for this portion of the PS will be determined based on total return targets approved by the compensation committee of the Board. Since this portion of the PS award represents a market condition, a Monte Carlo simulation was used to determine the grant-date fair value.

Xerox 2019 Form 10-Q
37


Table of Contents                                  
 

A summary of the key valuation input assumptions used in the Monte Carlo simulation relative to PS awards granted were as follows:
 
 
Program to Date September 30, 2019
Term
 
3 years

Risk-free interest rate(1)
 
2.51
%
Dividend yield(2)
 
3.97
%
Xerox’s blended volatility(3)
 
32.95
%
Weighted-average fair value(4)
 
$
16.25

____________
(1)
The risk-free interest rate was based on the zero-coupon U.S. Treasury yield curve on the valuation date, with a maturity matched to the performance period.
(2)
The dividend yield was calculated as the expected quarterly dividend divided by Xerox’s three-month average stock price as of the valuation date, annualized and continuously compounded.
(3)
Xerox’s volatility is calculated using a blended volatility approach, with 50% weight on Xerox's historical volatility calculated from daily stock returns over a three-year look-back term from the valuation date, and 50% weight on Xerox's implied volatility.
(4)
The weighted-average of fair values used to record compensation expense as determined by the Monte Carlo simulation.

The Absolute Share Price is compared against total return targets to determine the payout as follows:
Total Return Targets(1)
 
Payout Percentages
$40.00 and above
 
200
%
$35.00
 
100
%
$30.00
 
50
%
Below $30.00
 
0
%
____________
(1)
For performance between the levels described above, the degree of vesting is interpolated on a linear basis.
Compensation expense is recognized on a straight-line basis over the vesting period based on the fair value determined by the Monte Carlo simulation and, except in cases of employee forfeiture, cannot be reversed regardless of performance. Shares granted through September 30, 2019 under this program were 714.

Note: Management’s estimate of the number of shares expected to vest at the time of grant reflects an estimate for forfeitures based on our historical forfeiture rate to date. Should actual forfeitures differ from management’s estimate, the activity will be reflected in a subsequent period.

Xerox 2019 Form 10-Q
38


Table of Contents                                  
 

Note 20 - Other Comprehensive (Loss) Income
Other Comprehensive (Loss) Income is comprised of the following:
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
 
2019
 
2018
 
2019
 
2018
 
 
Pre-tax
 
Net of Tax
 
Pre-tax
 
Net of Tax
 
Pre-tax
 
Net of Tax
 
Pre-tax
 
Net of Tax
Translation adjustments losses
 
$
(153
)
 
$
(155
)
 
$
(13
)
 
$
(13
)
 
$
(121
)
 
$
(122
)
 
$
(164
)
 
$
(159
)
Unrealized gains (losses)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Changes in fair value of cash flow hedges gains (losses)
 
4

 
4

 
(13
)
 
(9
)
 
10

 
8

 
(3
)
 
(2
)
Changes in cash flow hedges reclassed to earnings(1)
 
(3
)
 
(3
)
 
1

 
(1
)
 
(6
)
 
(5
)
 
13

 
9

Other gains (losses)
 

 

 
1

 
1

 

 

 
(2
)
 
(2
)
Net Unrealized gains (losses)
 
1

 
1

 
(11
)
 
(9
)
 
4

 
3

 
8

 
5

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Defined benefit plans (losses) gains
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net actuarial/prior service (losses) gains
 
(126
)
 
(95
)
 
53

 
44

 
(162
)
 
(122
)
 
89

 
71

Prior service amortization(2)
 
(19
)
 
(14
)
 
(2
)
 
(1
)
 
(59
)
 
(44
)
 
(7
)
 
(5
)
Actuarial loss amortization/settlement(2)
 
34

 
26

 
53

 
40

 
123

 
93

 
146

 
110

Fuji Xerox changes in defined benefit plans, net(3)
 
(3
)
 
(3
)
 
6

 
6

 
(1
)
 
(1
)
 
(18
)
 
(18
)
Other gains (losses)(4)
 
38

 
38

 
(6
)
 
(6
)
 
36

 
36

 
33

 
33

Changes in defined benefit plans (losses) gains
 
(76
)
 
(48
)
 
104

 
83

 
(63
)
 
(38
)
 
243

 
191

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other Comprehensive (Loss) Income
 
(228
)
 
(202
)
 
80

 
61

 
(180
)
 
(157
)
 
87

 
37

Less: Other comprehensive income attributable to noncontrolling interests
 
1

 
1

 

 

 
1

 
1

 

 

Other Comprehensive (Loss) Income Attributable to Xerox Holdings
 
$
(229
)
 
$
(203
)
 
$
80

 
$
61

 
$
(181
)
 
$
(158
)
 
$
87

 
$
37

_____________________________
(1)
Reclassified to Cost of sales - refer to Note 14 - Financial Instruments for additional information regarding our cash flow hedges.
(2)
Reclassified to Total Net Periodic Benefit Cost - refer to Note 16 - Employee Benefit Plans for additional information.
(3)
Represents our share of Fuji Xerox's benefit plan changes.
(4)
Primarily represents currency impact on cumulative amount of benefit plan net actuarial losses and prior service credits in AOCL.

Accumulated Other Comprehensive Loss (AOCL)
AOCL is comprised of the following:
 
 
September 30,
2019
 
December 31,
2018
Cumulative translation adjustments
 
$
(2,146
)
 
$
(2,023
)
Other unrealized gains, net
 
7

 
4

Benefit plans net actuarial losses and prior service credits(1)(2)
 
(1,711
)
 
(1,546
)
Total Accumulated other comprehensive loss attributable to Xerox Holdings
 
$
(3,850
)
 
$
(3,565
)
_____________________________
(1)
Includes our share of Fuji Xerox.
(2)
The change from December 31, 2018 includes $(127) related to the adoption of ASU 2018-02 and the reclassification of stranded tax effects resulting from the Tax Act - refer to Note 2 - Recent Accounting Pronouncements - Income Taxes for additional information.

Xerox 2019 Form 10-Q
39


Table of Contents                                  
 

Note 21 – Earnings per Share
(shares in thousands)
The following table sets forth the computation of basic and diluted earnings per share of common stock of Xerox Holdings:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
Basic Earnings per Share
 
 
 
 
 
 
 
Net Income Attributable to Xerox Holdings
$
221

 
$
89

 
$
535

 
$
224

Accrued dividends on preferred stock
(4
)
 
(4
)
 
(11
)
 
(11
)
Adjusted Net income available to common shareholders
$
217

 
$
85

 
$
524

 
$
213

Weighted average common shares outstanding
220,269

 
251,290

 
224,257

 
253,360

 
 
 
 
 
 
 
 
Basic Earnings per Share
$
0.99

 
$
0.34

 
$
2.34

 
$
0.84

 
 
 
 
 
 
 
 
Diluted Earnings per Share
 
 
 
 
 
 
 
Net Income Attributable to Xerox Holdings
$
221

 
$
89

 
$
535

 
$
224

Accrued dividends on preferred stock

 
(4
)
 

 
(11
)
Adjusted Net income available to common shareholders
$
221

 
$
85

 
$
535

 
$
213

Weighted average common shares outstanding
220,269

 
251,290

 
224,257

 
253,360

Common shares issuable with respect to:
 
 
 
 
 
 
 
Stock options
42

 

 
37

 

Restricted stock and performance shares
4,014

 
2,763

 
4,429

 
2,875

Convertible preferred stock
6,742

 

 
6,742

 

Adjusted Weighted average common shares outstanding
231,067

 
254,053

 
235,465

 
256,235

 
 
 
 
 
 
 
 
Diluted Earnings per Share
$
0.96

 
$
0.34

 
$
2.27

 
$
0.83

 
 
 
 
 
 
 
 
The following securities were not included in the computation of diluted earnings per share as they were either contingently issuable shares or shares that if included would have been anti-dilutive:
Stock options
841

 
1,052

 
847

 
1,052

Restricted stock and performance shares
2,358

 
3,529

 
1,944

 
3,417

Convertible preferred stock

 
6,742

 

 
6,742

Total Anti-Dilutive Securities
3,199

 
11,323

 
2,791

 
11,211

 
 
 
 
 
 
 
 
Dividends per Common Share
$
0.25

 
$
0.25

 
$
0.75

 
$
0.75


 

Xerox 2019 Form 10-Q
40


Table of Contents                                  
 

Note 22 – Contingencies and Litigation
Legal Matters
We are involved in a variety of claims, lawsuits, investigations and proceedings concerning: securities law; governmental entity contracting; servicing and procurement law; intellectual property law; environmental law; employment law; the Employee Retirement Income Security Act (ERISA); and other laws and regulations. We determine whether an estimated loss from a contingency should be accrued by assessing whether a loss is deemed probable and can be reasonably estimated. We assess our potential liability by analyzing our litigation and regulatory matters using available information. We develop our views on estimated losses in consultation with outside counsel handling our defense in these matters, which involves an analysis of potential results, assuming a combination of litigation and settlement strategies. Should developments in any of these matters cause a change in our determination as to an unfavorable outcome and result in the need to recognize a material accrual, or should any of these matters result in a final adverse judgment or be settled for significant amounts, they could have a material adverse effect on our results of operations, cash flows and financial position in the period or periods in which such change in determination, judgment or settlement occurs.
Brazil Contingencies
Our Brazilian operations have received or been the subject of numerous governmental assessments related to indirect and other taxes. The tax matters principally relate to claims for taxes on the internal transfer of inventory, municipal service taxes on rentals and gross revenue taxes. We are disputing these tax matters and intend to vigorously defend our positions. Based on the opinion of legal counsel and current reserves for those matters deemed probable of loss, we do not believe that the ultimate resolution of these matters will materially impact our results of operations, financial position or cash flows. Below is a summary of our Brazilian tax contingencies:
 
 
September 30,
2019
 
December 31,
2018
Tax contingency - unreserved
 
$
425

 
$
500

Escrow cash deposits
 
53

 
58

Surety bonds
 
98

 
106

Letters of credit
 
87

 
104

Liens on Brazilian assets
 

 


The decrease in the unreserved portion of the tax contingency, inclusive of any related interest, was primarily related to currency. With respect to the unreserved tax contingency, the majority has been assessed by management as being remote as to the likelihood of ultimately resulting in a loss to the Company. In connection with the above proceedings, customary local regulations may require us to make escrow cash deposits or post other security of up to half of the total amount in dispute, as well as, additional surety bonds and letters of credit, which include associated indexation. Generally, any escrowed amounts would be refundable and any liens on assets would be removed to the extent the matters are resolved in our favor. We are also involved in certain disputes with contract and former employees. Exposures related to labor matters are not material to the financial statements as of September 30, 2019 and December 31, 2018. We routinely assess all these matters as to the probability of ultimately incurring a liability against our Brazilian operations and record our best estimate of the ultimate loss in situations where we assess the likelihood of an ultimate loss as probable.
Litigation Against the Company
Pending Litigation Relating to the Fuji Transaction:
1.
Deason v. Fujifilm Holdings Corp., et al.; Deason v. Xerox Corp., et al.; In re Xerox Corporation Consolidated Shareholder Litigation:
In February 2018, five complaints (the "Fuji Transaction Shareholder Lawsuits"), including four putative class actions (which have been consolidated), were filed by Xerox shareholders in the Supreme Court of the State of New York, County of New York (the "Court") in connection with the proposed transaction to combine Xerox and Fuji Xerox (the “Fuji Transaction”). All of the complaints name as defendants Xerox, its directors, and FUJIFILM Holdings Corporation (“Fujifilm”). The complaint in one of the actions also names as a defendant Ursula M. Burns, the former Chief Executive Officer of Xerox. The plaintiffs allege, among other things, that Xerox's directors breached their fiduciary duties in negotiating, approving, and purportedly making false and misleading disclosures about the Fuji Transaction, and that Fujifilm aided and abetted those breaches. The complaint in one of the actions further alleges that Xerox and the director defendants engaged in common law fraud by purportedly failing to disclose information about the joint venture agreements between Xerox and Fujifilm. The Fuji Transaction Shareholder Lawsuits seek injunctive relief preventing

Xerox 2019 Form 10-Q
41


Table of Contents                                  
 

the previously proposed transactions, and/or additional disclosures by Xerox’s directors, unspecified damages from Xerox’s directors, costs and attorneys’ fees, as well as other relief.
One of the Fuji Transaction Shareholder Lawsuits was brought by Darwin Deason, a Xerox shareholder ("Deason I"). Another complaint was filed by Mr. Deason against Xerox and its directors in the same Court on March 2, 2018 ("Deason II") alleging that defendants breached their fiduciary duties by refusing Mr. Deason’s request for a waiver of the deadline for nomination of a new slate of Xerox directors. In Deason II, Mr. Deason sought to enjoin Xerox and its directors from enforcing Xerox’s advance notice by-laws, thereby allowing Mr. Deason to proceed with the nominations, as well as costs, fees, and other relief.
On April 27, 2018, the Court issued decisions and orders granting plaintiffs’ preliminary injunction motions, which (i) enjoined Xerox from “taking any further action to consummate the change of control transaction between Xerox and Fuji that was announced on January 31, 2018 pending a final determination of the claims asserted in the underlying action;” (ii) enjoined Xerox from enforcing its advance notice bylaw provision requiring shareholders to nominate directors for election at the 2018 annual shareholder meeting by December 11, 2017; and (iii) required Xerox to waive such advance notice bylaw provision to permit the noticing of a slate of director nominees for election at the 2018 annual shareholder meeting, and denying defendants’ motions to dismiss.
On May 1, 2018, Xerox entered into a Director Appointment, Nomination and Settlement Agreement (the “Initial Settlement Agreement”) with Mr. Deason and Carl C. Icahn and certain of his affiliates who were also Xerox shareholders (the "Icahn Group"), among others, that would have resolved Deason I, Deason II and the pending proxy contest in connection with Xerox’s 2018 Annual Meeting of Shareholders. The Initial Settlement Agreement expired by its terms on May 3, 2018 without becoming effective.
On May 7, 2018, defendants filed with the Supreme Court of the State of New York, Appellate Division, First Judicial Department, notices of appeal of, and motions to stay pending appeal, the lower Court’s decision and order. Defendants also moved the appellate court for interim relief ordering that the appeal be heard on an expedited basis. At a hearing before the appellate court on May 7, 2018, the appellate court ruled that the appeals would be heard on an expedited basis and granted a partial interim stay allowing Xerox and Fujifilm to take steps to seek regulatory approvals related to the Fuji Transaction pending a ruling from the appellate court on defendants’ motions to stay pending appeal.
On May 13, 2018, a second Director Appointment, Nomination and Settlement Agreement (the "Final Settlement Agreement") with respect to Deason I, Deason II and the pending proxy contest in connection with Xerox's 2018 Annual Meeting of Shareholders that was initiated by the Icahn Group was signed on behalf of Mr. Deason, the Icahn Group and all defendants except Fujifilm, and a memorandum of understanding regarding settlement of the putative class case was signed by all defendants except Fujifilm. Pursuant to the settlements, the settling defendants withdrew their appeal and motion to stay in Deason I and Deason II. The settling defendants also withdrew their motion to stay in the putative class case. The Court entered a stipulation of discontinuance as to the settling parties in Deason II on May 14, 2018, and agreed on June 22, 2018 to do the same in Deason I.
On June 14, 2018, Fujifilm filed answers in Deason I and the putative class case, along with cross-claims against the members of the Xerox Board (as constituted before May 13, 2018) and a third-party complaint against Xerox director Jonathan Christodoro, seeking contribution for any potential award against Fujifilm for aiding and abetting purported breaches of fiduciary duties.
On June 19, 2018, the putative class plaintiffs filed a motion for preliminary approval of a stipulation of settlement that would resolve the claims asserted by the plaintiffs in the putative class case against all defendants, other than Fujifilm. Carmen Ribbe, the plaintiff in the below derivative action, and Fujifilm filed oppositions to the motion on July 10, 2018.
On June 22, 2018, the Court entered an order denying a joint motion by the putative class plaintiffs and the settling defendants to dissolve the injunction in the putative class case as against the settling defendants, and entered an order denying Fujifilm’s motion to dissolve the injunctions in the putative class case and Deason I in their entirety.
On July 16, 2018, the Court held a hearing concerning the putative class plaintiffs’ motion for preliminary approval of the settlement in the putative class case. The Court indicated that it was not inclined to consider motions for approval of the settlement prior to considering whether the putative class should be certified.
On August 2, 2018, the Appellate Division entered orders recognizing the Xerox defendants’ withdrawal of their appeal in the Deason cases and denying all appellants’ motions to stay pending determination of appeals in the Deason and putative class cases.
On August 2, 2018, the Appellate Division entered orders (i) at their request, deeming withdrawn the Xerox defendants’ appeal and motion to stay in the Deason cases; (ii) upon their request, deeming withdrawn the Xerox defendants’

Xerox 2019 Form 10-Q
42


Table of Contents                                  
 

motion to stay, pending determination of appeal, the putative class case; and (iii) denying Fujifilm’s motion to stay pending determination of its appeals in the Deason and putative case cases.
On September 21, 2018, putative class plaintiffs filed a motion for certification of a settlement class and a motion to transmit notice of the proposed settlement to the proposed class. On October 17, 2018, derivative plaintiff Carmen Ribbe and Fujifilm filed oppositions to the putative class plaintiffs’ motion to transmit notice to the proposed class. The class has not yet been certified, and preliminary approval has not been granted.
The Appellate Division heard oral argument on September 25, 2018 on Fujifilm’s appeal of the Court’s decision. On October 16, 2018, the Appellate Division entered a decision and order reversing the Court’s rulings, ordering that the claims brought against Fujifilm in the cases by Mr. Deason and the purported class be dismissed, and further ordering that the preliminary injunction of the proposed Fuji Transaction be dissolved (the “Appellate Decision and Order”).
On November 15, 2018, the putative class plaintiffs filed with the Appellate Division a motion seeking the opportunity to reargue Fujifilm’s appeal or, in the alternative, for leave to appeal the Appellate Decision and Order to the New York State Court of Appeals.
On December 6, 2018, pursuant to the Appellate Decision and Order, the Court entered a judgment dismissing the complaints against Fujifilm in Deason I and the putative class case. The Court further issued orders denying the putative class plaintiffs’ motion for class certification, without prejudice to renewing the motion after the outcome of any appeals of the Appellate Decision and Order.
On January 8, 2019, the Court entered an order staying all further proceedings in Deason I and the putative class case until thirty days after exhaustion of appeals, including any appeals to the New York State Court of Appeals, of the Appellate Decision and Order. On January 9, 2019, the Court entered an order denying the putative class plaintiffs’ motion to transmit notice to the proposed class, without prejudice to renewal of their motion at a later time.
On October 31, 2018 and January 3, 2019, respectively, Xerox and the Xerox director defendants in the putative class case filed with the Appellate Division a request and motion seeking an extension, until after any decision regarding approval of settlement of the putative class action, of the deadline by which to perfect their appeal of the Court’s April 27, 2018 decision and order. On May 16, 2019, the Appellate Division entered an order granting the motion and extended the deadline until the October 2019 Term.
On February 21, 2019, the Appellate Division issued an order denying the putative class plaintiffs’ motion seeking to reargue Fujifilm’s appeal or, in the alternative, for leave to appeal the Appellate Decision and Order to the New York State Court of Appeals. No further notice of appeal was filed, and the Appellate Decision and Order became final and unappealable on March 26, 2019.
On May 3, 2019, putative class plaintiffs filed a renewed motion for approval of the form of a notice to putative class members.  On May 6, 2019, putative class plaintiffs filed a renewed motion for class certification and notice of motion to approve class settlement and proposed final approval order.   On May 24, 2019, the Court entered an order approving the form notice and proposed manner of its dissemination.
On June 6, 2019, the Court entered an order pursuant to which plaintiffs submitted their motion to approve attorneys’ fees and expenses on July 19, 2019; requiring filing of any objections to or opt-outs from the proposed putative class settlement by August 9, 2019; and setting September 6, 2019 for its hearing on putative class plaintiffs’ motion for class certification and settlement approval. The hearing took place, and on September 12, 2019, the Court entered a decision and order denying both motions.
Xerox will vigorously defend these lawsuits to the extent that the proceedings continue as to Xerox. At this time, however, it is premature to make any conclusion regarding the probability of incurring material losses in these lawsuits. Should developments cause a change in our determination as to an unfavorable outcome, or result in a final adverse judgment or settlement, there could be a material adverse effect on our results of operations, cash flows and financial position in the period in which such change in determination, judgment, or settlement occurs.
2.
Ribbe v. Jacobson, et al.:
On April 11, 2019, Carmen Ribbe filed a putative derivative and class action stockholder complaint in the Supreme Court of the State of New York for New York County, naming as defendants Xerox, current Board members Gregory Q. Brown, Joseph J. Echevarria, Cheryl Gordon Krongard, Sara Martinez Tucker, Keith Cozza, Giovanni G. Visentin, Jonathan Christodoro, Nicholas Graziano, and A. Scott Letier, and former Board members Jeffrey Jacobson, William Curt Hunter, Robert J. Keegan, Charles Prince, Ann N. Reese, and Stephen H. Rusckowski. Plaintiff previously filed a putative shareholder derivative lawsuit on May 24, 2018 against certain of these defendants, as well as others, in the same court; that lawsuit was dismissed without prejudice on December 6, 2018. The new complaint includes

Xerox 2019 Form 10-Q
43


Table of Contents                                  
 

putative derivative claims on behalf of Xerox for breach of fiduciary duty against the members of the Xerox Board who approved Xerox’s entry into agreements to settle the Deason and In re Xerox Corporation Consolidated Shareholder Litigation (“XCCSL”) actions (described above). Plaintiff alleges that the settlements ceded control of the Board and the Company to Darwin Deason and Carl C. Icahn without a vote by, or compensation to, other Xerox stockholders; improperly provided certain benefits and releases to the resigning and continuing directors; and subjected Xerox to potential breach of contract damages in an action by Fuji relating to Xerox’s termination of the proposed Fuji Transaction. Plaintiff also alleges that the current Board members breached their fiduciary duties by allegedly rejecting plaintiff’s January 14, 2019 shareholder demand on the Board to remedy harms arising from entry into the Deason and XCCSL settlements. The new complaint further includes direct claims for breach of fiduciary duty on behalf of a putative class of current Xerox stockholders other than Mr. Deason, Mr. Icahn, and their affiliated entities (the “Ribbe Class”) against the defendants for causing Xerox to enter into the Deason and XCCSL settlements, which plaintiff alleges perpetuated control of Xerox by Mr. Icahn and Mr. Deason and denied the voting franchise of Xerox shareholders. Among other things, plaintiff seeks damages in an unspecified amount for the alleged fiduciary breaches in favor of Xerox against defendants jointly and severally; rescission or reformation of the Deason and XCCSL settlements; restitution of funds paid to the resigning directors under the Deason settlement; an injunction against defendants’ engaging in the alleged wrongful practices and equitable relief affording the putative Ribbe Class the ability to determine the composition of the Board; costs and attorneys’ fees; and other further relief as the Court may deem proper.
Defendants accepted service of the complaint as of May 16, 2019.  On June 4, 2019, the Court entered an order setting a briefing schedule for defendants’ motions to dismiss the complaint.  On July 12, 2019, plaintiff filed a motion to preclude defendants from referencing in their motions to dismiss the formation of, or work by, the committee of the Board established to investigate plaintiff’s shareholder demand.  On July 18, 2019, the Court denied plaintiff’s motion and adjourned sine die the deadline by which defendants must file any motions to dismiss the complaint.
Xerox will vigorously defend against this matter. At this time, it is premature to make any conclusion regarding the probability of incurring material losses in this litigation. Should developments cause a change in our determination as to an unfavorable outcome, or result in a final adverse judgment or settlement, there could be a material adverse effect on our results of operations, cash flows and financial position in the period in which such change in determination, judgment, or settlement occurs.
3.
Fujifilm Holdings Corp. v. Xerox Corporation:
On June 18, 2018, Fujifilm filed a complaint against Xerox in the U.S. District Court for the Southern District of New York, relating to the Fuji Transaction agreements. The complaint alleges that Xerox: (1) willfully breached the Fuji Transaction agreements by purporting to terminate them to appease Messrs. Icahn and Deason and using as a pretext issues with Fujifilm’s untimely submitted financials, and by settling Deason I and Deason II without notice to or consent by Fujifilm; (2) willfully breached the implied covenant of good faith and fair dealing by failing to support and use best efforts to conclude the Fuji Transaction, thus depriving Fujifilm of the benefit of its bargain; and (3) effected a change in Xerox’s recommendation regarding the Fuji Transaction, entitling Fujifilm to terminate the Fuji Transaction agreements and to receive from Xerox a $183 termination fee. Fujifilm seeks a judgment for damages to be determined at trial in an amount in excess of $1.0 billion plus punitive damages; a declaration regarding the alleged change in recommendation such that Fujifilm may terminate the transaction and Xerox must pay the $183 termination fee and other remedies; costs and attorneys’ fees; and other relief the court may deem appropriate.
At a conference on September 24, 2018, the Court stayed all discovery pending resolution of Xerox’s motion to dismiss. Xerox filed its motion to dismiss on October 1, 2018. On February 22, 2019, following oral argument, the Court denied the motion to dismiss.
On March 12, 2019, the Court entered a scheduling order setting various case deadlines. Xerox filed its answer denying the claims on March 15, 2019. Discovery has commenced and is ongoing. On June 24, 2019 and August 12, 2019, the Court entered stipulated revised scheduling orders extending certain case deadlines.
Xerox believes the lawsuit is meritless and will vigorously defend it. At this time, however, it is premature to make any conclusion regarding the probability of incurring material losses in this litigation. Should developments cause a change in our determination as to an unfavorable outcome, or result in a final adverse judgment or settlement, there could be a material adverse effect on our results of operations, cash flows and financial position in the period in which such change in determination, judgment, or settlement occurs.

Xerox 2019 Form 10-Q
44


Table of Contents                                  
 

All Other Pending Litigation:
1.
State of Texas v. Xerox Corporation, Xerox State Healthcare, LLC, and ACS State Healthcare, LLC:
On May 9, 2014, the State of Texas, via the Texas Office of Attorney General (the “State”), filed a lawsuit in the 53rd Judicial District Court of Travis County, Texas. The lawsuit alleged that Xerox Corporation, Xerox State Healthcare, LLC and ACS State Healthcare (collectively “the Defendants”) violated the Texas Medicaid Fraud Prevention Act in the administration of ACS State Healthcare’s contract with the Texas Department of Health and Human Services (“HHSC”). Xerox Corporation provided a guaranty of contractual performance with respect to the ACS State Healthcare contract. The State alleged that the Defendants made false representations of material facts regarding the processes, procedures, implementation and results regarding the prior authorization of orthodontic claims. The State sought recovery of actual damages, two times the amount of any overpayments made as a result of alleged unlawful acts, civil penalties, pre- and post-judgment interest and all costs and attorneys’ fees. The State referenced the amount in controversy as exceeding hundreds of millions of dollars. The Defendants filed their Answer in June 2014 denying all allegations. In August 2017, the State of Texas filed a Second Amended Petition, which made substantially similar allegations and sought similar remedies as the original lawsuit. On October 23, 2017, Xerox Corporation filed a Motion for Summary Judgment seeking judgment in Xerox's favor on all claims against it. On July 2, 2018, the Court denied the State of Texas’ motion for a determination of the adequacy of its pleadings as to Xerox or in the alternative, seeking leave to amend its petition to bring additional claims against Xerox.
On February 15, 2019, The State filed, without opposition, its Third Amended Petition against Conduent Business Services, LLC (f/k/a Xerox Business Services, LLC), Conduent State Healthcare, LLC (f/k/a Xerox State Healthcare, LLC, f/k/a ACS State Healthcare, LLC) and Conduent Incorporated (collectively, the “Conduent Entities”) and Xerox Corporation to add claims for breach of contract and negligence. On February 18, 2019, Xerox and the Conduent Entities entered into a Settlement Agreement and Release (“Agreement”) with the State and the HHSC to settle all claims arising from alleged failures by the defendants or Texas Medicaid & Healthcare Partnership to comply with obligations under two contracts between Conduent State Healthcare, LLC and the HHSC entered into in 2003 and 2010. Xerox is not required to make any payment under the Agreement. Pursuant to the terms of the Agreement, the Conduent Entities will pay the State $235.9 payable in installments through no later than July 31, 2021. Also pursuant to the Agreement, all proceedings in the lawsuit were suspended, as confirmed by an order issued by the Court on February 19, 2019, and the State and the HHSC agreed to dismiss the lawsuit with prejudice and release all of the defendants from all of the State’s claims after the settlement amount has been paid in full. No defendant made any admission of liability or wrongdoing in entering into the Agreement.
At the Conduent Entities’ request, the parties executed an amendment to the Agreement providing for accelerated payment terms and for one or more Conduent Entity letters of credit to facilitate earlier dismissal of the case. On August 19, 2019, the Court entered an order dismissing with prejudice the claims against Xerox and Conduent Entities.
2.
Oklahoma Firefighters Pension and Retirement System v. Xerox Corporation, Ursula M. Burns, Luca Maestri, Kathryn A. Mikells, Lynn R. Blodgett, Robert K. Zapfel, David H. Bywater and Mary Scanlon:
On October 21, 2016, the Oklahoma Firefighters Pension and Retirement System (“plaintiff”) filed a purported securities class action complaint against Xerox Corporation, Ursula Burns, Luca Maestri, Kathryn Mikells, Lynn Blodgett and Robert Zapfel (collectively, “defendants”) in the U.S. District Court for the Southern District of New York on behalf of the plaintiff and certain purchasers or acquirers of Xerox common stock. The complaint alleged that defendants made false and misleading statements, in violation of Sections 10(b) and 20(a) of the Securities Exchange Act and SEC Rule 10b-5, relating to the operations and prospects of Xerox’s Health Enterprise business. Plaintiff sought, among other things, unspecified monetary damages and attorneys’ fees. Other, similar lawsuits may follow. On December 28, 2016, the Court entered a stipulated order setting out a schedule for amendment of the complaint and for defendants’ response to that complaint following the Court’s appointment of lead plaintiff under the Private Securities Litigation Reform Act. On February 28, 2017, the Court issued an opinion and order appointing the Arkansas Public Employees Retirement System ("APERS") as lead plaintiff. On May 1, 2017, APERS filed an amended complaint, alleging substantially similar claims and seeking substantially similar relief, but adding David Bywater and Mary Scanlon as defendants. On June 30, 2017, defendants moved to dismiss the amended complaint, and the motions were fully briefed on October 13, 2017. On March 20, 2018, the Court entered an opinion and order granting the motions, and on March 23, 2018, the Court entered a judgment of dismissal and closed the case. On April 20, 2018, plaintiffs filed a notice of appeal in the U.S. Court of Appeals for the Second Circuit, and the appeal was fully briefed as of November 28, 2018. The Second Circuit heard oral argument on May 31, 2019. On June 6, 2019, the Second Circuit entered a summary order affirming the district court’s judgment dismissing the complaint. Plaintiff's time in which to request review by the U.S. Supreme Court expired on September 4, 2019; no such request was filed.

Xerox 2019 Form 10-Q
45


Table of Contents                                  
 

Guarantees
We have issued or provided approximately $297 of guarantees as of September 30, 2019 in the form of letters of credit or surety bonds issued to i) support certain insurance programs; ii) support our obligations related to the Brazil contingencies; and iii) support certain contracts, primarily with public sector customers, which require us to provide a surety bond as a guarantee of our performance of contractual obligations.
In general, we would only be liable for the amount of these guarantees in the event we defaulted in performing our obligations under each contract; the probability of which we believe is remote. We believe that our capacity in the surety markets as well as under various credit arrangements (including our Credit Facility) is sufficient to allow us to respond to future requests for proposals that require such credit support.
Indemnifications
We have indemnified, subject to certain deductibles and limits, the purchasers of businesses or divested assets for the occurrence of specified events under certain of our divestiture agreements. Where appropriate, an obligation for such indemnifications is recorded as a liability. Since the obligated amounts of these types of indemnifications are often not explicitly stated and/or are contingent on the occurrence of future events, the overall maximum amount of the obligation under such indemnifications cannot be reasonably estimated. Other than obligations recorded as liabilities at the time of divestiture, we have not historically made significant payments for these indemnifications. Additionally, under certain of our acquisition agreements, we have provided for additional consideration to be paid to the sellers if established financial targets are achieved post-closing. We have recognized liabilities for these contingent obligations based on an estimate of the fair value of these contingencies at the time of acquisition. Contingent obligations related to indemnifications arising from our divestitures and contingent consideration provided for by our acquisitions are not expected to be material to our financial position, results of operations or cash flows.
Note 23 – Subsequent Event
On November 5, 2019, Xerox Holdings Corporation (the “Company”) announced that it had restructured its relationship with FUJIFILM Holdings Corporation (“FH”) through a series of agreements intended to simplify and set a new course for the companies’ strategic sourcing relationship going forward. As further described below, the Company entered into definitive agreements relating, among other things, to: sales to indirect subsidiaries of FH of the Company’s indirect 25% equity interest in Fuji Xerox Co., Ltd., a Japanese company (“FX”), and of the Company’s indirect 51% partnership interest in Xerox International Partners (“XIP”); modified sourcing terms for future product programs; the grant of a trademark license to enable FX to transition to a new brand while compensating the Company for continued use of its name; the grant of an IP license to allow FX to provide certain OEM products to certain named parties on a worldwide basis in exchange for a fixed royalty; and dismissal of a pending lawsuit FH filed against Xerox Corporation (“XC”).
Total proceeds to Xerox from the transactions will include accrued but unpaid dividends through the date of the closings and are expected to be approximately $2.3 billion (approximately $2.2 billion for our 25% share in FX and $100 for the sale of XIP and the OEM license). Xerox expects to use the proceeds opportunistically to pursue accretive M&A in core and adjacent industries, return of capital to shareholders and pay down its $554 Senior Notes due December 2019.
Sale of FX Interest
Pursuant to the Stock Purchase Agreement, dated as of November 5, 2019 (the “Stock Purchase Agreement”), among XC, Xerox Limited (“XL”), FH, FUJIFILM Asia Pacific Pte. Ltd. (“FFAP”) and FX, among other things, FX will conduct a buyback of its shares from both FH and XL on a pro rata basis, pursuant to which XL will receive $770 (the “Share Buyback”). Following the Share Buyback, FFAP will purchase all of the outstanding equity interests of FX owned by XL (the “FFAP Purchase” and, together with the Share Buyback, the “FX Sale Transaction”), for a purchase price of $1,430 (the “FFAP Purchase Price”), which amount shall be increased by the amount of the dividends attributable to the period from October 1, 2019 to the date on which the FFAP Purchase occurs, calculated in accordance with the terms of the Stock Purchase Agreement.
Subject to the satisfaction or waiver of the conditions set forth in the Stock Purchase Agreement and on the terms set forth therein, the closing of the FX Sale Transaction will occur on November 8, 2019; provided, however, that if FH has not received early termination of the waiting period of the pre-transaction notification (jizen-todokede) required under the Foreign Exchange and Foreign Trade Act of Japan (the “FEFTA Approval”) on or before November 5, 2019, then the Share Buyback will occur on November 8, 2019 and the FFAP Purchase will occur within three (3) business days following receipt of the FEFTA Approval. If the FEFTA Approval has not been received by March 24, 2020, then FH will consummate the FFAP Purchase on March 30, 2020, by either (i) replacing FFAP with another entity as the purchaser in the FFAP Purchase so the FEFTA Approval is no longer required in connection with the FFAP Purchase or (ii)

Xerox 2019 Form 10-Q
46


Table of Contents                                  
 

implementing another transaction structure that allows XL to sell all of its remaining equity interest in FX and receive the FFAP Purchase Price.
The closing of the FX Sale Transaction is conditioned upon the absence of any legal requirement or order preventing or making unlawful the transactions contemplated thereby, other than the FEFTA Approval. Moreover, each party’s obligation to consummate such closing is conditioned upon the accuracy of the other party’s representations and warranties (generally subject to a Material Adverse Effect (as defined in the Stock Purchase Agreement) qualifier). The Stock Purchase Agreement contains customary representations and warranties regarding the parties thereto, customary covenants, indemnification provisions and other provisions customary for transactions of this nature.
The foregoing description of the Stock Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the Stock Purchase Agreement.
Amendment No. 1 to Technology Agreement
In connection with the FX Sale Transaction and concurrently with the execution and delivery of the Stock Purchase Agreement, FX and XC entered into Amendment 1, dated as of November 5, 2019 (the “TA Amendment”), to that certain Technology Agreement (the “TA”), dated as of April 1, 2006, by and between FX and XC, relating to licenses granted to FX by XC for XC’s trademarks and certain non-marking Document Processing Activities. The TA Amendment, among other things, (i) extends to two (2) years following the expiration of the TA (the “Transition Period”) the time period by which FX is required to transition away from the use of Xerox trademarks upon expiration of the TA, (ii) grants FX limited licenses to use Xerox trademarks for the Transition Period, subject to certain quality control standards and for a royalty in the amount of $100, payable to XC within three (3) business days from the first date of the Transition Period, and (iii) amends FX’s licenses for certain non-marking Document Processing Activities to become worldwide, royalty-free, and non-exclusive upon the expiration of the TA.
The TA Amendment will become effective concurrently with the FFAP Purchase unless the Share Buyback has occurred but the FEFTA Approval has not been received by November 24, 2019, in which case the TA Amendment will become effective as of the later of (i) November 27, 2019 or (ii) if such effectiveness is prohibited by any legal requirement or order, three (3) business days following the elimination of any such prohibition (such time, as to any Ancillary Agreement (as defined below), the “Ancillary Agreements Effectiveness”).
The foregoing description of the TA Amendment does not purport to be complete and is qualified in its entirety by reference to the TA Amendment.
Amendment No. 1 to Master Program Agreement
In connection with the FX Sale Transaction and concurrently with the execution and delivery of the Stock Purchase Agreement, FX and XC entered into Amendment No. 1, dated as of November 5, 2019 (the “MPA Amendment”), to that certain Master Program Agreement (the “MPA”), dated as of September 9, 2013, relating to the supply arrangement from FX to XC for xerographic document products. The MPA Amendment removes from the MPA termination provisions that are triggered by (i) a change in the composition of the board of directors of XC, (ii) a sale of substantially all assets of XC or (iii) any other change-in-control type scenario related to XC, and extends the effective term of certain product specific supply agreements governing existing product programs.
In addition, the MPA Amendment provides, among other things, that if the TA expires on March 31, 2021 solely due to non-renewal by FX or XC, then FX will be restricted for an agreed period from selling, licensing, leasing, or distributing Graphic Communications Products in certain jurisdictions (collectively, the “Limited Exclusive Territory”), except through XC, (ii) XC and its subsidiaries will be restricted from manufacturing, purchasing, or procuring Graphic Communications Products that are being sold or distributed in the Limited Exclusive Territory, unless procured through FX (excluding Graphic Communications Products that are not substantially similar in terms of specifications and availability, taken as a whole, as Graphic Communications Products designed and manufactured by FX) and (iii) XC will be appointed as FX’s nonexclusive reseller and distributor of its Graphic Communications Products outside the Limited Exclusive Territory. The MPA Amendment also includes provisions governing the entry into and/or termination of certain future documents relating to the MPA.
The MPA Amendment will become effective at the time of the Ancillary Agreements Effectiveness.
The foregoing description of the MPA Amendment does not purport to be complete and is qualified in its entirety by reference to the MPA Amendment.

Xerox 2019 Form 10-Q
47


Table of Contents                                  
 

ITEM 2 — MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
In March 2019, Xerox Corporation (“Xerox”) announced plans to create a new public holding company, Xerox Holdings Corporation (“Xerox Holdings”), by implementing a holding company reorganization (the “Reorganization”). On July 31, 2019, Xerox completed the Reorganization. In the Reorganization, Xerox became a direct, wholly owned subsidiary of Xerox Holdings and Xerox Holdings became the successor issuer to Xerox. We believe implementation of a holding company structure will provide us with flexibility to develop and realize a range of strategic growth opportunities, including by pursuing different capital structures for new businesses, whether incubated or acquired. Refer to Note 1 - Basis of Presentation, Corporate Reorganization, in the Condensed Consolidated Financial Statements for additional information regarding the Reorganization.
Currently, Xerox Holdings' sole direct subsidiary is Xerox and therefore Xerox reflects the entirety of Xerox Holdings' operations. Accordingly, the following Management’s Discussion and Analysis (MD&A) solely focuses on the operations of Xerox and is intended to help the reader understand the results of operations and financial condition of Xerox. The MD&A is provided as a supplement to, and should be read in conjunction with, the Condensed Consolidated Financial Statements and the accompanying notes. Throughout the MD&A, references are made to various notes in the Condensed Consolidated Financial Statements which appear in Item 1 of this form 10-Q, and the information contained in such notes is incorporated by reference into the MD&A in the places where such references are made.
Throughout the MD&A, references to “we,” “our,” the “Company,” and “Xerox” refer to Xerox Corporation and its subsidiaries. References to “Xerox Corporation” refer to the stand-alone parent company and do not include its subsidiaries. References to “Xerox Holdings Corporation” refer to the stand-alone parent company and do not include its subsidiaries.
Currency Impact
To understand the trends in our business, we believe that it is helpful to analyze the impact of changes in the translation of foreign currencies into U.S. Dollars on revenue and expenses. We refer to this analysis as "constant currency", “currency impact” or “the impact from currency.” This impact is calculated by translating current period activity in local currency using the comparable prior year period's currency translation rate. This impact is calculated for all countries where the functional currency is the local country currency. We do not hedge the translation effect of revenues or expenses denominated in currencies where the local currency is the functional currency. Management believes the constant currency measure provides investors an additional perspective on revenue trends. Currency impact can be determined as the difference between actual growth rates and constant currency growth rates.


Xerox 2019 Form 10-Q
48


Table of Contents                                  
 

Overview
Third Quarter 2019 Review
Total revenue of $2.20 billion for third quarter 2019 declined 6.5% from third quarter 2018, including a 1.2-percentage point unfavorable impact from currency. The decrease in revenue reflected a decrease of 7.3% in Post sale revenue, including a 1.1-percentage point unfavorable impact from currency, and a decrease of 3.3% in Equipment sales revenue, including a 1.1-percentage point unfavorable impact from currency. The decline in Post sale revenue reflected the continuing trends of lower page volumes, an ongoing competitive price environment, a lower population of devices, as well as lower transactional revenue from unbundled supplies and paper in our Latin America region. These declines were partially offset by the implementation of a large transactional IT sales arrangement from our XBS organization. The decline in Equipment sales primarily reflected lower sales of our office-centric devices (entry and mid-range products) partially offset by higher sales of our production-centric systems (high-end).
Total revenue of $6.70 billion for the nine months ended September 30, 2019 declined 8.2% as compared to the prior year period, including a 1.7-percentage point unfavorable impact from currency. The decrease in revenue reflected a decrease of 8.3% in Post sale revenue, including a 1.7-percentage point unfavorable impact from currency, and a decrease of 8.0% in Equipment sales revenue, including a 1.6-percentage point unfavorable impact from currency. The decline in Post sale revenue reflected the continuing trends of lower page volumes, an ongoing competitive price environment and a lower population of devices, as well as lower transactional revenue from unbundled supplies and paper in our Latin America region. The decline in Equipment sales primarily reflected lower revenues from our mid-range products, which were impacted by organizational changes within the XBS sales organization, that continue to stabilize, as we transitioned a significant number of accounts from U.S. Enterprise in the first half of 2019.
Net income attributable to Xerox Holdings and adjusted1 Net income attributable to Xerox Holdings were as follows:
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
(in millions)
 
2019
 
2018
 
B/(W)
 
2019
 
2018
 
B/(W)
Net income attributable to Xerox Holdings
 
$
221

 
$
89

 
$
132

 
$
535

 
$
224

 
$
311

Adjusted(1) Net income attributable to Xerox Holdings
 
248

 
222

 
26

 
700

 
613

 
87

Third quarter 2019 Net income attributable to Xerox Holdings increased $132 million as compared to third quarter 2018 primarily due to lower non-service retirement-related costs and Income tax expense as well as higher Equity in net income of unconsolidated affiliates. In addition, lower revenues were more than offset by the continued benefits of cost savings and productivity improvements from our Project Own It transformation actions. Third quarter 2019 Adjusted1 net income attributable to Xerox Holdings increased $26 million as compared to third quarter 2018. The increase reflected increased operating profits as a result of the continued benefits from cost savings and productivity improvements from Project Own It, which more than offset the pace of revenue decline, as well as higher Equity in net income of unconsolidated affiliates.
Net income attributable to Xerox Holdings for the nine months ended September 30, 2019 increased $311 million as compared to the prior year period primarily due to higher Equity in net income of unconsolidated affiliates as well as lower Income tax expense and non-service retirement-related costs. The increase also reflected the continued benefits of cost savings and productivity improvements from our Project Own It transformation actions, which more than offset the impact of lower revenues. These benefits were partially offset by higher Restructuring and related costs. Adjusted1 net income attributable to Xerox Holdings for the nine months ended September 30, 2019 increased $87 million as compared to the prior year period. The increase was primarily related to higher Equity in net income of unconsolidated affiliates as well as increased operating profits reflecting the continued benefits of cost savings and productivity improvements from Project Own It, which more than offset the decline in revenues.
Cash flows provided by operating activities for the nine months ended September 30, 2019 were $895 million, as compared to $725 million in the prior year period primarily reflecting lower working capital2, increased dividends from equity investments, and lower cash payments for Transaction and related costs, net. These benefits were partially offset by higher payments for restructuring related costs as well as taxes. Cash used in investing activities for the nine months ended September 30, 2019 was $68 million including capital expenditures of $48 million and acquisitions of $42 million partially offset by proceeds from the sale of non-core assets. Cash used in financing activities for the nine months ended September 30, 2019 was $983 million reflecting payments of $406 million on Senior Notes, $368 million for share repurchases and dividend payments of $183 million.

Xerox 2019 Form 10-Q
49


Table of Contents                                  
 

2019 Outlook
Revenues in the first half of 2019 were impacted by organizational changes, primarily in North America. This impact gradually mitigated during the latter part of the second quarter and was much less of an impact in the third quarter. We expect total revenues to decline approximately 7.9% in 2019, including an approximate 1.5-percentage point unfavorable impact from currency. Additionally, we continue to expect share repurchases of at least $600 million and dividend payments to shareholders of $250 million in 2019 and we increased our expectations for full year 2019 cash flows from operations to be between $1,175 million and $1,275 million, up from between $1,150 million to $1,250 million, and decreased our expectations for capital expenditures to $75 million, down from $150 million.
____________________________
(1)
See the “Non-GAAP Financial Measures” section for an explanation of the non-GAAP financial measure.
(2)
Working capital, net reflects Accounts receivable, net, Inventories and Accounts payable.
HP Inc. Agreement
During second quarter 2019, we entered into an arrangement to expand our existing sourcing relationship with HP Inc. (HP). As part of the new arrangement, we will start sourcing certain A4 and entry-level A3 products from HP to diversify our supply chain. Many of these devices will operate with our ConnectKey software, a key differentiator in the marketplace.
In addition, we will provide toner for both our printers included in this agreement and certain HP printers, which will allow us to add volume to our emulsion aggregation (EA) toner plant in Webster, NY. Further, as part of our growth strategy to increase our penetration of the small-to-medium size business (SMB) market, Xerox will also become a Device as a Service (DaaS) partner for HP in the US. We will be able to sell HP PCs, displays and accessories, with or without DaaS, to our US SMB clients. Lastly, HP will also make DocuShare Flex, Xerox's cloud-based content management platform, available on commercial PCs distributed in the U.S., giving a major lift to our software growth strategy.
Restructure of Fujifilm Relationship
On November 5, 2019, Xerox Holdings Corporation (the “Company”) announced that it had restructured its relationship with FUJIFILM Holdings Corporation (“FH”) through a series of agreements intended to simplify and set a new course for the companies’ strategic sourcing relationship going forward. As further described below, the Company entered into definitive agreements relating, among other things, to: sales to indirect subsidiaries of FH of the Company’s indirect 25% equity interest in Fuji Xerox Co., Ltd., a Japanese company (“FX”), and of the Company’s indirect 51% partnership interest in Xerox International Partners (“XIP”); modified sourcing terms for future product programs; the grant of a trademark license to enable FX to transition to a new brand while compensating the Company for continued use of its name; the grant of an IP license to allow FX to provide certain OEM products to certain named parties on a worldwide basis in exchange for a fixed royalty; and dismissal of a pending lawsuit FH filed against Xerox Corporation (“XC”).
Refer to Note 23 - Subsequent Event in the Condensed Consolidated Financial Statements for additional information regarding these agreements as well as in our Current Report on form 8-K filed with the SEC on November 5, 2019.


Xerox 2019 Form 10-Q
50


Table of Contents                                  
 

Financial Review
Revenues
 
 
Three Months Ended
September 30,
 
 
 
 
 
Nine Months Ended
September 30,
 
 
 
 
 
% of Total Revenue
(in millions)
 
2019
 
2018
 
% Change
 
CC % Change
 
2019
 
2018
 
% Change
 
CC % Change
 
2019
 
2018
Equipment sales
 
$
494

 
$
511

 
(3.3
)%
 
(2.2
)%
 
$
1,446

 
$
1,571

 
(8.0
)%
 
(6.4
)%
 
22
%
 
22
%
Post sale revenue
 
1,706

 
1,841

 
(7.3
)%
 
(6.2
)%
 
5,249

 
5,726

 
(8.3
)%
 
(6.6
)%
 
78
%
 
78
%
Total Revenue
 
$
2,200

 
$
2,352

 
(6.5
)%
 
(5.3
)%
 
$
6,695

 
$
7,297

 
(8.2
)%
 
(6.5
)%
 
100
%
 
100
%
Reconciliation to Condensed Consolidated Statements of Income:
 
 
 
 
 
 
 
 
Sales(1)
 
$
804

 
$
856

 
(6.1
)%
 
(5.0
)%
 
$
2,379

 
$
2,628

 
(9.5
)%
 
(7.9
)%
 
 
 
 
Less: Supplies, paper and other sales(1)
 
(310
)
 
(345
)
 
(10.1
)%
 
(9.2
)%
 
(933
)
 
(1,057
)
 
(11.7
)%
 
(10.3
)%
 
 
 
 
Equipment sales
 
$
494

 
$
511

 
(3.3
)%
 
(2.2
)%
 
$
1,446

 
$
1,571

 
(8.0
)%
 
(6.4
)%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Services, maintenance and rentals(1)
 
$
1,336

 
$
1,431

 
(6.6
)%
 
(5.6
)%
 
$
4,132

 
$
4,465

 
(7.5
)%
 
(5.6
)%
 
 
 
 
Add: Supplies, paper and other sales(1)
 
310

 
345

 
(10.1
)%
 
(9.2
)%
 
933

 
1,057

 
(11.7
)%
 
(10.3
)%
 
 
 
 
Add: Financing
 
60

 
65

 
(7.7
)%
 
(7.0
)%
 
184

 
204

 
(9.8
)%
 
(8.1
)%
 
 
 
 
Post sale revenue
 
$
1,706

 
$
1,841

 
(7.3
)%
 
(6.2
)%
 
$
5,249

 
$
5,726

 
(8.3
)%
 
(6.6
)%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Americas
 
$
1,487

 
$
1,544

 
(3.7
)%
 
(3.6
)%
 
$
4,401

 
$
4,691

 
(6.2
)%
 
(5.8
)%
 
66
%
 
64
%
EMEA
 
641

 
713

 
(10.1
)%
 
(6.8
)%
 
2,061

 
2,307

 
(10.7
)%
 
(6.0
)%
 
31
%
 
32
%
Other
 
72

 
95

 
(24.2
)%
 
(24.2
)%
 
233

 
299

 
(22.1
)%
 
(22.1
)%
 
3
%
 
4
%
Total Revenue(2)
 
$
2,200

 
$
2,352

 
(6.5
)%
 
(5.3
)%
 
$
6,695

 
$
7,297

 
(8.2
)%
 
(6.5
)%
 
100
%
 
100
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Memo:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Xerox Services(3)
 
$
830

 
$
883

 
(6.0
)%
 
(4.6
)%
 
$
2,536

 
$
2,704

 
(6.2
)%
 
(3.8
)%
 
38
%
 
37
%
_______________
CC - See "Currency Impact" section for a description of Constant Currency.
(1)
Certain prior year amounts have been conformed to the current year presentation. Refer to Note 1 - Basis of Presentation in our Condensed Consolidated Financial Statements for additional information.
(2)
Refer to the "Geographic Sales Channels and Product and Offerings Definitions" section.
(3)
Excluding Equipment revenue, Xerox Services for the three months ended September 30, 2019 and 2018 was $719 million and $760 million, respectively, representing a decrease of 5.4% including a 1.6-percentage point unfavorable impact from currency, and for the nine months ended September 30, 2019 and 2018 was $2,222 million and $2,352 million, respectively, representing a decrease of 5.5% including a 2.3-percentage point unfavorable impact from currency
Total revenue for the three months ended September 30, 2019 decreased 6.5%, as compared to the third quarter 2018, including a 1.2-percentage point unfavorable impact from currency, while total revenues for the nine months ended September 30, 2019 decreased 8.2% as compared to the prior year period, including a 1.7-percentage point unfavorable impact from currency. For the three and nine months ended September 30, 2019, total revenue included an approximate 0.7-percentage point and 0.6-percentage point unfavorable impact, respectively, from lower OEM sales. Total revenue reflected the following:
Post sale revenue
Post sale revenue primarily reflects contracted services, equipment maintenance, supplies and financing. These revenues are associated not only with the population of devices in the field, which is affected by installs and removals, but also by the page volumes generated from the usage of such devices, and the revenue per printed page. Post sale revenue also includes transactional IT hardware sales and implementation services from our XBS organization. For the three months ended September 30, 2019 Post sale revenue decreased 7.3% as compared to the third quarter 2018, including a 1.1-percentage point unfavorable impact from currency, while Post sale revenue for the nine months ended September 30, 2019 decreased 8.3% as compared to the prior year period, including a 1.7-percentage point unfavorable impact from currency and reflected the following:
Services, maintenance and rentals revenue includes rental and maintenance revenue (including bundled supplies) as well as the post sale component of the document services revenue from our Xerox Services offerings.
For the three months ended September 30, 2019 these revenues decreased 6.6% as compared to the third quarter 2018, including a 1.0-percentage point unfavorable impact from currency. The decline at constant

Xerox 2019 Form 10-Q
51


Table of Contents                                  
 

currency1 reflected the continuing trends of lower page volumes (including a higher mix of lower usage products), an ongoing competitive price environment and a lower population of devices, which are partially associated with continued lower Enterprise signings and installs in prior periods.
For the nine months ended September 30, 2019 these revenues decreased 7.5% as compared to the prior year period, including a 1.9-percentage point unfavorable impact from currency. The decline at constant currency1 reflected the continuing trends of lower page volumes (including a higher mix of lower usage products), an ongoing competitive price environment and a lower population of devices, which are partially associated with continued lower Enterprise signings and installs in prior periods. These declines were larger in the U.S. during the first half as a result of organizational changes being implemented as part of our Project Own It transformation actions. The impact began to moderate late in the second quarter, and was much less of an impact in third quarter 2019.
Supplies, paper and other sales includes unbundled supplies and other sales.
For the three months ended September 30, 2019 these revenues decreased 10.1% as compared to the third quarter 2018, including a 0.9-percentage point unfavorable impact from currency and a 3.9-percentage point unfavorable impact from lower OEM sales. Excluding OEM sales, the decline at constant currency1 reflected lower paper sales from developing markets (primarily from the Latin America region), as well as the impact of lower supplies revenues primarily associated with lower page volume trends. These declines were partially offset by the implementation of a large transactional IT sales arrangement from our XBS organization.
For the nine months ended September 30, 2019 these revenues decreased 11.7% as compared to the prior year period, including a 1.4-percentage point unfavorable impact from currency and a 2.8-percentage point unfavorable impact from lower OEM sales. Excluding OEM sales, the decline at constant currency1 reflected the impact of lower supplies revenues primarily from our developing market regions and indirect channels in the U.S., which is associated with lower page volume trends, as well as lower paper sales from developing markets (primarily from the Latin America region).
Financing revenue is generated from financed equipment sale transactions. For the three months ended September 30, 2019 these revenues decreased 7.7% as compared to the third quarter 2018, including a 0.7-percentage point unfavorable impact from currency, while Financing revenues for the nine months ended September 30, 2019 decreased 9.8% as compared to the prior year period, including a 1.7-percentage point unfavorable impact from currency. The decrease in both periods reflected the continued decline in the finance receivables balance due to lower equipment sales in prior periods.
_______________
(1)See the “Non-GAAP Financial Measures” section for an explanation of the non-GAAP financial measure.
Equipment sales revenue
 
 
Three Months Ended September 30,
 
 
 
 
 
Nine Months Ended September 30,
 
 
 
 
 
% of Equipment Sales
(in millions)
 
2019
 
2018
 
%
Change
 
CC % Change
 
2019
 
2018
 
% Change
 
CC % Change
 
2019
 
2018
Entry
 
$
49

 
$
56

 
(12.5)%
 
(10.9)%
 
$
154

 
$
171

 
(9.9)%
 
(7.9)%
 
11%
 
11%
Mid-range
 
344

 
351

 
(2.0)%
 
(1.2)%
 
996

 
1,075

 
(7.3)%
 
(6.0)%
 
69%
 
69%
High-end
 
96

 
94

 
2.1%
 
3.4%
 
282

 
286

 
(1.4)%
 
0.8%
 
19%
 
18%
Other
 
5

 
10

 
(50.0)%
 
(50.0)%
 
14

 
39

 
(64.1)%
 
(64.1)%
 
1%
 
2%
Equipment sales
 
$
494

 
$
511

 
(3.3)%
 
(2.2)%
 
$
1,446

 
$
1,571

 
(8.0)%
 
(6.4)%
 
100%
 
100%
_______________
CC - See "Currency Impact" section for a description of Constant Currency.
Equipment sales revenue decreased 3.3% for the three months ended September 30, 2019 as compared to the third quarter 2018, including a 1.1-percentage point unfavorable impact from currency. Equipment sales revenues also decreased 8.0% for the nine months ended September 30, 2019 as compared to the prior year period and included a 1.6-percentage point unfavorable impact from currency. For the three and nine months ended September 30, 2019, these revenues were impacted by price declines of approximately 5%, respectively, and included unfavorable impacts of 0.3-percentage point and 1.4-percentage point, respectively, from the absence of OEM equipment sales. The decline at constant currency1 was primarily impacted by lower sales of our office-centric devices (entry and mid-range products) and reflected the following:
Entry - The decrease in both the three and nine months ended September 30, 2019 as compared to the respective prior year periods, reflected lower sales of devices primarily from developing market regions in EMEA reflecting in part continued weakness and delayed decisions as a result of uncertainty in the economic environment. Revenues

Xerox 2019 Form 10-Q
52


Table of Contents                                  
 

from entry products through our indirect channels in the U.S. also declined as they were further impacted by price investments and lower sales of devices from the lower end of the portfolio.
Mid-range - The decrease for the three months ended September 30, 2019 as compared to third quarter 2018, reflected lower sales from EMEA, primarily from developing market regions reflecting in part continued weakness and delayed decisions as a result of uncertainty in the economic environment. Revenues from our Americas region were flat as compared to the prior year, reflecting the favorable impact of a large account order (part of a refresh cycle), some of which occurred earlier than anticipated, offsetting lower sales from our U.S. indirect channels and from our XBS sales organization, which continued to gradually stabilize from the impact of organizational changes that were part of our Project Own It transformation actions, (including the transitioning of accounts to implement coverage changes, consolidation of real estate locations and the reduction of management layers).
The decrease for the nine months ended September 30, 2019 as compared to the prior year period, was driven by lower sales in North America, primarily reflecting the transitional impact associated with recently implemented organizational changes in our XBS sales organization, which continued to gradually stabilize in the third quarter 2019. The organizational changes were part of our Project Own It transformation actions and include the transitioning of accounts to implement coverage changes, consolidation of real estate locations and the reduction of management layers. The decrease also reflected lower revenues from our indirect channels in the U.S. and lower installs, primarily in our Americas region, as well as a lack of large deals in EMEA.
High-end - The increase in both the three and nine months ended September 30, 2019 as compared to the respective prior year periods, reflected higher sales of color systems associated with continued demand for our Iridesse production press and installs of our Versant production systems, as well as higher sales of iGen press in the U.S. in third quarter 2019. These increases were partially offset by continued lower sales of black-and-white systems. Additionally, revenues for the nine months ended September 30, 2019 were impacted by lower sales from our XBS sales organization, which continued to gradually stabilize from the impact of organizational changes that were part of our Project Own It transformation actions, (including the transitioning of accounts to implement coverage changes, consolidation of real estate locations and the reduction of management layers).
Total Installs
Installs reflect new placement of devices only. Revenue associated with equipment installations may be reflected up-front in Equipment sales or over time either through rental income or as part of our Xerox Services revenues (which are both reported within our post sale revenues), depending on the terms and conditions of our agreements with customers. Installs include activity from Xerox Services and Xerox-branded products shipped to our XBS sales unit. Detail by product group (see Geographic Sales Channels and Product and Offerings Definitions) is shown below.
Installs in the third quarter of 2019:
Entry(1) 
10% increase in color multifunction devices reflecting higher installs of ConnectKey devices primarily from our indirect channels in the U.S. partially offset by lower installs from EMEA.
6% decrease in black-and-white multifunction devices driven by lower activity primarily from our indirect channels in the U.S. and from EMEA.
Mid-Range(2) 
2% increase in mid-range color installs primarily reflecting installs associated with a large account's refresh cycle order.
20% decrease in mid-range black-and-white reflecting lower installs of ConnectKey devices primarily from developing market regions and from our indirect channels in the U.S. The decline also reflected global market trends.
High-End(2) 
12% increase in high-end color installs reflecting continued demand for our Iridesse production press and higher installs of our lower-end Versant production systems as well as higher activity from iGen in North America.
22% decrease in high-end black-and-white systems.
Installs for the nine months ended September 30, 2019:
Entry(1) 
1% increase in color multifunction devices reflecting higher installs of ConnectKey devices primarily from our indirect channels in the U.S. partially offset by lower installs from EMEA.
2% decrease installs of black-and-white multifunction devices reflecting lower activity primarily from U.S. Enterprise and from EMEA, partially offset by higher activity from our indirect channels in the U.S., as well as from XBS.

Xerox 2019 Form 10-Q
53


Table of Contents                                  
 

Mid-Range(2) 
6% decrease in mid-range color installs reflecting lower installs of ConnectKey devices primarily in our Americas region. The decrease was significantly impacted by lower activity as a result of the transactional impact associated with recently implemented organizational changes in our XBS sales organization (as part of our Project Own It transformation actions), which included the transitioning of accounts to implement coverage changes, consolidation of real estate locations and the reduction of management layers.
16% decrease in mid-range black-and-white reflecting lower installs of ConnectKey devices primarily from indirect channels in the U.S. and from EMEA.
High-End(2) 
1% decrease in high-end color installs reflecting lower activity from iGen primarily in EMEA, partially offset by continued strong demand for our Iridesse production press and higher installs of our Versant production and inkjet cut-sheet systems.
22% decrease in high-end black-and-white systems reflecting market trends.
_______________
(1)
When combined with OEM sales, Entry color multifunction devices for the three and nine months ended September 30, 2019, increased 10% and decreased 17%, respectively, while Entry black-and-white multifunction devices decreased 7% and 13%, respectively.
(2)
Mid-range and High-end color installations exclude Fuji Xerox digital front-end sales; including Fuji Xerox digital front-end sales for the three and nine months ended September 30, 2019, Mid-range color devices increased 2% and decreased 6%, respectively, while High-end color systems increased 12% and decreased 1%, respectively.
Geographic Sales Channels and Product and Offerings Definitions
Our business is aligned to a geographic focus and is primarily organized on the basis of go-to-market sales channels, which are structured to serve a range of customers for our products and services. In 2019 we changed our geographic structure to create a more streamlined, flatter and more effective organization, as follows:
Americas, which includes our sales channels in the U.S. and Canada, as well as Mexico, and Central and South America.
EMEA, which includes our sales channels in Europe, the Middle East, Africa and India.
Other, primarily includes our OEM business, as well as sales to and royalties from Fuji Xerox, and our licensing revenue.
Our products and offerings include:
“Entry”, which includes A4 devices and desktop printers. Prices in this product group can range from approximately $150 to $3,000.
“Mid-Range”, which includes A3 Office and Light Production devices that generally serve workgroup environments in mid to large enterprises. Prices in this product group can range from approximately $2,000 to $75,000+.
“High-End”, which includes production printing and publishing systems that generally serve the graphic communications marketplace and large enterprises. Prices for these systems can range from approximately $30,000 to $1,000,000+.
Xerox Services, formerly known as Managed Document Services (MDS), which includes solutions and services that span from managing print to automating processes to managing content. Our primary offerings are Intelligent Workplace Services (IWS), which is our rebranded Managed Print Services, as well as Digital and Cloud Print Services (including centralized print services). Xerox Services also includes Communication and Marketing Solutions that were previously excluded from our former MDS definition.
Note: The prior year amounts reported as Xerox Services revenues have been revised to conform to the current year presentation as follows:
(in millions)
 
 
 
 
 
 
 
% Change
 
CC % Change
2018
 
As Reported
 
Change
 
As Revised
 
As Revised
First Quarter
 
$
862

 
$
46

 
$
908

 
4.7
 %
 
(0.2
)%
Second Quarter
 
871

 
42

 
913

 
3.7
 %
 
1.3
 %
Third Quarter
 
848

 
35

 
883

 
(1.6
)%
 
 %
Fourth Quarter
 
876

 
41

 
917

 
(5.0
)%
 
(2.6
)%
Full Year
 
$
3,457

 
$
164

 
$
3,621

 
0.3
 %
 
0.5
 %
 
 
 
 
 
 
 
 
 
 
 
2017
 
As Reported
 
Change
 
As Revised
 
 
 
 
Full Year
 
$
3,419

 
$
191

 
$
3,610

 
 
 
 

Xerox 2019 Form 10-Q
54


Table of Contents                                  
 

Costs, Expenses and Other Income
Summary of Key Financial Ratios
The following is a summary of key financial ratios used to assess our performance:
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
(in millions)
 
2019
 
2018
 
B/(W)
 
2019
 
2018
 
B/(W)
Gross Profit
 
$
880

 
$
942

 
$
(62
)
 
 
$
2,666

 
$
2,913

 
$
(247
)
 
RD&E
 
100

 
102

 
2

 
 
280

 
303

 
23

 
SAG
 
513

 
583

 
70

 
 
1,580

 
1,835

 
255

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equipment Gross Margin
 
34.4
%
 
34.6
%
 
(0.2
)
pts.
 
32.9
%
 
33.0
%
 
(0.1
)
pts.
Post sale Gross Margin
 
41.6
%
 
41.6
%
 

pts.
 
41.7
%
 
41.8
%
 
(0.1
)
pts.
Total Gross Margin
 
40.0
%
 
40.1
%
 
(0.1
)
pts.
 
39.8
%
 
39.9
%
 
(0.1
)
pts.
RD&E as a % of Revenue
 
4.5
%
 
4.3
%
 
(0.2
)
pts.
 
4.2
%
 
4.2
%
 

pts.
SAG as a % of Revenue
 
23.3
%
 
24.8
%
 
1.5

pts.
 
23.6
%
 
25.1
%
 
1.5

pts.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pre-tax Income
 
$
230

 
$
192

 
$
38

 
 
$
513

 
$
459

 
$
54

 
Pre-tax Income Margin
 
10.5
%
 
8.2
%
 
2.3

pts.
 
7.7
%
 
6.3
%
 
1.4

pts.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted(1) Operating Profit
 
$
267

 
$
257

 
$
10

 
 
$
806

 
$
775

 
$
31

 
Adjusted(1) Operating Margin
 
12.1
%
 
10.9
%
 
1.2

pts.
 
12.0
%
 
10.6
%
 
1.4

pts.
_______________
(1)See the “Non-GAAP Financial Measures” section for an explanation of the non-GAAP financial measure.
Pre-tax Income Margin
Third quarter 2019 pre-tax income margin of 10.5% increased 2.3-percentage points as compared to third quarter 2018. The increase was primarily driven by lower operating expenses, primarily reflecting the net benefit from our Project Own It transformation actions, which more than offset the adverse impact of lower revenues. The increase also reflected lower Other Expenses, net, partially offset by higher Transaction and related costs, net, due to a prior year credit associated with recoveries from insurance and other vendors.
Pre-tax income margin for the nine months ended September 30, 2019 of 7.7% increased 1.4-percentage points as compared to the prior year period. The increase was primarily driven by lower Transaction and related costs, net and lower Other Expenses, net as well lower operating expenses, primarily reflecting the net benefit from our Project Own It transformation actions. These benefits more than offset the adverse impact of higher Restructuring and related costs and lower revenues.
Adjusted1 Operating Margin
Third quarter 2019 adjusted1 operating margin of 12.1% increased 1.2-percentage points as compared to third quarter 2018 primarily reflecting the impact of SAG reductions and cost productivity associated with our Project Own It transformation actions, which more than offset the pace of revenue decline and an approximate 0.2-percentage point unfavorable impact from transaction currency. The increase also reflected a $5 million favorable impact from higher costs in the prior year related to the termination of certain IT projects.
Adjusted1 operating margin for the nine months ended September 30, 2019 of 12.0% increased 1.4-percentage points as compared to the prior year period primarily reflecting the impact of SAG reductions and cost productivity associated with our Project Own It transformation actions, which more than offset the pace of revenue decline and an approximate 0.3-percentage point unfavorable impact from transaction currency. The increase also reflected a $34 million favorable impact from higher costs in the prior year related to the termination of certain IT projects and the accelerated depreciation associated with the exit of a surplus real estate facility.
______________
(1)Refer to the Operating Income and Margin reconciliation table in the "Non-GAAP Financial Measures" section.
Gross Margin
Third quarter 2019 gross margin of 40.0% decreased 0.1-percentage points as compared to third quarter 2018, and reflected an approximate 0.2-percentage point unfavorable impact from transaction currency, and the impact of lower equipment and supplies sales revenues as well as lower page volumes offset by cost productivity and restructuring savings associated with our Project Own It transformation actions.

Xerox 2019 Form 10-Q
55


Table of Contents                                  
 

Gross margin for the nine months ended September 30, 2019 of 39.8% decreased 0.1-percentage points as compared to the prior year period, and reflected an approximate 0.3-percentage point unfavorable impact from transaction currency, due to lower equipment and post sale margin, which reflected the unfavorable volume and mix impacts of lower sales, primarily from mid-range equipment in our XBS organization, as well as targeted price actions almost entirely offset by cost productivity.
Third quarter 2019 equipment gross margin of 34.4% decreased 0.2-percentage points as compared to third quarter 2018, reflecting cost productivity and the favorable mix impact of higher sales of high-end production systems offset by an approximate 0.6-percentage point unfavorable impact from transaction currency and selective price investments.
Equipment gross margin for the nine months ended September 30, 2019 of 32.9% decreased 0.1-percentage points as compared to the prior year period, including an approximate 0.8-percentage point unfavorable impact from transaction currency reflecting cost productivity, partially offset by the unfavorable volume and mix impacts of lower sales, primarily from mid-range equipment in our XBS organization, as well as selective price investments.
Third quarter 2019 post sale gross margin of 41.6% was flat as compared to third quarter 2018 as a result of productivity and restructuring savings associated with our Project Own It transformation actions, which entirely offset the impact of lower revenues, including lower pricing on contract renewals.
Post sale gross margin for the nine months ended September 30, 2019 of 41.7% decreased 0.1-percentage points as compared to the prior year period, driven by the impact of lower revenues, including lower pricing, almost entirely offset by productivity and restructuring savings associated with our Project Own It transformation actions.
Gross margins are expected to be negatively impacted in future periods as a result of an increase in the cost of our imported products from higher import tariffs. We are taking actions to mitigate the impacts of these tariffs, such as raising prices on certain products, however, we currently estimate approximately $24 million of gross cost impacts from these higher tariffs in 2019, with a significant portion impacting the fourth quarter 2019.
Research, Development and Engineering Expenses (RD&E)
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
(in millions)
2019
 
2018
 
Change
 
2019
 
2018
 
Change
R&D
$
84

 
$
83

 
$
1

 
$
234

 
$
247

 
$
(13
)
Sustaining engineering
16

 
19

 
(3
)
 
46

 
56

 
(10
)
Total RD&E Expenses
$
100

 
$
102

 
$
(2
)
 
$
280

 
$
303

 
$
(23
)
Third quarter 2019 RD&E as a percentage of revenue of 4.5% increased by 0.2-percentage points as compared to third quarter 2018, primarily due to lower revenues as expenses were essentially flat year-over-year.
RD&E of $100 million decreased $2 million as compared to third quarter 2018 and reflected cost productivity and restructuring savings from our Project Own It transformation actions, partially offset by the timing of investments that started to ramp up during the quarter.
RD&E as a percentage of revenue for the nine months ended September 30, 2019 of 4.2% was flat as compared to the prior year period.
RD&E of $280 million for the nine months ended September 30, 2019 decreased $23 million as compared to the prior year period and reflected cost productivity and restructuring savings from our Project Own It transformation actions, including savings in sustaining engineering, partially offset by modest investments in innovation in complementary market areas.
Selling, Administrative and General Expenses (SAG)
SAG as a percentage of revenue of 23.3% decreased by 1.5-percentage points as compared to third quarter 2018, primarily reflecting the benefit from productivity and restructuring associated with our Project Own It transformation actions.
SAG of $513 million decreased $70 million as compared to third quarter 2018, reflecting productivity and restructuring savings associated with our Project Own It transformation actions as well as lower compensation and incentives (consistent with lower revenues); the decrease also includes the favorable impacts of approximately $6 million from translation currency and $5 million from higher costs in the prior year associated with the termination of certain IT projects. Bad debt expense of $13 million was $3 million higher compared to third quarter 2018 and on a trailing twelve month basis (TTM) remained at less than one percent of total receivables.

Xerox 2019 Form 10-Q
56


Table of Contents                                  
 

SAG as a percentage of revenue for the nine months ended September 30, 2019 of 23.6% decreased by 1.5-percentage points as compared to the prior year period, primarily reflecting the benefit from productivity and restructuring associated with our Project Own It transformation actions.
SAG for the nine months ended September 30, 2019 of $1,580 million decreased $255 million as compared to the prior year period, reflecting productivity and restructuring savings associated with our Project Own It transformation actions as well as lower compensation and incentives (consistent with lower revenues); the decrease also includes favorable impacts of approximately $28 million from translation currency and $34 million from higher costs in the prior year related to the termination of certain IT projects and the accelerated depreciation associated with the exit of a surplus real estate facility. Bad debt expense of $38 million was $3 million higher compared to the prior year period and on a trailing twelve month basis (TTM) remained at less than one percent of total receivables.
Restructuring and Related Costs
During the second half of 2018, we started our Project Own It transformation initiative. The primary goal of this initiative is to improve productivity by driving end-to-end transformation of our processes and systems to create greater focus, speed, accountability and effectiveness and to reduce costs. We incurred restructuring and related costs of $27 million and $176 million for the three and nine months ended September 30, 2019, respectively, primarily related to costs to implement initiatives under our business transformation projects including Project Own It. The following is a breakdown of those costs:
(in millions)
 
Three Months Ended September 30, 2019
 
Nine Months Ended September 30, 2019
Restructuring and severance(1)
 
$
12

 
$
37

Asset impairments(2)
 
2

 
48

Other contractual termination costs(3)
 
1

 
18

Net reversals(4)
 
(7
)
 
(23
)
Restructuring and asset impairment costs
 
8

 
80

Retention related severance/bonuses(5)
 
11

 
31

Contractual severance costs(6)
 
3

 
41

Consulting and other costs(7)
 
5

 
24

Total
 
$
27

 
$
176

____________________________
(1)
Reflects headcount reductions of approximately 150 employees worldwide in third quarter 2019 and 450 employees worldwide for the nine months ended September 30, 2019.
(2)
Primarily related to the exit and abandonment of leased and owned facilities. The charge includes the accelerated write-off of $2 million and $36 million for the three and nine months ended September 30, 2019, respectively, for leased right-of-use asset balances and $0 million and $12 million for the three and nine months ended September 30, 2019, respectively, for owned asset balances upon exit from the facility, net of any potential sublease income and other recoveries.
(3)
Primarily includes additional costs incurred upon the exit from our facilities including decommissioning costs and associated contractual termination costs.
(4)
Reflects net reversals for changes in estimated reserves from prior period initiatives as well as $4 million and $6 million in favorable adjustments from the early termination of prior period impaired leases for the three and nine months ended September 30, 2019, respectively.
(5)
Includes retention related severance and bonuses for employees expected to continue working beyond their minimum notification period before termination.
(6)
Reflects severance costs and other related costs we are contractually required to pay on employees transferred (approximately 2,200 employees) as part of the shared service arrangement entered into with HCL Technologies.
(7)
Represents professional support services associated with our business transformation initiatives.
Third quarter 2019 actions impacted several functional areas, with approximately 50% focused on gross margin improvements, approximately 45% focused on SAG reductions, and the remainder focused on RD&E optimization.
Restructuring and asset impairment costs were $80 million for the nine months ended September 30, 2019 and included $37 million of severance costs related to headcount reductions of approximately 450 employees worldwide, $18 million of other contractual termination costs and $48 million of asset impairment charges. These costs were partially offset by $23 million of net reversals, primarily resulting from changes in estimated reserves from prior period initiatives as well as $6 million in favorable adjustments from the early termination of prior period impaired leases.
The implementation of our Project Own It initiatives as well as other business transformation initiatives is expected to result in significant cost savings in 2019 and future years. However, expected savings associated with these initiatives may be offset to some extent by business disruption during the implementation phase and until the initiatives are fully implemented and stabilized.
Third quarter 2018 Restructuring and related costs of $29 million included $40 million of severance costs related to headcount reductions of approximately 900 employees worldwide and $1 million of lease cancellation costs. These

Xerox 2019 Form 10-Q
57


Table of Contents                                  
 

costs were partially offset by $12 million of net reversals for changes in estimated reserves from prior period initiatives. Third quarter 2018 actions impacted several functional areas, with approximately 30% focused on gross margin improvements, approximately 65% on SAG reductions and the remainder focused on RD&E optimization.
Restructuring and related costs were $91 million for the nine months ended September 30, 2018 and included $104 million of severance costs related to headcount reductions of approximately 1,850 employees worldwide and $13 million of lease cancellation costs partially offset by $26 million of net reversals for changes in estimated reserves from prior period initiatives.
The restructuring reserve balance as of September 30, 2019 for all programs was $57 million, which is expected to be paid over the next twelve months.
Refer to Note 12 - Restructuring Programs in the Condensed Consolidated Financial Statements for additional information regarding our restructuring programs.
Transaction and Related Costs, Net
Transaction and related costs, net are expenses incurred in connection with Xerox's planned transaction with Fuji, which was terminated in May 2018, net of recoveries and settlements, as well as costs associated with certain litigation as a result of the terminated transaction and other shareholder actions. Transaction and related costs, net for the nine months ended September 30, 2019 were $8 million as compared to $63 million in the prior year period. The costs in 2019 primarily relate to ongoing costs for litigation associated with the terminated Fuji transaction, which are expected to continue. We also continue to pursue additional recoveries from insurance carriers and other parties for costs and expenses related to the terminated Fuji transaction and related shareholder litigation and therefore additional recoveries and adjustments may be recorded in future periods, when finalized.
Amortization of Intangible Assets
Amortization of intangible assets for the nine months ended September 30, 2019 of $35 million decreased by $1 million as compared to the prior year period.
Worldwide Employment
Worldwide employment was approximately 27,600 as of September 30, 2019 and decreased by approximately 4,800 from December 31, 2018. The reduction resulted from net attrition (attrition net of gross hires), of which a large portion is not expected to be backfilled, as well as the impact of organizational changes including employees transferred as part of the shared services arrangement entered into with HCL Technologies earlier this year.
Other Expenses, Net
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
(in millions)
2019
 
2018
 
2019
 
2018
Non-financing interest expense
$
27

 
$
28

 
$
80

 
$
84

Non-service retirement-related costs
(2
)
 
33

 
21

 
83

Interest income
(2
)
 
(5
)
 
(9
)
 
(12
)
Gains on sales of businesses and assets
(19
)
 
(3
)
 
(20
)
 
(35
)
Litigation matters
(8
)
 
1

 
(8
)
 
1

Contract termination costs - IT services
(8
)
 

 
(8
)
 

Currency losses, net
4

 
3

 
6

 
2

Loss on sales of accounts receivable
1

 
1

 
2

 
2

All other expenses, net
4

 
(1
)
 
10

 
1

Other expenses, net
$
(3
)
 
$
57

 
$
74

 
$
126

Non-Financing Interest Expense
Third quarter non-financing interest expense of $27 million was $1 million lower than third quarter 2018. When combined with financing interest expense (Cost of financing), total interest expense decreased by $1 million from third quarter 2018 primarily due to a lower debt balance.
Non-financing interest expense for the nine months ended September 30, 2019 of $80 million was $4 million lower than the prior year period. When combined with financing interest expense (Cost of financing), total interest expense decreased by $6 million from the prior year period primarily due to a lower debt balance.
Refer to Note 13 - Debt in the Condensed Consolidated Financial Statements, for additional information regarding the interest expense.

Xerox 2019 Form 10-Q
58


Table of Contents                                  
 

Non-Service Retirement-Related Costs
Non-service retirement-related costs for the three and nine months ended September 30, 2019 decreased $35 million and $62 million, respectively, as compared to the prior year periods, primarily driven by the favorable impact of a 2018 amendment to our U.S. Retiree Health Plan and lower losses from pension settlements in the U.S.
Refer to Note 16 - Employee Benefit Plans in the Condensed Consolidated Financial Statements, for additional information regarding non-service retirement-related costs.
Gains on Sales of Businesses and Assets
Gains on sales of businesses and assets for the three months ended September 30, 2019 increased $16 million as compared to the third quarter 2018, reflecting the sale of non-core business assets in the third quarter 2019. Gains on sales of businesses and assets for the nine months ended September 30, 2019 decreased by $15 million as compared to the prior year period, reflecting the higher sales of non-core business assets in the prior year.
Litigation Matters
Litigation matters for the nine months ended September 30, 2019 were $9 million lower than the prior year period, reflecting the favorable resolution of certain litigation matters in third quarter 2019.
Contract Termination Costs - IT Services
Contract termination costs for the nine months ended September 30, 2019 were an $8 million credit reflecting an adjustment to a $43 million penalty recorded in fourth quarter 2018, associated with the termination of an IT service arrangement.
Income Taxes
Third quarter 2019 effective tax rate was 28.7%. On an adjusted1 basis, third quarter 2019 effective tax rate was 26.5%. These rates were higher than the U.S. federal statutory tax rate of 21% primarily due to state taxes and the geographical mix of profits. The adjusted1 effective tax rate excludes the tax impacts associated with the following charges: Restructuring and related costs, Amortization of intangible assets, Transaction and related costs, net as well as non-service retirement-related costs and other discrete, unusual or infrequent items as described in our Non-GAAP Financial Measures section.
The effective tax rate for the nine months ended September 30, 2019 was 21.1% and includes a benefit of $31 million related to the January 2019 finalization of regulations that govern the repatriation tax from the 2017 Tax Cuts and Jobs Act (the "Tax Act"). On an adjusted1 basis, the effective tax rate for the nine months ended September 30, 2019 was 26.0%. This rate was higher than the U.S. federal statutory tax rate of 21% primarily due to state taxes and the geographical mix of profits. In addition to excluding the impact of the Tax Act, the adjusted1 effective tax rate excludes the tax impacts associated with the following charges: Restructuring and related costs, Amortization of intangible assets, Transaction and related costs, net as well as non-service retirement-related costs and other discrete, unusual or infrequent items as described in our Non-GAAP Financial Measures section.
Third quarter 2018 effective tax rate was 74.0% and included an additional charge of $95 million related to the change in the provisional estimated impact from the 2017 Tax Cuts and Jobs Act (the "Tax Act"). On an adjusted1 basis, third quarter 2018 effective tax rate was 24.5%. This rate was higher than the U.S. federal statutory tax rate of 21% primarily due to state taxes and the geographical mix of profits. In addition to excluding the impact of the Tax Act, the adjusted1 effective tax rate excludes the tax impacts associated with the following charges: Restructuring and related costs, Amortization of intangible assets, Transaction and related costs, net, and non-service retirement-related costs.
The effective tax rate for the nine months ended September 30, 2018 was 47.9% and included an additional charge of $95 million related to the change in the provisional estimated impact from the Tax Act. On an adjusted1 basis, the effective tax rate for the nine months ended September 30, 2018 was 26.5%. This rate was higher than the U.S. federal statutory tax rate of 21% primarily due to the geographical mix of profits. In addition to excluding the impact of the Tax Act, the adjusted1 effective tax rate excludes the tax impacts associated with the following charges: Restructuring and related costs, Amortization of intangible assets, Transaction and related costs, net, and non-service retirement-related.
Our effective tax rate is based on nonrecurring events as well as recurring factors, including the taxation of foreign income. In addition, our effective tax rate will change based on discrete or other nonrecurring events that may not be predictable.
______________
(1)
Refer to the Effective Tax Rate reconciliation table in the "Non-GAAP Financial Measures" section.

Xerox 2019 Form 10-Q
59


Table of Contents                                  
 

Equity in Net Income (Loss) of Unconsolidated Affiliates
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
(in millions)
 
2019
 
2018
 
2019
 
2018
Total Equity in net income (loss) of unconsolidated affiliates
 
$
58

 
$
43

 
$
137

 
$
(6
)
Fuji Xerox after-tax restructuring and other charges included in equity income (loss)
 

 
7

 
19

 
90

Equity in net income (loss) of unconsolidated affiliates primarily reflects our 25% share of Fuji Xerox Net income (loss). For the three and nine months ended September 30, 2019, equity income increased $15 million and $143 million as compared to the prior year periods, primarily reflecting savings from Fuji Xerox restructuring. Equity income for the three and nine months ended September 30, 2019, also increased as a result of $7 million and $71 million of lower year-over-year charges related to our share of Fuji Xerox after-tax restructuring and other charges, as compared to the respective prior year periods. Additionally, equity income for the nine months ended September 30, 2019 increased as a result of an approximate $28 million charge related to an out-of-period charge at Fuji Xerox in the prior year.
Refer to Note 11 - Investments in Affiliates, at Equity in the Condensed Consolidated Financial Statements for additional information regarding our Investment in Fuji Xerox as well as the prior period out-of-period adjustment.
Net Income
Third quarter 2019 Net income attributable to Xerox Holdings was $221 million, or $0.96 per diluted share. On an adjusted1 basis, Net income attributable to Xerox Holdings was $248 million, or $1.08 per diluted share and includes adjustments for Restructuring and related costs, Amortization of intangible assets, Transaction and related costs, net as well as non-service retirement-related costs and other discrete, unusual or infrequent items as described in our Non-GAAP Financial Measures section.
Net income attributable to Xerox Holdings for the nine months ended September 30, 2019 was $535 million, or $2.27 per diluted share. On an adjusted1 basis, Net income attributable to Xerox Holdings was $700 million, or $2.97 per diluted share and includes adjustments for Restructuring and related costs, Amortization of intangible assets, Transaction and related costs, net as well as non-service retirement-related costs and other discrete, unusual or infrequent items as described in our Non-GAAP Financial Measures section.
Third quarter 2018 Net income attributable to Xerox Holdings was $89 million, or $0.34 per diluted share, which included an estimated non-cash charge of $95 million or $0.37 per diluted share associated with the Tax Act. On an adjusted1 basis, Net income attributable to Xerox Holdings was $222 million, or $0.85 per diluted share and includes adjustments for Restructuring and related costs, Amortization of intangible assets, Transaction and related costs, net as well as non-service retirement-related costs and other discrete, unusual or infrequent items as described in our Non-GAAP Financial Measures section.
Net income attributable to Xerox Holdings for the nine months ended September 30, 2018 was $224 million, or $0.83 per diluted share, which included an estimated non-cash charge of $95 million or $0.37 per diluted share associated with the Tax Act. On an adjusted1 basis, Net income attributable to Xerox Holdings was $613 million, or $2.33 per diluted share and includes adjustments for Restructuring and related costs, Amortization of intangible assets, Transaction and related costs, net as well as non-service retirement-related costs and other discrete, unusual or infrequent items as described in our Non-GAAP Financial Measures section.
Refer to Note 21 - Earnings per Share in the Condensed Consolidated Financial Statements, for additional information regarding the calculation of basic and diluted earnings per share.
___________
(1)
Refer to the Net Income and EPS reconciliation table in the "Non-GAAP Financial Measures" section.
Other Comprehensive (Loss) Income
Third quarter 2019 Other Comprehensive Loss, Net Attributable to Xerox Holdings was $203 million and included the following: i) net translation adjustment losses of $155 million reflecting the significant weakening of our major foreign currencies against the U.S. Dollar during the third quarter 2019 and ii) $48 million of net losses from the changes in defined benefit plans, primarily due to net actuarial losses as a result of lower discount rates in the U.S., partially offset by settlements and the positive impacts from currency. This compares to Other Comprehensive Income, Net Attributable to Xerox Holdings of $61 million for the third quarter 2018, which reflected the following: i) $83 million of net gains from the changes in defined benefit plans, primarily due to net actuarial gains and settlements; ii) $13 million of net translation adjustment losses, reflecting the weakening of our major foreign currencies against the U.S. Dollar during third quarter 2018; and iii) $9 million of net unrealized losses on derivatives.

Xerox 2019 Form 10-Q
60


Table of Contents                                  
 

Other Comprehensive Loss, Net Attributable to Xerox Holdings for the nine months ended September 30, 2019 was $158 million and included the following: i) net translation adjustment losses of $122 million reflecting the significant weakening of our major foreign currencies against the U.S. Dollar during 2019; ii) $38 million of net losses from the changes in defined benefit plans; and iii) $3 million of net unrealized gains. This compares to Other Comprehensive Income, Net Attributable to Xerox Holdings of $37 million for the nine months ended September 30, 2018, which reflected the following: i) $191 million of net gains from the changes in defined benefit plans, primarily due to settlements and the impact of currency on net actuarial losses, partially offset by our share of the negative impacts from changes in Fuji Xerox's benefit plans; ii) $5 million of net unrealized gains on derivatives; and iii) $159 million of net translation adjustment losses, reflecting the weakening of our major foreign currencies against the U.S. Dollar during 2018.
Refer to Note 20 - Other Comprehensive (Loss) Income in the Condensed Consolidated Financial Statements, for the components of Other Comprehensive (Loss) Income, Note 14 - Financial Instruments in the Condensed Consolidated Financial Statements, for additional information regarding unrealized gains (losses), net, and Note 16 - Employee Benefit Plans in the Condensed Consolidated Financial Statements, for additional information regarding net changes in our defined benefit plans.
Capital Resources and Liquidity
As of September 30, 2019 and December 31, 2018, total cash, cash equivalents and restricted cash were $979 million and $1,148 million, respectively. There were no borrowings under our Credit Facility at September 30, 2019 or December 31, 2018, respectively. The decrease in total cash, cash equivalents and restricted cash primarily reflects the repayment of $406 million of maturing Senior Notes in first quarter 2019.
We have updated our expectations for operating cash flows from continuing operations to be between $1,175 million and $1,275 million from our original expectation of between $1,150 million and $1,250 million, as well as our expectation for capital expenditures to be approximately $75 million from our original expectation of $150 million. We continue to expect dividend payments to shareholders of approximately $250 million and share repurchases of at least $600 million in 2019.
Cash Flow Analysis
The following summarizes our cash, cash equivalents and restricted cash:
 
 
Nine Months Ended
September 30,
 
Change
(in millions)
 
2019
 
2018
 
Net cash provided by operating activities
 
$
895

 
$
725

 
$
170

Net cash used in investing activities
 
(68
)
 
(40
)
 
(28
)
Net cash used in financing activities
 
(983
)
 
(815
)
 
(168
)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
 
(13
)
 
(20
)
 
7

Decrease in cash, cash equivalents and restricted cash
 
(169
)
 
(150
)
 
(19
)
Cash, cash equivalents and restricted cash at beginning of period
 
1,148

 
1,368

 
(220
)
Cash, Cash Equivalents and Restricted Cash at End of Period
 
$
979

 
$
1,218

 
$
(239
)
Cash Flows from Operating Activities
Net cash provided by operating activities was $895 million for the nine months ended September 30, 2019. The $170 million increase in operating cash from the prior year period was primarily due to the following:
$31 million decrease in pre-tax income before Transaction and related costs, net, Depreciation and amortization, Net gain on sales of businesses and assets, Restructuring and asset impairment charges, Defined benefit pension costs and Retiree Health costs.
$124 million increase primarily due to lower levels of inventories partially reflecting lower sales volume and improved inventory management.
$69 million increase due to lower placements of equipment on operating leases.
$59 million increase from lower restructuring payments primarily due to timing of initiatives and actions.
$45 million increase due to lower net payments for transaction and related costs as current year payments are primarily limited to costs related to on-going litigation.
$32 million increase in dividends received from equity investments primarily due to increased net income from Fuji Xerox.
$28 million increase from the settlements of foreign currency derivative contracts associated with our Yen-denominated inventory purchases.
$25 million increase from accounts receivable primarily due to the timing of collections and lower revenues.

Xerox 2019 Form 10-Q
61


Table of Contents                                  
 

$61 million decrease due to payments associated with restructuring related costs primarily for our contractual severance obligation incurred as part of the shared service arrangement with HCL Technologies and professional support services associated with our business transformation initiatives.
$57 million decrease due to a lower net run-off of finance receivables reflecting a lower balance of receivables as well as an increased level of originations.
$32 million decrease from the change in accounts payable primarily related to lower inventory and other spending as well as the year-over-year timing of supplier and vendor payments.
$26 million decrease due to higher net tax payments
Cash Flows from Investing Activities
Net cash used in investing activities was $68 million for the nine months ended September 30, 2019. The $28 million change from the prior year period was primarily due to the following:
$42 million decrease primarily due to two acquisitions.
$11 million decrease primarily due to lower proceeds from the sales of assets.
$25 million increase reflecting lower capital expenditures.
Cash Flows from Financing Activities
Net cash used in financing activities was $983 million for the nine months ended September 30, 2019. The $168 million increase in the use of cash from the prior year period was primarily due to the following:
$93 million increase from net debt activity. 2019 reflects payments of $406 million on Senior Notes compared to prior year payments of $265 million on Senior Notes, $25 million related to the termination of a capital lease obligation and $19 million of bridge facility costs.
$84 million increase due to share repurchases.
Adoption of New Leasing Standard
On January 1, 2019, we adopted ASU 2016-02, Leases (ASC Topic 842). This update, as well as additional amendments and targeted improvements issued in 2018 and early 2019, supersedes existing lease accounting guidance found under ASC 840, Leases (ASC 840) and requires the recognition of right-of-use (ROU) assets and lease obligations by lessees for those leases originally classified as operating leases under prior lease guidance.
Refer to the following Notes in the Condensed Consolidated Financial Statements for additional information related to the adoption of this standard:
Note 2 - Recent Accounting Pronouncements
Note 3 - Adoption of New Leasing Standard - Lessee
Note 4 - Adoption of New Leasing Standard - Lessor
Potential Customer Financing Transaction
In connection with the Company's strategic initiative to simplify and optimize its operations, the Company conducted a thorough evaluation of its customer financing business, including consideration of strategic alternatives for the business. The Company received multiple bids to purchase all or a portion of the business at an attractive premium, but has determined that retaining and optimizing the business through Project Own It will generate the greatest return for shareholders.
Cash, Cash Equivalents and Restricted Cash
Refer to Note 7 - Supplementary Financial Information in the Condensed Consolidated Financial Statements for additional information regarding Cash, cash equivalents and restricted cash.

Xerox 2019 Form 10-Q
62


Table of Contents                                  
 

Debt and Customer Financing Activities
The following summarizes our debt:
(in millions)
 
September 30, 2019
 
December 31, 2018
Principal debt balance(1)
 
$
4,867

 
$
5,281

Net unamortized discount
 
(19
)
 
(25
)
Debt issuance costs
 
(19
)
 
(25
)
Fair value adjustments(2)
 
 
 
 
     - terminated swaps
 
1

 
2

     - current swaps
 
2

 
(3
)
Total Debt
 
$
4,832

 
$
5,230

____________________________
(1)
Includes no Notes Payable as of September 30, 2019 and December 31, 2018.
(2)
Fair value adjustments include the following: (i) fair value adjustments to debt associated with terminated interest rate swaps, which are being amortized to interest expense over the remaining term of the related notes; and (ii) changes in fair value of hedged debt obligations attributable to movements in benchmark interest rates. Hedge accounting requires hedged debt instruments to be reported inclusive of any fair value adjustment.
Finance Assets and Related Debt
The following represents our total finance assets, net associated with our lease and finance operations:
(in millions)
 
September 30, 2019
 
December 31, 2018
Total finance receivables, net(1)
 
$
3,288

 
$
3,472

Equipment on operating leases, net
 
374

 
442

Total Finance Assets, net(2)
 
$
3,662

 
$
3,914

___________________________ 
(1)
Includes (i) Billed portion of finance receivables, net, (ii) Finance receivables, net and (iii) Finance receivables due after one year, net as included in our Condensed Consolidated Balance Sheets.
(2)
The change from December 31, 2018 includes a decrease of $40 million due to currency.
Our lease contracts permit customers to pay for equipment over time rather than at the date of installation; therefore, we maintain a certain level of debt (that we refer to as financing debt) to support our investment in these lease contracts, which are reflected in total finance assets, net. For this financing aspect of our business, we maintain an assumed 7:1 leverage ratio of debt to equity as compared to our finance assets. Approximately 35% of our finance receivables, net balance include lease financing provided to end-user customers who purchased equipment we sold to distributors and resellers.
Based on this leverage, the following represents the breakdown of total debt between financing debt and core debt:
(in millions)
 
September 30, 2019
 
December 31, 2018
Finance receivables debt(1)
 
$
2,877

 
$
3,038

Equipment on operating leases debt
 
327

 
387

Financing debt
 
3,204

 
3,425

Core debt
 
1,628

 
1,805

Total Debt
 
$
4,832

 
$
5,230

____________________________
(1)
Finance receivables debt is the basis for our calculation of "Cost of financing" expense in the Condensed Consolidated Statements of Income.
Debt Activity
Senior Notes Repayment
In first quarter 2019, we repaid approximately $406 million of maturing Senior Notes.
Sales of Accounts Receivable
Activity related to sales of Accounts receivable is as follows:  
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
(in millions)
2019
 
2018
 
2019
 
2018
Estimated decrease to operating cash flows(1)
$
(33
)
 
$
(34
)
 
$
(33
)
 
$
(61
)
__________________________
(1)
Represents the difference between current and prior period accounts receivable sales adjusted for the effects of currency.

Xerox 2019 Form 10-Q
63


Table of Contents                                  
 

Refer to Note 8 - Accounts Receivable, Net in the Condensed Consolidated Financial Statements for additional information regarding our accounts receivable sales arrangements.
Liquidity and Financial Flexibility
We manage our worldwide liquidity using internal cash management practices, which are subject to i) the statutes, regulations and practices of each of the local jurisdictions in which we operate, ii) the legal requirements of the agreements to which we are a party and iii) the policies and cooperation of the financial institutions we utilize to maintain and provide cash management services.
Our principal debt maturities are in line with historical and projected cash flows and are spread over the next five years as follows:
(in millions)
 
Amount
2019 Q4
 
$
554

2020
 
1,051

2021
 
1,062

2022
 
300

2023
 
1,000

2024
 
300

2025 and thereafter
 
600

Total
 
$
4,867

Treasury Stock
In connection with the reorganization of Xerox Corporation’s corporate structure into a holding company structure, in July 2019, Xerox Holdings Corporation’s Board of Directors authorized a $1.0 billion share repurchase program (exclusive of any commissions and other transaction fees and costs related thereto.) This program replaced the $1.0 billion of authority remaining under Xerox Corporation’s previously authorized $2.0 billion share repurchase program.
Xerox Holdings repurchased 2.4 million shares of our common stock for an aggregate cost of $68 million, including fees, in third quarter 2019. Xerox Holdings repurchased 11.6 million shares of our common stock for an aggregate cost of $368 million, including fees, during the nine months ended September 30, 2019. The full year repurchases include the shares repurchased under Xerox Corporation's previously authorized share repurchase program. The cumulative total shares repurchased by Xerox Holdings, including the shares repurchased under Xerox Corporation's previously authorized program from July 2018, is 37.7 million shares at a cost of $1.1 billion, including fees through September 30, 2019.
Xerox Holdings repurchased an additional 2.8 million shares with an aggregate cost of $83 million, including fees, from October 1, 2019 through October 31, 2019. We continue to expect full year 2019 share repurchases of at least $600 million.
For information related to the Reorganization of Xerox Corporation and Xerox Holdings, refer to Note 1 - Basis of Presentation - Corporate Reorganization in the Condensed Consolidated Financial Statements. For additional information regarding our share repurchase program, refer to Note 17 - Shareholders' Equity of Xerox Holdings Corporation in the Condensed Consolidated Financial Statements and Note 18 - Shareholders' Equity of Xerox Corporation in the Condensed Consolidated Financial Statements.

Xerox 2019 Form 10-Q
64


Table of Contents                                  
 

Financial Risk Management
We are exposed to market risk from foreign currency exchange rates and interest rates, which could affect operating results, financial position and cash flows. We manage our exposure to these market risks through our regular operating and financing activities and, when appropriate, through the use of derivative financial instruments. We utilize derivative financial instruments to hedge economic exposures, as well as to reduce earnings and cash flow volatility resulting from shifts in market rates. We enter into limited types of derivative contracts, including interest rate swap agreements, foreign currency spot, forward and swap contracts and net purchased foreign currency options to manage interest rate and foreign currency exposures. Our primary foreign currency market exposures include the Japanese Yen, Euro and U.K. Pound Sterling. The fair market values of all our derivative contracts change with fluctuations in interest rates and/or currency exchange rates and are designed so that any changes in their values are offset by changes in the values of the underlying exposures. Derivative financial instruments are held solely as risk management tools and not for trading or speculative purposes. The related cash flow impacts of all of our derivative activities are reflected as cash flows from operating activities.
We are required to recognize all derivative instruments as either assets or liabilities at fair value in the balance sheet. As permitted, certain of these derivative contracts have been designated for hedge accounting treatment. Certain of our derivatives that do not qualify for hedge accounting are effective as economic hedges. These derivative contracts are likewise required to be recognized each period at fair value and therefore do result in some level of volatility. The level of volatility will vary with the type and amount of derivative hedges outstanding, as well as fluctuations in the currency and interest rate markets during the period. The related cash flow impacts of all of our derivative activities are reflected as cash flows from operating activities.
By their nature, all derivative instruments involve, to varying degrees, elements of market and credit risk. The market risk associated with these instruments resulting from currency exchange and interest rate movements is expected to offset the market risk of the underlying transactions, assets and liabilities being hedged. We do not believe there is significant risk of loss in the event of non-performance by the counterparties associated with these instruments because these transactions are executed with a diversified group of major financial institutions. Further, our policy is to deal with counterparties having a minimum investment grade or better credit rating. Credit risk is managed through the continuous monitoring of exposures to such counterparties.
The current market events have not required us to materially modify or change our financial risk management strategies with respect to our exposures to interest rate and foreign currency risk. Refer to Note 14 – Financial Instruments in the Condensed Consolidated Financial Statements for further discussion and information on our financial risk management strategies.
Non-GAAP Financial Measures
We have reported our financial results in accordance with generally accepted accounting principles (GAAP). In addition, we have discussed our financial results using the non-GAAP measures described below. We believe these non-GAAP measures allow investors to better understand the trends in our business and to better understand and compare our results. Accordingly, we believe it is necessary to adjust several reported amounts, determined in accordance with GAAP, to exclude the effects of certain items as well as their related income tax effects.
A reconciliation of these non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are set forth below as well as in the third quarter 2019 presentation slides available at www.xerox.com/investor.
These non-GAAP financial measures should be viewed in addition to, and not as a substitute for, the Company’s reported results prepared in accordance with GAAP.
Adjusted Earnings Measures
Net income and Earnings per share (EPS)
Effective tax rate
The above measures were adjusted for the following items:
Restructuring and related costs: Restructuring and related costs include restructuring and asset impairment charges as well as costs associated with our transformation programs beyond those normally included in restructuring and asset impairment charges. Restructuring consists of costs primarily related to severance and benefits paid to employees pursuant to formal restructuring and workforce reduction plans. Asset impairment includes costs incurred for those assets sold, abandoned or made obsolete as a result of our restructuring actions, exiting from a business or other strategic business changes. Additional costs for our transformation programs are primarily related to the implementation of strategic actions and initiatives and include third-party professional service costs as well as one-time incremental

Xerox 2019 Form 10-Q
65


Table of Contents                                  
 

costs. All of these costs can vary significantly in terms of amount and frequency based on the nature of the actions as well as the changing needs of the business. Accordingly, due to that significant variability, we will exclude these charges since we do not believe they provide meaningful insight into our current or past operating performance nor do we believe they are reflective of our expected future operating expenses as such charges are expected to yield future benefits and savings with respect to our operational performance.
Amortization of intangible assets: The amortization of intangible assets is driven by our acquisition activity which can vary in size, nature and timing as compared to other companies within our industry and from period to period. The use of intangible assets contributed to our revenues earned during the periods presented and will contribute to our future period revenues as well. Amortization of intangible assets will recur in future periods.
Transaction and related costs, net: Transaction and related costs, net are expenses incurred in connection with Xerox's planned transaction with Fuji, which was terminated in May 2018, as well as costs and expenses related to the previously disclosed settlement agreement reached with certain shareholders and litigation related to the terminated transaction and other shareholder actions. These costs are considered incremental to our normal operating charges and were incurred or are expected to be incurred solely as a result of the planned combination transaction and the related shareholder settlement agreement and litigation. Accordingly, we are excluding these expenses from our Adjusted Earnings Measures in order to evaluate our performance on a comparable basis.
Non-service retirement-related costs: Our defined benefit pension and retiree health costs include several elements impacted by changes in plan assets and obligations that are primarily driven by changes in the debt and equity markets as well as those that are predominantly legacy in nature and related to employees who are no longer providing current service to the company (e.g. retirees and ex-employees). These elements include (i) interest cost, (ii) expected return on plan assets, (iii) amortization of prior plan amendments, (iv) amortized actuarial gains/losses and (v) the impacts of any plan settlements/curtailments. Accordingly, we consider these elements of our periodic retirement plan costs to be outside the operational performance of the business or legacy costs and not necessarily indicative of current or future cash flow requirements. This approach is consistent with the classification of these costs as non-operating in Other expenses, net. Adjusted earnings will continue to include the service cost elements of our retirement costs, which is related to current employee service as well as the cost of our defined contribution plans.
Restructuring and other charges - Fuji Xerox: We adjust our 25% share of Fuji Xerox’s net income for similar items noted above such as Restructuring and related costs and Transaction and related costs, net based on the same rationale discussed above.
Other discrete, unusual or infrequent items: We excluded the following items given their discrete, unusual or infrequent nature and their impact on our results for each period:
Contract termination costs - IT Services
Impacts associated with the Tax Cuts and Jobs Act (the "Tax Act") enacted in December 2017
We believe the exclusion of these items allows investors to better understand and analyze the results for the period as compared to prior periods and expected future trends in our business.
Adjusted Operating Income and Margin
We calculate and utilize adjusted operating income and margin measures by adjusting our reported pre-tax income and margin amounts. In addition to the costs and expenses noted as adjustments for our Adjusted Earnings measures, adjusted operating income and margin also exclude the remaining amounts included in Other expenses, net, which are primarily non-financing interest expense and certain other non-operating costs and expenses. We exclude these amounts in order to evaluate our current and past operating performance and to better understand the expected future trends in our business.
Constant Currency (CC)
Refer to "Currency Impact" for a discussion of this measure and its use in our analysis of revenue growth.
Summary
Management believes that all of these non-GAAP financial measures provide an additional means of analyzing the current period’s results against the corresponding prior period’s results. However, these non-GAAP financial measures should be viewed in addition to, and not as a substitute for, the Company’s reported results prepared in accordance with GAAP. Our non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures and should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP. Our management regularly uses our supplemental non-GAAP financial measures internally to understand, manage and evaluate our business and make operating decisions. These non-GAAP measures are

Xerox 2019 Form 10-Q
66


Table of Contents                                  
 

among the primary factors management uses in planning for and forecasting future periods. Compensation of our executives is based in part on the performance of our business based on these non-GAAP measures.
A reconciliation of these non-GAAP financial measures and the most directly comparable measures calculated and presented in accordance with GAAP are set forth on the following tables:
Net Income and EPS reconciliation:
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2019
 
2018
 
2019
 
2018
(in millions, except per share amounts)
 
Net  Income
 
EPS
 
Net  Income
 
EPS
 
Net  Income
 
EPS
 
Net Income
 
EPS
Reported(1)
 
$
221

 
$
0.96

 
$
89

 
$
0.34

 
$
535

 
$
2.27

 
$
224

 
$
0.83

Adjustments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Restructuring and related costs
 
27

 
 
 
29

 
 
 
176

 
 
 
91

 
 
Amortization of intangible assets
 
9

 
 
 
12

 
 
 
35

 
 
 
36

 
 
Transaction and related costs, net
 
4

 
 
 
(33
)
 
 
 
8

 
 
 
63

 
 
Non-service retirement-related costs
 
(2
)
 
 
 
33

 
 
 
21

 
 
 
83

 
 
Contract termination costs - IT services
 
(8
)
 
 
 

 
 
 
(8
)
 
 
 

 
 
Income tax on adjustments(2)
 
(7
)
 
 
 
(10
)
 
 
 
(55
)
 
 
 
(69
)
 
 
Restructuring and other charges - Fuji Xerox(3)
 

 
 
 
7

 
 
 
19

 
 
 
90

 
 
Tax Act
 
4

 
 
 
95

 
 
 
(31
)
 
 
 
95

 
 
Adjusted
 
$
248

 
$
1.08

 
$
222

 
$
0.85

 
$
700

 
$
2.97

 
$
613

 
$
2.33

Dividends on preferred stock used in adjusted EPS calculation(4)
 
 
 
$

 
 
 
$

 
 
 
$

 
 
 
$

Weighted average shares for adjusted EPS(4)
 
 
 
231

 
 
 
261

 
 
 
235

 
 
 
263

Fully diluted shares at end of period(5)
 
 
 
230

 
 
 
 
 
 
 
 
 
 
 
 
 ____________________________
(1)
Net income and EPS attributable to Xerox Holdings.
(2)
Refer to Effective Tax Rate reconciliation.
(3)
Other charges represent costs associated with the terminated transaction.
(4)
For those periods that exclude the preferred stock dividend, the average shares for the calculations of diluted EPS include 7 million shares associated with our Series A Convertible preferred stock, as applicable.
(5)
Represents common shares outstanding at September 30, 2019 as well as shares associated with our Series A Convertible preferred stock plus potential dilutive common shares as used for the calculation of diluted earnings per share for the third quarter 2019.

Xerox 2019 Form 10-Q
67


Table of Contents                                  
 

Effective Tax Rate reconciliation:
 
 
Three Months Ended September 30,
 
 
2019
 
2018
(in millions)
 
Pre-Tax Income
 
Income  Tax Expense
 
Effective
Tax Rate
 
Pre-Tax Income
 
Income  Tax Expense
 
Effective
Tax Rate
Reported
 
$
230

 
$
66

 
28.7
%
 
$
192

 
$
142

 
74.0
%
Non-GAAP Adjustments(1)
 
30

 
7

 
 
 
41

 
10

 
 
Tax Act
 

 
(4
)
 
 
 

 
(95
)
 
 
Adjusted(2)
 
$
260

 
$
69

 
26.5
%
 
$
233

 
$
57

 
24.5
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nine Months Ended September 30,
 
 
2019
 
2018
(in millions)
 
Pre-Tax Income
 
Income Tax Expense
 
Effective
Tax Rate
 
Pre-Tax Income
 
Income Tax Expense
 
Effective
Tax Rate
Reported
 
$
513

 
$
108

 
21.1
%
 
$
459

 
$
220

 
47.9
%
Non-GAAP Adjustments(1)
 
232

 
55

 
 
 
273

 
69

 
 
Tax Act
 

 
31

 
 
 

 
(95
)
 
 
Adjusted(2)
 
$
745

 
$
194

 
26.0
%
 
$
732

 
$
194

 
26.5
%
____________________________
(1)
Refer to Net Income and EPS reconciliation for details.
(2)
The tax impact on Adjusted Pre-Tax Income is calculated under the same accounting principles applied to the Reported Pre-Tax Income under ASC 740, which employs an annual effective tax rate method to the results.
Operating Income and Margin reconciliation:
 
 
Three Months Ended September 30,
 
 
2019
 
2018
(in millions)
 
Profit
 
Revenue
 
Margin
 
Profit
 
Revenue
 
Margin
Reported(1)
 
$
230

 
$
2,200

 
10.5
%
 
$
192

 
$
2,352

 
8.2
%
Adjustments:
 
 
 
 
 
 
 
 
 
 
 
 
Restructuring and related costs
 
27

 
 
 
 
 
29

 
 
 
 
Amortization of intangible assets
 
9

 
 
 
 
 
12

 
 
 
 
Transaction and related costs, net
 
4

 
 
 
 
 
(33
)
 
 
 
 
Other expenses, net
 
(3
)
 
 
 
 
 
57

 
 
 
 
Adjusted
 
$
267

 
$
2,200

 
12.1
%
 
$
257

 
$
2,352

 
10.9
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nine Months Ended September 30,
 
 
2019
 
2018
(in millions)
 
Profit
 
Revenue
 
Margin
 
Profit
 
Revenue
 
Margin
Reported(1)
 
$
513

 
$
6,695

 
7.7
%
 
$
459

 
$
7,297

 
6.3
%
Adjustments:
 
 
 
 
 
 
 
 
 
 
 
 
Restructuring and related costs
 
176

 
 
 
 
 
91

 
 
 
 
Amortization of intangible assets
 
35

 
 
 
 
 
36

 
 
 
 
Transaction and related costs, net
 
8

 
 
 
 
 
63

 
 
 
 
Other expenses, net
 
74

 
 
 
 
 
126

 
 
 
 
Adjusted
 
$
806

 
$
6,695

 
12.0
%
 
$
775

 
$
7,297

 
10.6
%
____________________________
(1)
Pre-Tax Income and Revenue.

Xerox 2019 Form 10-Q
68


Table of Contents                                  
 

ITEM 3 — QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The information set forth under the “Financial Risk Management” section of this Quarterly Report on Form 10-Q is hereby incorporated by reference in answer to this Item.
 
ITEM 4 — CONTROLS AND PROCEDURES
(a)Evaluation of Disclosure Controls and Procedures
Xerox Holdings Corporation
The management of Xerox Holdings Corporation evaluated, with the participation of our principal executive officer and principal financial officer, or persons performing similar functions, the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as of the end of the period covered by this report. Based on this evaluation, the principal executive officer and principal financial officer of Xerox Holdings Corporation have concluded that, as of the end of the period covered by this report, the disclosure controls and procedures of Xerox Holdings Corporation were effective to ensure that information that is required to be disclosed in the reports that is filed or submitted under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms relating to Xerox Holdings Corporation, including our consolidated subsidiaries, and was accumulated and communicated to the management of Xerox Holdings Corporation, including the principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. 
Xerox Corporation
The management of Xerox Corporation evaluated, with the participation of our principal executive officer and principal financial officer, or persons performing similar functions, the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as of the end of the period covered by this report. Based on this evaluation, the principal executive officer and principal financial officer of Xerox Corporation have concluded that, as of the end of the period covered by this report, the disclosure controls and procedures of Xerox Corporation were effective to ensure that information that is required to be disclosed in the reports that is filed or submitted under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms relating to Xerox Corporation, including our consolidated subsidiaries, and was accumulated and communicated to the management of Xerox Corporation, including the principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. 
(b)Changes in Internal Controls
Xerox Holdings Corporation
As required by paragraph (d) of Rule 13a-15 under the Exchange Act, we evaluated changes in our internal control over financial reporting during the last fiscal quarter. There were no changes identified in our internal control over financial reporting that occurred during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Xerox Corporation
As required by paragraph (d) of Rule 13a-15 under the Exchange Act, we evaluated changes in our internal control over financial reporting during the last fiscal quarter. There were no changes identified in our internal control over financial reporting that occurred during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
In March 2019, the Company entered into a shared services arrangement with HCL Technologies (HCL) pursuant to which we are outsourcing certain global administrative and support functions, including, among others, selected information technology, order to collection and finance functions (excluding accounting). The transition of these functions to HCL is expected to take up to 18 months. HCL is expected to make certain up-front and ongoing investments in software, tools and other technology to consolidate, optimize and automate the transferred functions. This arrangement is not in response to any identified deficiency or weakness in the Company’s internal control over financial reporting. In response to this arrangement, the Company has and will continue to align and streamline the design and operation of its financial control environment. Refer to Note 1 - Basis of Presentation in the Condensed Consolidated Financial Statements for additional information.


Xerox 2019 Form 10-Q
69


Table of Contents                                  
 

PART II — OTHER INFORMATION

ITEM 1 — LEGAL PROCEEDINGS
The information set forth under Note 22 – Contingencies and Litigation in the Condensed Consolidated Financial Statements of this Quarterly Report on Form 10-Q is incorporated by reference in answer to this item.
 
ITEM 1A — RISK FACTORS
Reference is made to the Risk Factors set forth in Part I, Item 1A of Xerox Corporation's 2018 Annual Report.

ITEM 2 — UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
(a)
Sales of Unregistered Securities during the Quarter ended September 30, 2019
During the quarter ended September 30, 2019, Xerox Holdings Corporation issued the following securities in transactions that were not registered under the Securities Act of 1933, as amended (the “Act”).
Dividend Equivalent:
a.
Securities issued on July 31, 2019: Xerox Holdings Corporation issued 1,133 deferred stock units (DSUs), representing the right to receive shares of Common Stock, par value $1 per share, at a future date.
b.
No underwriters participated. The shares were issued to each of the non-employee Directors of Xerox Holdings Corporation and to two former non-employee Directors of Xerox Corporation: Gregory Q. Brown, Jonathan Christodoro, Keith Cozza, Joseph J. Echevarria, Nicholas Graziano, Cheryl Gordon Krongard, Scott Letier and Sara Martinez Tucker.
c.
The DSUs were issued at a deemed purchase price of $35.335 per DSU (aggregate price $40,035), based upon the market value on the date of record, in payment of the dividend equivalents due to DSU holders pursuant to Xerox Holdings Corporation's 2004 Equity Compensation Plan for Non-Employee Directors.
d.
Exemption from registration under the Act was claimed based upon Section 4(2) as a sale by an issuer not involving a public offering.
    
(b)
Issuer Purchases of Equity Securities during the Quarter ended September 30, 2019
In connection with the reorganization of Xerox Corporation’s corporate structure into a holding company structure, in July 2019, Xerox Holdings Corporation’s Board of Directors authorized a $1.0 billion share repurchase program (exclusive of any commissions and other transaction fees and costs related thereto.) This program replaced the $1.0 billion of authority remaining under Xerox Corporation’s previously authorized $2.0 billion share repurchase program. Shares of Xerox Holdings Corporation’s common stock may be repurchased on the open market, or through derivative or negotiated transactions. Open-market repurchases will be made in compliance with the Securities and Exchanges Commission’s Rule 10b-18, and are subject to market conditions, as well as applicable legal and other considerations.
Repurchases of Xerox Holdings Corporation Common Stock, par value $1 per share include the following:
Board Authorized Share Repurchases Program:
 
Total Number of Shares Purchased
 
Average Price Paid per Share(1)
 
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2)
 
Maximum Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs(2)
July 1 through 31

 
$

 

 
$
1,000,000,001

August 1 through 31
1,248,036

 
27.84

 
1,248,036

 
965,254,865

September 1 through 30
1,080,900

 
30.24

 
1,080,900

 
932,569,534

Total
2,328,936

 
 
 
2,328,936

 
 
 ____________________________
(1)
Exclusive of fees and costs.
(2)
Of the cumulative $1.0 billion of share repurchase authority previously granted by our Board of Directors, exclusive of fees and expenses, approximately $67 million has been used through September 30, 2019. Repurchases may be made on the open market, or through derivative or negotiated contracts. Open-market repurchases will be made in compliance with the Securities and Exchange Commission's Rule 10b-18, and are subject to market conditions, as well as applicable legal and other considerations.

Xerox 2019 Form 10-Q
70


Table of Contents                                  
 

Repurchases Related to Stock Compensation Programs(1):
 
Total Number of Shares Purchased
 
Average Price Paid per Share(2)
 
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
 
Maximum That May Be Purchased under the Plans or Programs
July 1 through 31
278,910

 
$
36.21

 
n/a
 
n/a
August 1 through 31

 

 
n/a
 
n/a
September 1 through 30

 

 
n/a
 
n/a
Total
278,910

 
 
 
 
 
 
 ____________________________
(1)
These repurchases are made under a provision in our restricted stock compensation programs for the indirect repurchase of shares through a net-settlement feature upon the vesting of shares in order to satisfy minimum statutory tax-withholding requirements.
(2)
Exclusive of fees and costs.

ITEM 3 — DEFAULTS UPON SENIOR SECURITIES
None.

ITEM 4 — MINE SAFETY DISCLOSURES
Not applicable.

ITEM 5 — OTHER INFORMATION
None.

Xerox 2019 Form 10-Q
71


Table of Contents                                  
 

ITEM 6 — EXHIBITS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Xerox 2019 Form 10-Q
72


Table of Contents                                  
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
101
 
The following financial information from Xerox Holdings Corporation and Xerox Corporation's combined Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 was formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Xerox Holdings Corporation Condensed Consolidated Statements of Income, (ii) Xerox Holdings Corporation Condensed Consolidated Statements of Comprehensive Income, (iii) Xerox Holdings Corporation Condensed Consolidated Balance Sheets, (iv) Xerox Holdings Corporation Condensed Consolidated Statements of Cash Flows, (v) Xerox Corporation Condensed Consolidated Statements of Income, (vi) Xerox Corporation Condensed Consolidated Statements of Comprehensive Income, (vii) Xerox Corporation Condensed Consolidated Balance Sheets, (viii) Xerox Corporation Condensed Consolidated Statements of Cash Flows, and (ix) Notes to the Condensed Consolidated Financial Statements.
104
 
 The cover page from this Quarterly Report on Form 10-Q, (formatted as Inline XBRL and contained in Exhibit 101).


Xerox 2019 Form 10-Q
73


Table of Contents                                  
 

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, each registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. The signatures for each undersigned shall be deemed to relate only to matters having reference to such company and its subsidiaries.
XEROX HOLDINGS CORPORATION
(Registrant)
 
By:
/S/ JOSEPH H. MANCINI, JR.
 
Joseph H. Mancini, Jr.
Vice President and
Chief Accounting Officer
(Principal Accounting Officer)
Date: November 6, 2019

 
XEROX CORPORATION
(Registrant)
 
By:
/S/ JOSEPH H. MANCINI, JR.
 
Joseph H. Mancini, Jr.
Vice President and
Chief Accounting Officer
(Principal Accounting Officer)
Date: November 6, 2019
 

Xerox 2019 Form 10-Q
74


Table of Contents                                  
 

EXHIBIT INDEX
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Xerox 2019 Form 10-Q
75


Table of Contents                                  
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
101
 
The following financial information from Xerox Holdings Corporation and Xerox Corporation's combined Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 was formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Xerox Holdings Corporation Condensed Consolidated Statements of Income, (ii) Xerox Holdings Corporation Condensed Consolidated Statements of Comprehensive Income, (iii) Xerox Holdings Corporation Condensed Consolidated Balance Sheets, (iv) Xerox Holdings Corporation Condensed Consolidated Statements of Cash Flows, (v) Xerox Corporation Condensed Consolidated Statements of Income, (vi) Xerox Corporation Condensed Consolidated Statements of Comprehensive Income, (vii) Xerox Corporation Condensed Consolidated Balance Sheets, (viii) Xerox Corporation Condensed Consolidated Statements of Cash Flows, and (ix) Notes to the Condensed Consolidated Financial Statements.
104
 
 The cover page from this Quarterly Report on Form 10-Q, (formatted as Inline XBRL and contained in Exhibit 101).
 


Xerox 2019 Form 10-Q
76
Exhibit
EXHIBIT 31(a)(1)
Xerox Holdings Corporation


CEO CERTIFICATIONS
I, Giovanni Visentin, certify that:
1.
I have reviewed this Quarterly Report on Form 10-Q of Xerox Holdings Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
November 6, 2019
 
/S/  GIOVANNI VISENTIN
 
Giovanni Visentin
Principal Executive Officer
 



Exhibit
EXHIBIT 31(a)(2)
Xerox Corporation


CEO CERTIFICATIONS
I, Giovanni Visentin, certify that:
1.
I have reviewed this Quarterly Report on Form 10-Q of Xerox Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
November 6, 2019
 
/S/  GIOVANNI VISENTIN
 
Giovanni Visentin
Principal Executive Officer
 



Exhibit
EXHIBIT 31(b)(1)
Xerox Holdings Corporation

CFO CERTIFICATIONS
I, William F. Osbourn, Jr., certify that:
 
1.
I have reviewed this Quarterly Report on Form 10-Q of Xerox Holdings Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
November 6, 2019
/S/  WILLIAM F. OSBOURN, JR.
 
William F. Osbourn, Jr.
Principal Financial Officer
 



Exhibit
EXHIBIT 31(b)(2)
Xerox Corporation


CFO CERTIFICATIONS
I, William F. Osbourn, Jr., certify that:
 
1.
I have reviewed this Quarterly Report on Form 10-Q of Xerox Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
November 6, 2019
/S/  WILLIAM F. OSBOURN, JR.
 
William F. Osbourn, Jr.
Principal Financial Officer
 



Exhibit
EXHIBIT 32(a)
Xerox Holdings Corporation


CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. § 1350,
AS ADOPTED PURSUANT TO § 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Form 10-Q of Xerox Holdings Corporation, a New York corporation (the “Company”), for the quarter ended September 30, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Giovanni Visentin, Vice Chairman and Chief Executive Officer of the Company, and William F. Osbourn, Jr., Executive Vice President and Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, to the best of his/her knowledge, that:
 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/S/  GIOVANNI VISENTIN
 
Giovanni Visentin
Chief Executive Officer            
 
November 6, 2019
 
 
 
/S/  WILLIAM F. OSBOURN, JR.
 
William F. Osbourn, Jr.
Chief Financial Officer
 
November 6, 2019
 

This certification accompanies this Report pursuant to § 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of § 18 of the Securities Exchange Act of 1934, as amended.
A signed original of this written statement required by § 906 has been provided to Xerox Holdings Corporation and will be retained by Xerox Holdings Corporation and furnished to the Securities and Exchange Commission or its staff upon request.



Exhibit
EXHIBIT 32(b)
Xerox Corporation


CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. § 1350,
AS ADOPTED PURSUANT TO § 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Form 10-Q of Xerox Corporation, a New York corporation (the “Company”), for the quarter ended September 30, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Giovanni Visentin, Vice Chairman and Chief Executive Officer of the Company, and William F. Osbourn, Jr., Executive Vice President and Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, to the best of his/her knowledge, that:
 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/S/  GIOVANNI VISENTIN
 
Giovanni Visentin
Chief Executive Officer            
 
November 6, 2019
 
 
 
/S/  WILLIAM F. OSBOURN, JR.
 
William F. Osbourn, Jr.
Chief Financial Officer
 
November 6, 2019
 

This certification accompanies this Report pursuant to § 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of § 18 of the Securities Exchange Act of 1934, as amended.
A signed original of this written statement required by § 906 has been provided to Xerox Corporation and will be retained by Xerox Corporation and furnished to the Securities and Exchange Commission or its staff upon request.